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Abstract
Ischaemia results from the cessation of blood flow to all or part of the 
brain, causing a rapid depletion of O2 and impairment of oxidative 
phosphorylation. Bioenergetic failure follows within minutes, which 
precipitates directly immediate neuronal death. Upon reperfusion, despite 
the return of energy substrates, further neuronal death can occur up to 
several days later, depending on the severity of the initial insult. 
Astrocytes have been shown to be considerably more resistant to 
ischaemia/reperfusion injury than neurones and may play either a 
neuroprotective role or indeed exacerbate the neuronal injury. We have 
explored the possible interactions between astrocytes and neurones 
following ischaemia using an in vitro model of ischaemia/reperfusion 
injury, as a controlled environment that lends itself more easily to 
manipulation of the numerous variables involved in such an insult. As 
such we have produced an oxygen glucose deprivation model. We have 
constructed a chamber in which O2 can be lowered to a concentration of 
1pM. We have further developed a primary cortical neuronal culture that 
is >99% pure and which can survive to at least 10 days in vitro. We have 
additionally established a novel system for the co-culture of astrocytes 
and neurones in order to study the communication between these cells in 
a manner that can allow the complete separation of one cell-type from 
another. Astrocytes cultured alone do not exhibit signs of cell death 
during reperfusion of 24hrs duration following ischaemia of up to 2hrs 
whereas neuron cultures show profound cell death following an ischaemic 
period of only 15mins. We have co-cultured neurones, which have been 
subjected to a 15min ischemic insult, with either non-insulted astrocytes 
or astrocyte conditioned medium during the reperfusion stage. Results 
show that both astrocytes and astrocyte-conditioned medium enhance 
neuronal survival. We have finally investigated possible mechanisms to 
account for this.
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Chapter 1
1.1 Cerebral ischaemia
1.1.1 What is ischaemia?
To answer the question as simply as possible, ischaemia describes a 
situation where blood flow to an area of the brain is halted, thereby 
cutting the supply of vital nutrients and O2 to that area whilst also 
preventing the removal of waste products. As with every cell in the body, 
the cells that make up the brain generate and use ATP as their main 
energy source. But, more so than many other parts of the body, the brain 
is extremely dependent on the aerobic oxidation of glucose for the 
generation of its ATP. To put this in context, the brain’s O2 requirement 
accounts for around 20% of total consumption yet it accounts for only 2% 
of body mass. However, there is a huge disparity between the amount of 
0 2 and glucose required by the brain and the amount stored by the brain 
which is very little (Fiskum 1986). A perturbation in blood flow has the 
immediate effect of interrupting energy production by oxidative 
phosphorylation and leaves the brain with only a less than four-minute 
window of ATP usage (Fiskum 1983) after which the effects to the 
individual can be devastating and long lasting.
1.1.2 Causes of ischaemia
Cerebral ischaemia can occur due to a wide variety of disease states and 
insults such as stroke, head injury or cardiac arrest. Although the 
aetiology may vary, the cellular events are very similar and the insult 
generally falls in to either of two categories, focal or global. Global 
ischaemia describes the situation in which the blood supply to the entire 
brain is terminated, such as may happen following a cardiac arrest. In 
focal ischaemia only a particular brain area is effected which may be the 
case following the occlusion of specific blood vessels due for example to 
clot formation. The induction of ischaemia in laboratory animals is based 
upon reproducing either of these two events.
Focal ischaemia is usually induced by the occlusion of the middle 
cerebral artery (MCA). This is generally done in one of three ways. A 
ligature can be applied to the appropriate artery, blood can be induced to
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coagulate chemically, or drugs that have vasoconstrictive properties can 
be injected in to the animal. Recently the ‘macrosphere model’ has been 
introduced in which spheres of 0.3-0.4mm diameter are placed inside the 
MCA to cause a blockage (Gerriets et al 2003). Particles of smaller size 
but greater number have also been used to specifically block major 
arteries (Oshikawa et al 2004). Global ischaemia can be induced by the 
occlusion of two or more of the main vessels supplying the brain, usually 
branches of the carotid artery. This is normally carried out by injecting a 
hypertensive agent coupled with partially occluding the feeder artery (Fig 
1 .1).
Middle cerebral artery
Vertebral artery
Common carotid artery
Arch of aorta
Fig 1.1 Main arteries of the brain. The figure illustrates the main arteries of the brain, 
which are often targets of occlusion. Adapted from
http://stroke. upmc.com/Overview.htm.
1.1.3 Patterns of ischaemic damage
The development of ischaemic damage can be divided into two phases, 
one mediated directly by early events during the ischaemic period itself 
and one mediated by knock on events such as the production of free 
radicals (both described later). An ischaemic insult may be permanent or 
it may be followed by a period of reperfusion during which blood flow is
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returned to the injured area. Most injury, and most of the mediators of 
secondary damage, is observed during the reperfusion period. However, 
precisely how well the brain survives is mostly dependent upon the length 
of the ischaemic period.
Delayed death is a particular feature of global ischaemia. A sublethal 
global insult (generally less than 30mins) will result in immediate 
bioenergetic failure and loss of ion homeostasis in the entire brain. At this 
point not all cells are affected equally and it is observed that cell death 
occurs chiefly in neuronal populations (Lipton 1999). Reperfusion 
stimulates an apparent return to normal function, which is only briefly 
sustained in certain ‘vulnerable’ regions of the brain. Here, death is seen 
to occur several days later concomitant with a secondary energy failure, 
but in a cell specific manner (Horn et al 1992). This phenomenon, called 
delayed neuronal death, was first described in pyramidal cells of the CA1 
hippocampal area (Kirino 1982) but has since been observed in other cell 
groups, such as the CA2 and CA3 hippocampal regions and layers of the 
cortex, as a function of insult length and severity (Pulsinelli et al 1982, 
Cervos-Navarro et al 1991). Precisely how this phenomenon occurs is a 
topic of much research.
Although classical ‘delayed death’ is associated with global insults, focal 
ischaemia too is marked by cell death for considerable periods of time 
following ischaemia. Severe focal ischaemia (60-120mins) usually results 
in the development of a core region consisting of damaged cells of all 
types. This area represents the part of the brain formerly supplied by the 
occluded vessel and the mass of damage is called the infarct. The 
surrounding area, the penumbra, shows a graded decrease in cell loss 
with distance from the core and these cells can die up to several hours 
after the insult. The longer the ischaemic period however, the greater is 
the spread of the infarct during reperfusion (Memezawa et al 1992). 
There is generally a sharp division between the mass of damaged cells at 
the core and the surrounding area, as the glia present swell and 
proliferate to wall off the area in a process called anisomorphic gliosis
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(Liberto et al 2004). Very brief focal insults (15mins) are similar to global 
insults in that they can produce a smattering of vulnerable dead cells in 
the core rather than a huge generalised infarct (Li et al 1995).
1.1.4 Type of ischaemic cell death
The measurement of cell death during and after ischaemia is an 
important benchmark of ischaemic damage, so much so that the strength 
of an ischaemic insult and the efficacy of therapeutics is gauged by the 
level and type of death induced. The initial in vivo studies on cell death 
established two distinct classifications, apoptosis and necrosis, to reflect 
the observation that physiological and pathological cell death, 
respectively, appeared morphologically different from each other. 
Apoptosis was first described by Kerr et al in 1972, according to a 
number of structural features. The dying cell separates from its 
neighbours, undergoes condensation of the cytosol and of nuclear 
chromatin, nuclear fragmentation, plasma membrane blebbing, cell 
shrinkage and ultimately phagocytosis, leaving no evidence of its 
previous existence (Wyllie 1997, Carmody et al 1998). In sharp contrast 
to this, cells undergoing necrosis suffer severe membrane disruption, 
swell and lyse, often triggering a damaging immune response (Nicotera et 
al 1999).
Apoptosis is a controlled energy dependent process, which highlights the 
fact that the apoptotic cell is trying to remove itself with minimum damage 
to its surroundings. It is often called a ‘programmed’ cell death, as there 
are a number of dedicated signalling cascades activated by the process 
involving transcription of nuclear factors, release of signalling molecules 
and the activation of specific proteases. Most importantly, up to a point, 
apoptosis is not necessarily an all or nothing event and so inhibitors of 
apoptosis have been shown to prevent cell death. Particularly, inhibitors 
of caspases, the proteases responsible for effecting death (Wyllie 1997).
Necrosis on the other hand lacks the surgical removal observed following 
the apoptotic dissection of a cell. Instead, there is a marked drop in ATP
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level such that ionic gradients can no longer be maintained. This is 
followed by membrane depolarisation, Ca2+ entry and the activation of 
lipases and proteases, all of which culminates in severe membrane 
disruption and the leakage of the cell’s content, as mentioned previously 
(Nicotera etal 1999).
Death observed in an infarcted area during the ischaemic insult has been 
described as necrotic. Apoptosis is an energy requiring process and there 
is insufficient energy to support it under extreme ischaemic conditions. 
On the other hand death during the reperfusion phase and delayed 
neuronal death in particular, are often described as being apoptotic due 
to evidence of the activation of caspases (Love 2003) but the issue is 
muddied somewhat.
It has become clear that ischaemic cell death does not fall neatly into 
either category, as morphological and biochemical characteristics of each 
can be found following both global and focal insults (Graham et al 2001, 
Lipton 1999). Two schools of thought have thus emerged on this topic. 
First that necrosis and apoptosis form the poles between which there is a 
broad continuum of death type (Hou et al 2002, Martin et al 1998) and 
second that necrosis masks an underlying apoptotic process (Benchoua 
et al 2001, Gwag et al 1995).
1.1.5 Early events of ischaemia
Here we describe the events that occur in direct response to the lack of 
blood flow to a particular area. These events are common to focal and 
global insults and are not in themselves damaging but will trigger a 
cascade of damaging events that will precipitate cell death if blood supply 
is not returned in a timely manner.
1.1.5.1 Inhibition of electron transport
As alluded to previously, the brain produces most of its ATP by the 
process of oxidative phosphorylation, which takes place in the 
mitochondrion. To summarise, glucose is metabolised in the cytoplasm
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to pyruvate, which is then transported into the mitochondrion where it is 
oxidised to CO2 and H20 . Reducing equivalents are removed from the 
sequential degradation of glucose molecules and passed via the electron 
transport chain to awaiting 0 2 molecules. The energy released in 
sending these equivalents from molecules with positive redox potential to 
negative redox potential (0 2), is used to generate a proton gradient 
across the inner mitochondrial membrane. The electro-chemical energy 
stored in the gradient is used to drive the generation of ATP from ADP 
and Pi. Under normal conditions it is estimated that over 95% of ATP is 
synthesised in neurones via oxidative phosphorylation, with very little 
lactate produced (fig 1.2).
Clearly, the immediate effect of ischaemia is to inhibit the activity of the 
electron transport chain and ATP production by oxidative 
phosphorylation. There is only enough 0 2 stored in the vasculature to 
support the generation of ATP via oxidative phosphorylation for a few 
seconds (Hansen AJ 1985) however it takes around 90 secs of ischaemia 
for ATP to fall to its lowest levels (Katsura et al 1993). This is mainly 
because neurones have stores of phosphocreatine from which ATP can 
be produced.
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Succinate Fumarate
Intermembrane
space
H+
NADH ADP + P
Matrix
Fig 1.2 Electron transfer chain. Reducing equivalents are passed from NADH and succinate to complex I and II respectively. Electrons are then 
transferred to co-enzyme Q (Q) which transports electrons through the lipid bilayer to complex III. Electrons are then transferred to cytochrone C (C) which 
moves along the outside of the inner membrane to complex IV. Complex IV then catalyses the reduction of molecular 0 2. Protons (H+) are extruded to the 
inner membrane space at complexes I, III and IV. The gradient created by the extrusion of H+ is used to drive the synthesis of ATP at complex V. Lack of 0 2 
prevents electron flow at complex IV, highlighted in red. (Based on principles explained in Lehninger et al).
H+
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1.1.5.2 Loss of ion homeostasis
Loss of ATP is first seen as a disturbance in active ion transport and thus 
membrane polarisation. Ion pumping consumes around 50% of ATP 
produced at rest but this percentage rises during increased activity 
(Hansen 1985). Different cells have been shown to exhibit either a 
hyperpolarisation or a depolarisation at around 1min of ischaemia, 
depending on the dominant conductances in the cell type. However, 
most neurones do exhibit an increase in K+ conductance leading to a 
slow rise in extracellular [K+] (Martin et al 1994). When ATP levels fall 
sufficiently low the ‘anoxic depolarisation’ follows. This is suggested to 
result principally from a failure of the Na+/K+ ATPase at the plasma 
membrane (Rossi et al 2000). This enzyme not only consumes the 
largest amount of ATP but also is very sensitive to ATP decrease due to 
its very low apparent Km for ATP (0.4-0.7mM), the regulatory and 
catalytic sites both bind ATP with the regulatory site having the lower 
apparent Km (Erecinska et al 2001). The anoxic depolarisation therefore 
sees all neurones in the effected area collectively depolarise rapidly and 
significantly at around 4mins of ischaemia (Hansen 1985). At this time 
there are large reductions in extracellular Ca2+, Na+ and Cl' ions.
1.1.5.3 Acidosis
At 15secs of ischaemia, intracellular pH has been shown to drop to 
around 6.5 (Hansen 1985). This actually precedes the anoxic 
depolarisation and occurs at a time when the ATP levels are still rather 
high. The most likely explanation for the decrease in pH is again directly 
related to the inhibition of oxidative phosphorylation. It is suggested that 
continued functioning of the glycolytic pathway results in lactate 
accumulation (Lipton 1999). The lactate produced would then cause the 
amount of HCO3' to be lowered and CO2 to increase. The buffering 
capacity of the cell is compromised and intracellular H+ produced cause 
the drop in pH (Tombaugh et al 1993).
Reperfusion returns a significant amount of function to the cell if blood 
flow is restored within around 30mins (Nowak et al 1985, Pulsinelli et al
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1983). In fact it is thought that damage sustained during the ischaemic 
period is not irreversible but only becomes so as reperfusion progresses 
(Sims et al 2002). Because this thesis is based around the development 
of damage during reperfusion, the next two sections will focus largely on 
processes that may cause cerebral damage. Global and focal insults will 
be described simultaneously for ease of reference but events specific to 
either will be clearly demarcated, as will any references to in vitro studies.
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1.2 Ischaemia and excitotoxicitv
The process of excitotoxicity is a major point of study in the field of 
ischaemic research. As a result this section is designed to introduce the 
reader to the phenomenon and to detail evidence of the process in the 
evolution of ischaemic damage.
1.2.1 Glutamate in the CNS
An introduction to the world of glutamate will invariably start with a 
statement of the fact that it is the principal excitatory neurotransmitter in 
the central nervous system. And it is, but glutamate’s sphere of influence 
extends far beyond the brain to every other cell in the body, as it is an 
essential component of protein synthesis and intermediary metabolism. 
However, despite its necessity to the maintenance of life, glutamate is in 
fact a very potent neurotoxin at high concentrations. Lucas and 
Newhouse first suggested this in 1957, following their observations that 
glutamate overexposure could destroy part of the mouse retina. The 
observation has grown in to a field of study and it has been shown time 
and again that glutamate release is responsible for a significant amount 
of neuronal death relating to cerebral ischaemia (Choi et al 1990). The 
toxic effects of glutamate do not stop at neuronal populations as has 
been demonstrated by Chen et al (2000) who show that astrocytes too 
can be damaged albeit by a predominantly different mechanism.
1.2.2 Glutamate release
It has been estimated that neuronal cytosolic glutamate concentration is 
around 5mM, that of astrocytes is around 3mM, while the extracellular 
space has a resting glutamate concentration of around 2pM at the very 
most (Nedergaard et al 2002, Anderson et al 2000). Extracellular levels 
are kept low by glutamate cellular uptake, which is chiefly accomplished 
by the Na+ dependent excitatory amino acid transporters (EAATs) of 
which there are five identified subtypes (EAAT1-5). EAAT1 and EAAT2 
are predominantly glial whereas the other three are neuronal (O’Shea 
2002). EAATs have also been found on oligodendrocytes, microglia and
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endothelia (Anderson et al 2000). These transporters function by moving 
one molecule of glutamate, three molecules of Na+ and one H+ in to the 
cell and one K+ out (Barbour et al 1988). The activation of the EAATs is 
also associated with a Cl" conductance (Wadiche et al 1995).
During ischaemia, [glutamate] in the extracellular space has been shown 
to rise to 20-fold or even around 40-fold its original concentration in some 
experimental preparations. The immediate increase in [glutamate] is 
most likely due to Ca2+ dependent exocytosis but the bulk thereafter is 
due to reversal of the EAATs as the driving force for glutamate uptake in 
to cells (the Na+ gradient) is diminished (Rossi et al 2000).
Feustal et al (2004) suggest that glutamate release in less severely 
ischaemic areas is due mainly to the activation of volume-regulated 
organic anion channels. This is not a likely route of release in an 
ischaemic core as the process is ATP dependent. Indeed, it has been 
shown that the inhibition of these anion channels can occur as a result of 
inhibiting mitochondrial respiration (Patel et al 1998), which is likely to be 
prevalent in the core. It could however play a part in glutamate release 
during the reperfusion period.
1.2.3 Receptor mediated ischaemic damage
Glutamate works as a signalling molecule by binding to two 
pharmacologically and functionally distinct receptor classes at the plasma 
membrane. These are the metabotropic glutamate receptors (mGluR) 
and the ionotropic glutamate receptors (iGluR). Excessive glutamate 
release causes over activation of these receptors. Overstimulation leads 
to an intracellular accumulation of ions such as Ca2+ and Na+ and 
messengers such as inositol-1,4,5-trisphosphate (IP3) and diacylglycerol 
(DAG) (Choi 1990) which mediate the toxic effects of glutamate.
1.2.3.1 Ionotropic receptors
The iGluRs activate ligand gated ion channels and are grouped in to 
three separate families named according to agonist specificity. These
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comprise of the NMDA (N-methyl-D-aspartate), AMPA (a-amino-3- 
hydroxy-5-methylisoxazole-4-propoinate) and kainate receptors. Each 
family assumes a heteromeric structure composed of a number of 
subunits whose particular combination of assembly is dependent on 
tissue type and stage of development. NMDA receptor channels have 
seven subunits (NR1, NR2A-D, and two NR3) and are highly permeable 
to Ca2+and Na+. They also have a voltage-dependent Mg2+ block and 
require glycine as a co-agonist. The particular combination of NR1 and 2 
subunits will determine not only the agonist affinity but also the sensitivity 
of the Mg2+ block and single-channel conductance. AMPA channels have 
four subunits (GluR1-4) and kainate channels have five (GluR5-7, KA1 
and KA2) and are both permeable to Na+ and K+(Dingledine et al 1999, 
Madden 2002). AMPA receptors are also permeable to Ca2+ unless 
there is at least one GluR2 subunit present.
The NMDA receptors have received the most attention in terms of 
glutamate toxicity as antagonists to this receptor class were first shown to 
have possible neuroprotective effects (Simon et al 1984). Goldberg and 
Choi (1993) showed that activation of NMDA receptors could mediate an 
influx of Na+ and Cl" ions and the movement of water that mediates early 
cell swelling. Furthermore they showed that delayed cell death was due 
to Ca2+ entry via NMDA receptor channels. In fact it is this relationship 
between Ca2+ influx and cell death that has gained most notoriety for the 
NMDA receptors. Although the swelling effects related to Na+ are 
important, Ca2+ has been shown to be the main mediator of neuronal 
death (Kristian et al 1996). Rossi et al (2000) have linked glutamate 
release via reversed transport to the initiation of the anoxic 
depolarisation. In their hippocampal slice preparation, they have 
proposed a feed forward mechanism whereby NMDA receptor activation 
depolarises the cell, releasing more glutamate and K+, to activate more 
NMDA receptors and so on.
AMPA receptors have been implicated in ischaemic neuronal death 
directly and indirectly. Indirectly, AMPA receptors can contribute to Ca2+
29
Chapter 1
influx by depolarising the membrane in a Na+ dependent manner and 
thus removing the Mg2+-dependent block on the NMDA receptors. 
Brorson et al (1994) first suggested that, at least in the cerebellum, Ca2+ 
entry via AMPA/(Kainate) channels could mediate excitotoxicity. Recent 
work by Liu et al (2004) suggests that the lack of expression of the NR2 
subunit is responsible for selective CA1 region hippocampal cell death 
following transient forebrain ischaemia, as greater Ca2+ permeability 
results. Oguro et al (2004) support this idea by correlating neuronal 
death following OGD, at different stages of development, with NR2 
expression.
Kainate receptors are far less studied than either AMPA or NMDA 
receptors. It is thought that kainate channels may not play a major role in 
glutamate excitotoxicity as they are rapidly desensitized (Wilding et al 
1997) and have very limited Ca2+ permeability. Again, Na+-mediated 
membrane depolarisation has been postulated to be the only contribution 
made by kainate channels towards excitotoxicity.
1.2.3.2 Metabotropic receptors
The mGluRs are G-protein coupled receptors of which there are at least 
eight types divided into three groups. Group I mGluRs include mGlul 
and mGlu5, which have five and two splice variants respectively. They 
are coupled to the Gaq protein and so mobilize intercellular Ca2+ through 
the activation of phospholipase C. Group II mGluRs comprise mGlu2 
and 3 whereas group III includes mGlu4, 6, 7 and 8 (each with splice 
variants). Groups II and III are coupled to the Ga; protein and so act to 
inhibit the formation of cyclic adenosine monophosphate (cAMP) (Jingami 
et al 2003, Pin et al 2002, Pin et al 1995, Bruno et al 2001).
The mGluRs, specifically mGluRI and 5, have been implicated in the 
neurotoxicity of glutamate but are thought to have a more modulatory role 
(Bruno et al 2001). Conflicting results have emerged showing that they 
can both attenuate and exacerbate the toxic effects mediated by the 
iGluRs (Pizzi et al 1996, Bruno et all 995).
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1.2.4 Ca2+ dysregulation
One of the most salient features of ischaemia, both during the actual 
insult and the following reperfusion period, is a very large increase in 
intracellular Ca2+ (Lipton 1999). Ca2+ based cell signalling is very tightly 
regulated and contributes to a very wide range of cellular events from 
activation of proteases to secretion events to cell division. The capacity 
of the cell to buffer Ca2+ is very important in modulating the spikes and 
waves that constitute Ca2+ signalling such that they can be decoded in 
the correct manner. Clearly, both severe increases and decreases will 
derail such signalling and have pathological potential. There is a very 
steep gradient in Ca2+ concentration across the plasma membrane (mM 
to pM) but there are also a number of gradients existing between the 
cytosol and intracellular compartments such as mitochondria and the 
endoplasmic reticulum (ER). So, the cytosolic level and profile of Ca2+ is 
dependent on, and has influences upon, a number of sources.
The rise in intracellular Ca2+ during ischaemia is predominantly due to 
entry via NMDA receptor channels as discussed. It has been shown that 
intracellular Ca2+ stores also contribute to the cytosolic rise particularly 
due to Calcium-induced-calcium release (CICR) and IP3 stimulation at the 
ER (Verkhratsky et al 2003).
So how does Ca2+ mediate cell death? Mitochondrial Ca2+ overload may 
be one of the key factors in translating the rise in cytosolic Ca2+ to cell 
damage during reperfusion at least. Under physiological conditions, 
uniporters in the mitochondrion can transport Ca2+ from the cytosol when 
levels are raised particularly when Ca2+ is released from the ER, given 
the close apposition of ER and mitochondrial membranes (Rizzuto et al
2000). Na+/Ca2+ exchangers also exist to bring Ca2+ back to the cytosol. 
In fact reversal of these exchangers has been documented during 
hypoxia leading to a rise in mitochondrial Ca2+ (Griffiths et al 1998). It is 
unlikely that the transporter functions to increase mitochondrial Ca2+ 
during severe ischaemia, as its function requires the mitochondrial 
membrane potential. However, a number of groups have catalogued an
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increase in mitochondrial Ca2+ at the onset of reperfusion suggesting an 
import of cytosolic Ca2+ as mitochondrial function returns (Zaidan et al 
1994). Levels of Ca2+ usually return to normal following global ischaemia 
but there is a second large mitochondrial influx later in the reperfusion 
period concomitant with delayed energy failure and death in certain cells 
(Kristian et al 1998).
The importance of mitochondrial accumulation was suggested when 
inhibition of mitochondrial Ca2+ uptake proved to be protective during an 
excitotoxic insult despite a continuing accumulation of cytosolic Ca2+ 
(Stout et al 1998). Ca2+ uptake at its most profound is accompanied by 
mitochondrial membrane depolarisation and induction of the permeability 
transition pore, which mediates the release of a number of pro-apoptotic 
factors (Duchen 1999). Inside the mitochondria, Ca2+ activates a number 
of key enzymes in the TCA cycle and can thus stimulate increased 
metabolism. The increases in Ca2+ during reperfusion, when the cell is in 
a considerably more oxidised state, could therefore result in the 
overproduction of mitochondrially generated reactive oxygen species 
(ROS). The consequence of this will be discussed later.
In the cytosol, Ca2+ accumulation has potentially toxic consequences as a 
result of the sustained activation of a number of key enzymes: The 
protease calpain has been shown to cause cytoskeletal breakdown 
following both focal and global ischaemia (Neumar et al 2001, Liebetrau 
et al 2004); endonucleases have been shown to cause DNA 
fragmentation (Tominaga et al 1993); phospholipase A2 is associated 
with injury following ischaemia (Tabuchi et al 2003) due to arachidonic 
acid formation and an accumulation of ROS (Adibhatla et al 2003). For a 
more comprehensive introduction to the role of Ca2+ in neuronal death 
see Paschen (2003) and references within.
1.2.5 Na+
NMDA receptors have been suggested to mediate cell damage via Na+ 
entry (Goldberg et al 1986). Beck et al (2003) have also demonstrated
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the possibility that Na+ and indeed Cl- entry via the Na-K-CI cotransporter 
isoform 1 (NKCC1) can mediate early excitotoxic damage. The 
accumulation of these ions would result in the marked cell swelling that is 
evident during ischaemia.
33
Chapter 1
1.3 Ischaemia and oxidative stress
1.3.1 Oxidative stress
Oxidative stress describes the situation where the cell’s anti-oxidant 
capacity is compromised either by the excess production of damaging 
oxidizing species or the down-regulation of endogenous anti-oxidant 
systems. Either way, the cell is incapable of inactivating oxidizing agents 
such as reactive oxygen species (ROS) and a host of damaging events 
ensues. Oxidative stress has been implicated in neuronal death following 
both global ischaemia (Hayashi et al 2003) and focal ischaemia (Saito et 
al 2004). In fact the brain is particularly vulnerable to this type of insult 
due to its large O2 consumption, high levels of polyunsaturated fatty acids 
and a surprising dearth of antioxidant defenses compared to the rest of 
the body (Floyd 1999, Juurlink et al 1997).
1.3.2 Evidence of oxidative stress in ischaemia
The production of free radicals, particularly radical O2 species, is a major 
contributor to oxidative stress. Areas of the brain that are severely 
ischaemic do not contain 0 2 so ROS formation is largely a phenomenon 
of reperfusion. However, infiltration of ROS from penumbral regions 
following a focal insult may produce a certain amount of damage during 
the ischaemic period. The events that occur during ischaemia very nicely 
set the stage for ROS production during reperfusion and it is at this point 
that oxidative stress becomes evident and damaging. In fact ROS have 
been shown to elevate very rapidly, in a burst like manner, at the onset of 
reperfusion (Dirnagl et al 1995, Kumura et al 1996) as O2 availability 
returns.
There is evidence of hydroxyl radical (OH) formation during focal 
ischaemia (Ste-Marie et al 2000) and indeed evidence of a progressive 
increase in superoxide ion (O2") during reperfusion following a focal 
ischaemic insult (Mori et al 1999). It has also been shown that the core of 
the lesion produces far more OH than the penumbra and as such 
correlates well with damage (Liu et al 2003). One of the most highly toxic
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of the ROS is peroxynitrite (ONOO'), which is formed when O2' reacts 
with NO. It is extremely membrane permeable and so has the potential to 
spread its damaging effects a distance from its source of production.
In demonstration of the type of damage ROS can do, peroxynitrite can 
peroxidate lipids, hydroxylate and nitrate aromatic residues of proteins 
and nucleotides and can also cause DNA strand breaks (Thiyagarajan et 
al 2004). Evidence of increased peroxynitrite production following 
ischaemia has been documented in a number of laboratories and indeed 
its reduction has been shown to be neuroprotective (Hattori et al 2002, 
Thiyagarajan et al 2004a, Nagai et al 2002).
1.3.3 Origin of radical species
As mentioned previously, a number of events occur during ischaemia 
which prepare the way for massive ROS production at the onset of 
reperfusion. The production of radical species therefore, has its true 
origins during the ischaemic event. We will discuss just a few of these.
There are a number of mechanisms by which ROS are thought to be 
produced. First of all the mitochondrion is particularly adept at producing 
O2' . Under normal circumstances there is a certain amount of electron 
‘leak’ from the respiratory chain and so molecular 0 2 is not completely 
converted to H20  but instead produces O2' (Turrens 1997). This is 
thought to result from the addition of electrons via complexes I and III 
particularly (Kudin et al 2004). During ischaemia the complexes of the 
respiratory chain become very reduced and so conditions are ripe for 
extra ‘leak’ and ROS production on the return of O2 at the start of 
reperfusion.
The O2' anion itself is not particularly membrane permeable but H2O2, 
produced by mitochondrial manganese-superoxide dismutase (MnSOD) 
activity, is and so can leave mitochondria (Raha et al 2000). H2O2 may 
also be converted to OH and OH' in the presence of reduced iron (Fe2+) 
through the Fenton reaction:
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Fe2+ + H20 2 ->■ Fe3+ + OH + OH'
The brain contains a very large amount of iron, so is particularly disposed 
to the production of these extremely reactive species.
As mentioned in section 1.3.2, oxidizing species cause a significant 
amount of direct damage to biological molecules. Another major 
consequence of the induction of oxidative stress is the opening of the 
permeability transition pore in mitochondria and the release of 
cytochrome c and other pro-apoptotic factors (Chernyak et al 1996). 
Inhibiting the opening of the pore has in fact been shown to reduce 
neuronal death following global ischaemia (Abe et al 2004) and focal 
ischaemia (Oshikawa et al 2004).
The enzyme xanthine oxidase (XO) has also been attributed with the 
generation of free radicals. Normally XO exists as a dehydrogenase 
(XDH) and both enzyme forms convert hypoxanthine to urate. However 
only XO actually produces O2' in the process. XDH is converted to XO 
during ischaemia by a proteolytic process (Lipton 1999). The substrate 
of the reaction hypoxanthine also accumulates during ischaemia due to 
adenosine monophosphate breakdown (Parkinson et al 2002) so again 
upon reperfusion a lot of O2' can result. Ghoneim et al (2002) support 
the idea that the XO reaction is a contributor to ROS production, as 
discussed, by inhibiting the XO-XDH conversion during ischaemia.
Nitric oxide (NO) is another radical species that is generated following 
ischaemia. NO is produced by the nitric oxide synthase (NOS) family of 
enzymes from the oxidative metabolism of arginine. There are three 
principal isoforms, neuronal NOS (nNOS), endothelial NOS (eNOS) and 
the glial inducible NOS (iNOS). All three isoforms are found to be 
upregulated following ischaemia (Bolanos et al 1999). NO can be directly 
harmful to proteins and lipids but can also produce the even more harmful 
ONOO' molecule.
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1.3.4 Antioxidant systems and neuroprotection
The brain houses a number of systems with which to cope with the 
generation of oxidants. Clearly the burst in ROS production during 
reperfusion will heavily burden the systems in place. How efficient an 
antioxidant system the cell has, or how quickly a cell can turnover its 
antioxidants, will therefore determine the extent of damage. This is made 
all the more critical when the antioxidant systems themselves become 
targets of the radical species produced by the cell. The development of 
damage during ischaemia has been correlated with the failure of 
antioxidants and is thought to contribute to the selective vulnerability seen 
in the brain.
1.3.2.1 Antioxidant enzymes
As mentioned above, 0 2‘ is constantly produced by mitochondria under 
normal physiological conditions. This is usually disposed of by 
superoxide dismutase (SOD), which dismutates 0 2' to produce H20 2 and 
0 2. There are three SOD isoforms, Cu/Zn SOD (cytosolic), MnSOD 
(mitochondrial) and extracellular SOD. There is much evidence 
supporting a neuroprotective role for these enzymes following ischaemia. 
Fujimara et al (1999) showed, using MnSOD knockout mice that this 
isoform attenuates mitochondrially-mediated apoptosis following focal 
ischaemia. This group has also shown that the overexpession of Cu/Zn 
SOD is neuroprotective following the same insult (Fujimara et al 2000). 
SOD mimetics have also been used successfully to achieve 
neuroprotection at least in young rat brains following a hypoxic period 
(Shimizu et al 2003). There is some evidence linking the lack of 
upregulation of both Cu/Zn SOD and MnSOD following ischaemia to 
vulnerability to delayed death (Takeutchi et al 2000). Furthermore Chan 
et al (1998) have shown that overexpression of Cu/Zn SOD protects CA1 
neurones following global ischaemia.
The H20 2 formed by SOD is scavenged by the enzymes catalase (CAT), 
found in peroxisomes, and glutathione peroxidase (GSHPx), found in the
37
Chapter 1
cytosol and mitochondria, which essentially terminate the toxic effects of 
02 " .
CAT, which decomposes H2O2 to O2 and H2O, is expressed constitutively 
at comparatively low levels in neurones and so GSHPx is very important 
for detoxifiying H2O2. Chen et al (2000a) have shown that the activities 
of CAT, GSHPx and indeed MnSOD are all increased in late reperfusion 
following ischaemia. Interestingly, Homi et al (2002) have shown that 
vulnerable regions such as the hippocampus show a more marked decay 
in CAT activity than areas that are resistant, early in the reperfusion 
phase following global ischaemia. This may indeed contribute to 
selective vulnerability later on as these cells have further to go to match 
the general increase in ROS mentioned earlier.
GSHPx detoxifies H2O2 at the expense of glutathione (GSH), which is 
considered to be the cell’s major antioxidant. The overexpression of 
GSHPx has been shown to be neuroprotective following ischaemia 
(Hoehn et al 2003, Ishibashi et al 2002). In support of these findings, the 
GSHPx mimetic ebselen has also been shown to reduce oxidative 
damage following ischaemia (Imai et al 2003). Li et al (2002) have further 
attributed the protective effects of spiramine T in ischaemia-reperfusion 
injury in part to an upregulation of GSHPx. Finally, transgenic mice 
deficient in cytosolic GSHPx show exaggerated injury in response to 
ischaemia/reperfusion (Crack et al 2001 and 2003).
1.3.4.2 Antioxidant molecules
GSH is the principal antioxidant molecule in the brain and is present at 
mM concentrations within the cell (Dringen 2000). It is synthesised in two 
steps, first, glutamate and cysteine (cys) are combined to form y- 
glutamyl-cysteine (yGluCys) by the enzyme yGluCys synthetase and then 
glycine is added by the enzyme GSH synthetase. GSH can work to 
directly scavenge ROS nonenzymatically or as a substrate of GSHPx. 
The product is either the oxidised form of glutathione (GSSG) or protein- 
glutathione mixed disulfides. GSSG can then be recycled to GSH by the
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enzyme glutathione reductase (GR) at the expense of NADPH (Dringen 
et al 2000).
Fig 1.3 GSH metabolism. This figure highlights the main enzymes in GSH metabolism 
concerned with this discussion; yglutamylcysteine synthetase (1); glutathione synthetase 
(2); glutathione peroxidase (3); glutathione reductase (4).
The role of GSH in oxidant scavenging is supported most obviously by 
the recordings of its decline during the reperfusion period, when ROS are 
reported to flourish (Shivakumar et al 1995). In culture, the actions of 
ROS-generating excitotoxins have been shown to depend on intracellular 
GSH level (Ceccon et al 2000, Parihar et al 2003). Curiously, extracellular 
GSH has been shown to be neuroprotective both in vivo and in vitro (Cho 
et al 2003) but it has also been suggested to exacerbate ischaemia- 
related neuronal injury in culture by reducing the redox site of the NMDA 
receptor (Regan et al 1999a and b).
It has been shown that a specific reduction of brain GSH with inhibitors of 
its biosynthetic pathway leads to the elevation of ROS (Gupta et al 2000) 
and renders the brain far more sensitive to ischaemic injury (Mizui et al
1992). This has also been observed in astrocyte cultures during 
aglycaemia (Papadopoulos et al 1997). The corollaries of these 
experiments are those that show increasing cellular GSH to be protective 
against oxidative stress. Sola et al (1996) showed that fructose-1,6- 
bisphosphate is protective in a model of ischaemia and have gone on to
Glu + Cys
yGluCys
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show that this is due to a preservation of cellular GSH as a result of 
NADPH being made available for the GSH reductase reaction (Vexler et 
al 2003). However, it should be mentioned that GSH depletion is actually 
neuroprotective in some situations. Vanella et al (1993) deplete GSH 
24hrs before ischaemia-reperfusion and conclude it to be 
neuroprotective. Yang et al (1995) have produced evidence that this 
effect is mediated by decreased glutamate release.
We have already mentioned that mitochondria are the principal source of 
ROS following ischaemia. Fittingly the GSH content of this organelle is 
very important in determining the extent to which ROS can harm the cell. 
Anderson et al (2002) have observed that the development of tissue 
infarction following focal ischaemia is associated with changes in the 
mitochondrial GSH pool. They have recently added to this by showing 
that specific increase of mitochondrial GSH is neuroprotective in the 
same injury (Anderson et al 2004 a and b). Such an observation has also 
been made in vitro as Huang et al (1996) show that specific reduction of 
mitochondrial GSH in astrocyte cultures leaves them highly susceptible to 
injury. The link between mitochondrial protection and GSH levels is 
further strengthened by Makarov et al (2002). They show that there is a 
threshold level of cellular GSH below which further, ischaemia-induced 
depletion and mitochondrial damage is exaggerated.
Ascorbate, like GSH, is present in the brain at mM concentrations and is 
also assumed to be an important antioxidant. Interestingly, unlike GSH, 
ascorbate concentrations are greater in neurones than in astrocytes (Rice 
et al 1998, Berger et al 2003). Ascorbate cannot be synthesised in the 
brain by mammals and in fact cannot be synthesised at all by humans 
(Rice 2000) so it must therefore be consumed in the diet and transported 
into the cells of the brain. This task is primarily achieved by the Na+ 
dependent vitamin C transporter 2 (SVCT2) and once inside, any 
oxidised ascorbate must be recycled using endogenous reducing 
molecules (Tsukaguchi et al 1999). Ascorbate can also be transported in 
heteroexchange with glutamate and via a glucose transporter, both of
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which we will refer again to later (Cammack et al 1991, Rebec et al 1994, 
Vera et al 1993).
In its actions as an antioxidant, ascorbate can be fully oxidised to 
dehydroascorbate but the loss of only one of its two electrons results in 
the formation of the ascorbyl radical, which is itself, a marker of oxidative 
stress (Rice 2000). With respect to ischaemia, ascorbate release to the 
extracellular space has been recorded as an early event of focal 
ischaemia and global ischaemia-reperfusion (Crespi 1996 Yusa 2000). It 
has been shown to be neuroprotective through a number of experiments.
Administration of ascorbate reduced infarct size following focal ischaemia 
in a primate model (Henry et al 1998). Evidence suggests that its actions 
in preventing neuronal damage are due to free radical scavenging 
(Perez-Pinzon et al 1997, McGregor et al 1996). However it has also 
been shown that ascorbate attenuates NMDA receptor mediated insults 
through a direct redox modulation of the receptor (Majewska et al 1990, 
Bell et al 1996). However, although Perez-Pinzon (1997) demonstrate 
neuroprotection in a hippocampal slice, Stamford et al (1999) claim that 
ascorbate is not protective in the hippocampus but is in the striatum 
following global ischaemia. In fact, apart from having no action in some 
conditions ascorbate has been shown to have pro-oxidant actions in 
others. This story will be picked up again in section1.4.
The final antioxidant molecule we will mention is a-tocopherol (vitamin E), 
which is derived from vegetable oils, taken up in the intestine and 
distributed throughout the body where it forms part of the cell’s 
membranes. As such it has been shown to be crucial in protecting 
membrane lipids from peroxidation (Herrera et al 2001). Cellular uptake 
of a-tocopherol is mediated, at least in culture, by the scavenger receptor 
class B type I (SR-B1) (Mardones et al 2002). It is a potent antioxidant 
with proven neuroprotective effects following cerebral ischaemia 
(Yamamoto et al 1983, Hara et al 1990, Tagami et al 1999, Chaudhary et 
al 2003, Sikorska et al 2003). Analogues of a-tocopherol have likewise 
been used to attenuate infarction following ischaemia (Van der Worp
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1999, Cowley et al 1996). The brevity of this section is testament to the 
fact that a-tocopherol is not as well explored as other antioxidant 
molecules and indeed there is no evidence to suggest that ischaemia 
targets a-tocopherol uptake and distribution in any way.
1.4 Astrocytes and ischaemia
As an information-processing unit, the brain must be considered to be the 
sum of its parts, it cannot work efficiently (or at all) unless all its 
constituent cells are present. As such, neurones are no longer 
considered to be the sole components of networks in the brain, even if 
fast synaptic transmission is the accepted tool of brain function, as it has 
become abundantly evident that each cell type has evolved its own 
specialized function that contributes to the regulation and fine-tuning of 
each and every processed signal. The death, or indeed damage of glia 
will affect neurones and fast synaptic signalling and it is with this in mind 
that the following section will be presented. Only the role of astrocytes 
will be described, as these are the best-characterised glia to date with 
respect to ischaemia-reperfusion. We will begin however by illustrating 
the critical role astrocytes play in the brain in the form of a case study of 
the glutamate system.
1.4.1 Astrocyte-neurone partnership
Astrocytes and neurones are intimately linked by the glutamate system 
on a number of levels and it is the study of this system that has 
uncovered the true importance of astrocytes. First of all astrocyte EAATs 
are the main scavengers of glutamate from the synaptic cleft (Anderson 
et al 2000) and so play an important role in the modulation and fine tuning 
of synaptic transmission. Pfrieger et al (1997) and Oliet et al (2001) have 
neatly demonstrated the importance of glial presence to the efficacy of 
synaptic transmission and specifically the role played by glutamate 
clearance in this process. Further to this, astrocyte glutamate uptake is 
also important to the regulation of ‘spillover’ and thus intersynaptic 
crosstalk (Barbour et al 1997, Mitchell et al 2000, Piet et al 2004).
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Beyond a direct role in synaptic transmission glutamate forms a metabolic 
link between astrocytes and neurones. Glutamate is produced in the 
mitochondrial matrix following the transamination of a-ketoglutarate, a 
TCA-cycle intermediate, by the action of glutamate dehydrogenase. This, 
and the neurotransmitter pool, can be subsequently used to produce 
glutamine in a reaction catalysed by glutamine synthetase. These two 
amino acids are essential in providing nitrogen for the synthesis of 
proteins, nucleic acids and a host of other molecules. However neurones 
lack the enzyme glutamine synthetase and so do not have the capacity to 
generate their own glutamine. They therefore rely on astrocytes to 
convert their glutamate to glutamine and export it back to the neurone 
(Hertz et al 1999) (fig 1.4).
Glutamate uptake has been shown to alter astrocyte metabolism. 
Transport of neuronal derived glutamate by astrocytes has been 
suggested to increase glycolytic rate and the subsequent release of 
lactate for neurones to use as fuel, at least in vitro (Pellerin et al 1994, 
Magistretti et al 1999). The relevance of this ‘lactate-shuttle’ hypothesis 
as it is called is however hotly debated as it has yet to be shown that 
such a system functions in vivo (See Dienel et al 2004 and Pellerin et al 
2004 for a detailed argument).
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Fig1.4 Likely metabolic coupling. This figure highlights the points of metabolic exchange between astrocytes and neurones. Both cells synthesise ATP in 
the mitochondrion through oxidative phosphorylation. Both cells also produce glutamate via the tricarboxylic acid cycle (TCA) however only astrocytes can 
synthesise glutamine, which they shuttle to neurones. Included is the transfer from astrocytes to neurones, which has been shown in culture.
(Based on principles in Hertz et al 1999).
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The story does not stop simply with the uptake of glutamate. Astrocytes 
have been shown to express a number of glutamate receptor subunits 
(Nedergaard et al 2002). In fact Cornell-Bell et al (1990) showed for the 
first time that applied glutamate was capable of inducing Ca2+ waves in 
astrocytes, an observation that was repeated later with neuron derived 
glutamate in vitro (Dani et al 1992, Porter et al 1996) and most recently in 
vivo (Hirase et al 2004). Interestingly, a consequence of these Ca2+ 
waves is the release by astrocytes of glutamate, amongst other 
molecules, that can feedback to the neuron (Parpura et al 1994, Pasti et 
al 1997). The idea of a feedback system is elegantly demonstrated by 
Dziedzic et al (2003) in the neuroendocrine system. They have 
suggested that neuronal glutamatergic signaling stimulates an erbB- 
related back signal from the astrocyte resulting in the release of 
luteinizing hormone-releasing hormone (LHRH) from neurones.
The precise mechanisms of glutamate release from astrocytes remain to 
be fully elucidated. We have just described the existence of a Ca2+ 
dependent glutamate release and it has been suggested that a vesicle- 
mediated mechanism, similar to neurones may be at least partly 
responsible. In fact Bezzi et al (2004) have recently established, quite 
convincingly that astrocytes house glutamate vesicles containing 
vesicular glutamate transporters (VGLUTs) that undergo SNARE (soluble 
NSF attachment protein receptors) dependent fusion and glutamate 
release. Release has also been shown to occur through volume- 
sensitive organic anion channels (VSOACs), which also allow the 
passage of aspartate and taurine down their concentration gradients 
(Kimelberg et al 1990, Feustal et al 2004) and which may or may not be 
Ca2+ related. It has recently been suggested that glutamate may be 
released through connexin hemichannels (Ye et al 2003). As has 
previously been discussed glutamate is also released due to reverse 
operation of the Na+ glutamate transporters during ischaemia but no role 
has yet been evidenced for this mechanism to exist under normal 
physiological conditions (Barbour et al 1998, Rossi et al 2000).
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1.4.2 Fate of astroglia
Ischaemic cell death is not the preserve of neuronal populations, as 
astrocytes and other glia have also been shown to die following 
ischaemic insults. Liu et al (1999) report astrocyte death to precede 
neuronal death during permanent focal ischaemia. Petito et al (1998) 
showed that not only are glia susceptible to ischaemic damage but that 
oligodendrocytes are even more susceptible than neurones in certain 
regions. Microglia on the other hand have been reported to show a high 
degree of resistance to ischaemia thought to be on a par with astrocytes 
(Yenari et al 2001). Loss of glia will directly affect neurones, for example 
oligodendrocyte death will result in demyelination and defective synaptic 
transmission (Dewar et al 2003, Tanaka et al 2001). The spotlight is 
often shone on microglia and macrophages because of the neurotoxic 
substances they secrete during and after ischaemia (Banati et al 1993, 
Mabuchi et al 2000).
Astrocytes have been shown to be far more resilient than neurones to 
ischaemic insults in culture (Almeida et al 2002), furthermore two of the 
most interesting phenomena of ischaemia, delayed death and selective 
vulnerability, were largely considered to be sole features of neurones. 
These facts coupled with the long held opinion that astrocytes (and glia 
generally) were inconsequential bystander cells in the brain led to glia 
being ignored for quite a while. However, astrocytes too exhibit a 
regional and type-specific vulnerability. Zhao et al (2000) show, in culture, 
that hippocampal astrocytes are more sensitive than cortical astrocytes to 
02-glucose deprivation (OGD). Whereas Lukaszevicz et al (2002) show 
that protoplasmic astrocytes are more prone to ischaemic injury than 
fibrous astrocytes.
It was mentioned in section 1.1.3 that glia respond to severe focal 
ischaemia in a process called anisomorphic gliosis. This results in the 
formation of a ‘glial scar’, the wall that surrounds the infarct, and the 
release of a number of neurotoxic molecules as the glia become 
‘activated’. As part of the glial scar activated astrocytes are more
46
Chapter 1
correctly called reactive astrocytes although this terminology isn’t widely 
acknowledged. The appearance of activated/reactive astrocytes is one of 
the most salient features of ischaemia (Gabryel et al 2001). These 
astrocytes exhibit marked hypertrophy and proliferation and show an 
increase in the cytoskeletal proteins GFAP and vimentin (Petito et al 
1990, Kunkler et al 1997). Astrocyte processes also become elongated 
particularly in the area surrounding the infarction (Kajihara et al 2001). 
Although reactive gliosis is attributed with the production of a number of 
neurotoxic molecules, reactive astrocytes may not in themselves be 
harmful, as reactive microglia appear to be the major source of 
neurotoxins (Liberto et al 2004). In less severe ischaemia, there is also a 
general astrocyte upregulation of antioxidant enzymes such as SOD and 
GSHPx and a host of growth and signaling factors (Liu et al 1993 and see 
Gabryel et al 2001 for extensive list). Such a reaction is considered 
beneficial to surrounding neurones and this type of astrocyte is 
considered to be activated (Liberto et al 2004).
1.4.3 The role of gap junctions
Astrocytes signal extensively between themselves and can in fact be 
considered to exist as part of a glial syncytium as they are intimately 
connected to both other astrocytes and oligodendroglia via gap junctions 
(Dermietzel et al 1993, Altevogt et al 2004). Gap junctions are composed 
of protein channels, which directly link the cytoplasm of one cell with that 
of another allowing the passage of ions and molecules of up to 1kDa 
such as Ca2+ and inositol trisphosphate. Each channel is composed of 
two connecting channels called connexons, one contributed by either cell. 
Each connexon is then made of connexins, which belong to a family of 
highly related proteins. Connexins show a regional expression pattern 
with Cx43 being particularly prominent in astrocytes (Nagy et al 2001). 
Neurones too have been shown to express the connexin proteins that 
make up the gap junction channels (Rash et al 2000) and there is 
evidence that they can form gap junctions with themselves and with 
astrocytes (Duan et al 2004, Nedergaard 1994).
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An illustration of the extent to which astrocytes are capable of 
communicating is seen in Ca2+ mediated signaling. We have already 
mentioned the findings that Ca2+ waves have been shown to spread 
through astrocyte layers in culture and indeed in vivo. This has been 
shown to occur via gap junctions directly (Charles 1998) but also 
indirectly via the release of ATP through hemichannels (half a gap 
junction, leading to the extracellular space) and subsequent activation of 
purinergic receptors (Stout et al 2002).
Gap junctions have roles in processes other than signalling for example 
the maintenance of ion homeostasis. Astrocytes are very important in 
maintaining and restoring extracellular ion concentrations after sustained 
neuronal activity. They are involved in limiting extracellular [K+] and 
redistributing it through gap junctions to other cells in a process called 
spatial buffering (Karwoski et al 1989). Extracellular [H+] and thereby pH 
is also controlled by astrocyte uptake (Deitmer et al 1996).
Ion uptake and redistribution via gap junctions is not always considered to 
be a positive step. For example, it has been suggested to contribute to 
ischaemic spreading depression in focal ischaemia (Nedergaard et al
1993). This is a process whereby depolarization of neurones spreads in a 
wave-like manner from the ischaemic core. The Ca2+ ion has received 
particular attention in this regard due to the multiplicity of intracellular 
processes it is involved in. There is evidence for and against the spread 
of Ca2+ waves through astrocytes as a mechanism for propagating 
spreading depression. Peters et al (2003) seem to have resolved this by 
showing that the velocity of the Ca2+ wave through astrocytes is 
dependent on spreading depression but that it is propagated in a different 
manner.
The role of astrocyte gap junctions in ischaemic injury is somewhat of a 
grey area. Gap junction communication can be disrupted by high levels 
of Ca2+, low pH and the generation of ROS conditions (Martinez et al
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2000), which abound after ischaemia. But what effect does this have on 
cell survival?
Lian et al (2004a and b) support the view that astrocytes are involved in 
regulating K+ and Ca2+ concentrations during spreading depression but 
they claim that astrocyte dysfunction, and the inability to redistribute ions, 
exacerbates neuronal damage to this type of insult. Nakase et al (2003) 
also demonstrate increased penumbral damage in ischaemic mice 
deficient in connexin43, a major astrocyte gap junction protein. Similarly 
Blanc et al (1998) have shown that astrocyte gap junctions reduced 
neuronal vulnerability to oxidative stress in culture. However, Lin et al 
(1998) argue that gap junctions provide a route by which pro-death 
signals can be propagated from one cell to another implicating them in 
the production of secondary injury following ischaemia. In support of this 
hypothesis Frantseva et al (2002) show in hippocampal slices that 
knockdown of both astrocyte and neuronal connexin subtypes inhibits 
ischaemic cell death. With respect to gap junctions in other cell types, 
Oguro et al (2001) link an increase in neuron and oligodendrocyte 
specific connexins with selective neuronal resistance following global 
ischaemia.
Clearly the contribution of gap junctions to ischaemic injury is a 
complicated one. Contreras et al (2002) show that, in culture, ischaemia- 
like conditions promote the opening of hemichannels. This may marry 
the previous observations, as the proportion of full channels versus 
hemichannels that are open could vary under different conditions in 
different cell types and thus produce different injury profiles.
1.4.4 Antioxidant support
Another fine example of how heavily neurones, and indeed some other 
brain cells rely on astrocytes, is in the role they play as part of the brain’s 
antioxidant defence system. As mentioned previously, the generation of 
ROS is a major cause of cell damage following ischaemia. The burden 
largely falls upon astrocytes as to whether the outcome of a ROS insult is
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positive or negative. This is due to the intimate redox coupling between 
astrocytes and neurones centered on the molecules GSH and ascorbate.
We have shown that GSH is protective against ischaemic neuronal 
damage but what part do astrocytes play? First of all astrocytes are 
thought to have a more efficient GSH system than neurones. Culture 
studies suggest that not only do they have much higher levels of GSH 
immediately available but also much higher levels of the crucial enzymes 
involved in GSH metabolism (Wilson 1997, Makar et al 1994). For 
example, Almeida et al (2002) have shown that astrocytes in culture 
could use their glucose from their glycogen stores to generate NADPH, 
via the pentose phosphate pathway, in order to recycle GSH during 02- 
glucose deprivation, rendering them more resistant than neurones.
Astrocytes are therefore more competent to deal with ROS but also 
support ROS scavenging in neurones especially as ascorbate, the 
dominant antioxidant in neurones, is not synthesized by the neurones. It 
is conceivable that astrocytes may relieve neurones of some stress by 
offering themselves as an alternate target for ROS attack, using their 
endogenous GSH directly (Chen et al 2001) or indeed GSH released 
from the astrocytes may itself act as a scavenger extra-cellularly (Cho et 
al 2003).
Astrocytes do in fact support the levels of GSH found in neurones 
(Dringen et al 2000) and it has been shown that cultured neurones have 
very low levels of GSH unless they are in coculture with astrocytes 
(Sagara et al 1993). Dringen et al (1999) have suggested that astrocytes 
in culture release GSH, which is cleaved by the ectoenzyme y-glutamyl 
transpeptidase to produce Cys-Gly, which is then used by neurones to 
make GSH under some conditions. Wang et al (2000) suggest that the 
released GSH is used to generate Cysteine from Cystine and is then 
taken up by neurones. In either event, neurones cultured with astrocytes 
are far more resistant to attack by ROS than neurons cultured alone 
(Tanaka et al 1999). Going one step further astrocytes, which have been
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depleted of GSH, lose their ability to help co-cultured neurones (Chen et 
al 2001).
The GSH system also plays a part in the recycling of ascorbate to form a 
single redox cycling unit. Astrocytes in culture have been shown to 
recycle dehydroascorbic acid to ascorbate, in a GSH dependent manner. 
But more importantly it is suggested that they can then release this 
ascorbate to the extracellular space for neurones to take up (Siushansian 
et al 1997, Wilson 1997). Dehydroascorbate treatment has been shown 
to reduce ischaemic injury in vivo following a focal insult (Huang et al
2001) but dehydroascorbate cannot itself scavenge free radicals, it must 
be converted to ascorbate first. This would therefore suggest an 
important role for astrocytes in shuttling converted dehydroascorbate to 
neurones, as ascorbate, to elicit the beneficial effects.
The role of astrocytes is further strengthened by Wilson et al (2000) who 
provide evidence that astrocytes in culture release ascorbate via 
glutamate activated ascorbate channels in response to application of 
extracellular glutamate. The implication is that such a system exists to 
prevent oxidative stress during physiological glutamate signalling, and 
further during excitotoxicity.
When it is working properly, the astrocyte-neurone redox system is 
clearly effective at maintaining neuronal viability. However, the oxidative 
stress that follows ischaemia can sour the relationship and astrocytes can 
exacerbate neuronal damage. GSH depletion in mixed cultures has 
actually been shown to affect glial GSH levels more than neuron levels 
(Keelan et al 2001). Furthermore Mytilineou et al (1999) have shown that 
glia actually mediate neuronal injury following GSH depletion in culture.
With respect to ascorbate, it is at this point that we can rejoin the 
recounting of ascorbate as a pro-oxidant. Song et al (2001) suggest that, 
in vitro, dehydroascorbate uptake is toxic to neurones cultured on their 
own. It is thought to be transported in to the cell via the glucose
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transporter GLUT-1 (Patel et al 2001); once inside it is converted to 
ascorbate but this process uses up endogenous antioxidants and so 
excess uptake leads to oxidative stress (Song et al 2002). Oxidative 
stress reduces the ability of astrocytes to take up dehydroascorbate 
(Daskalopoulos et al 2002), which leaves more around for neuronal 
uptake. Interestingly, very high levels of ascorbate have been shown to 
disrupt glucose transporters (Patel et al 2001), which may have adverse 
effects on astrocyte metabolism during ischaemia.
See figure 1.5 for an illustration of astrocyte-neurone redox coupling.
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Fig 1.5 Redox coupling. This figure is an overview of the fate of antioxidant cycling between astrocytes and neurones. Ascorbate (Asc) is taken up 
by astrocytes and neurones by SVCT2, and oxidised to dehydroascorbate (DeAsc). Dehydroascorbate can be recycled to ascorbate at the expense of GSH. 
Astrocytes release both ascorbate and GSH for eventual neuronal uptake. GSH is released via MRP proteins and is cleaved by yglutamyl transpeptidase. 
Cys-gly is cleaved by neuronal PEPT2. Included is the point at which pentose phosphate-derived NADPH fits in to GSH synthesis. (Based on principles in 
Dringen et al 2000)
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1.4.5 Secretion of other neuromodulatory substances
We have already seen the bi-directional communication between 
astrocytes and neurones from the point of view of just one signaling 
system, glutamate. Astrocytes do however release a whole host of other 
molecules that modulate neuron function and indeed the function of other 
cell types. These include neurotrophins such as nerve growth factor 
(NGF) and brain derived neurotrophic factor (BDNF), both on neuronal 
demand (Galv-Roperh et al 1997, Mizuta et al 2001, Wu et al 2004); 
inflammatory cytokines such as interleukin-6 (IL-6) and tumour necrosis 
factor (TNF) (Acarin et al 2000); and finally chemokines such as 
erythropoietin (Epo) (Ruscher et al 2002). Astrocytes have also been 
shown to release molecules such as cholesterol, which reportedly affects 
neuronal glutamate transport (Canolle et al 2004).
Ischaemia also increases the astrocyte production of cytokines such as 
tumour necrosis factors, interleukins and interferons as they become 
activated (Dong et al 2001). The ultimate effects on neuronal survival of 
this reaction is mixed. IL-6 for example is suggested to be 
neuroprotective against excitotoxic insults (Pizzi et al 2004) and Matsuda 
et al (1996) demonstrated its ability to prevent CA1 neuronal loss 
following ischaemia. However, another pro-inflammatory cytokine TNF-a 
is suggested to mediate neuronal death following ischaemia and 
excitotoxic insults (Liao et al 2002, Yu et al 2002). It remains to be 
determined precisely what role specific astrocyte release of these 
cytokines has in vivo.
One of the key features of astrocytes’ response to ischaemia is to induce 
expression of iNOS and thus release NO (Endoh et al 1993). As 
mentioned, NO is implicated in neuronal death following ischaemia. In 
fact astrocyte-derived NO from iNOS upregulation is suggested to have 
significant neurotoxic effects in culture following 0 2 -glucose deprivation 
(Hewett et al 1996). Furthermore, the expression of iNOS coincides with 
delayed neuronal death and as such this has been proposed as one of
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the factors implicated in the occurrence of this phenomenon (Yamashita 
et al 2000).
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1.5 Modelling ischaemia
An ischaemic insult can be modelled both in vivo and in vitro in a variety 
of different ways. We will concentrate on the detail of simulating 
ischaemia in vitro given that this is the thrust of the current thesis. For a 
comprehensive review on the use of whole animal systems, please see 
Lipton 1998.
1.5.1 Terminology
Ischaemia/reperfusion injury is a field of study that has been explored at 
many levels in vivo. When using an in vitro model however, protocol 
dictates that the insult be called oxygen-glucose deprivation 
(OGD)/reoxygenation, which neatly breaks the task of establishing the 
model into three parts. Oxygen must reach acceptably low levels, 
metabolic substrates must be eliminated and finally, the system must be 
returned to ‘normal’ conditions. A point to note is the use of the term 
‘glucose deprivation’. It has become the generic term for substrate 
deprivation as most groups actually deprive cells of glucose, amino acids, 
serum and any other metabolisable factors.
1.5.2 Simulating ischaemia
1.5.2.1 Oxygen deprivation
Without doubt, the most challenging part in simulating ischaemia is in the 
creation of a hypoxic environment. Hypoxia in cell culture is usually 
achieved by replacing atmospheric O2 with an inert gas mixture within an 
airtight chamber. Typically combinations of 95%N2/5% C02 or 
85%N2/5%CO2/10%H2 are used. Commercial units are available from 
companies such as Forma scientific and Don Whitely scientific, which 
consist of dedicated incubators equipped with temperature controlling, 0 2 
sensing and 0 2 scavenging systems. Some units have glove box access, 
which allows cultures to be manipulated within the anoxic environment. In 
such cases, the anoxic gas mixture can be efficiently bubbled through the 
culture media to remove 0 2. Excess 0 2 is then often mopped up by kits, 
which exploit the reaction between 0 2 and H2 in the presence of a Pd
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catalyst (GasPak, Beckton Dickinson) or the reaction between activated 
carbon and ascorbic acid (Anaerogen, Oxoid Ltd). These anaerobic 
chambers can be very expensive to buy and maintain and so a number of 
alternative approaches have been devised. Furthermore, the 
replacement of O2 with N2 is a relatively slow process in terms of 
producing a decline in ATP similar to in vivo hypoxia.
Some groups have bypassed the necessity for a dedicated airtight 
incubator by substituting N2 with Ar (Kusumoto et al 1996, Meloni et al
2001). Because of its high molecular mass, Ar not only replaces O2 far 
more quickly than N2 but it eliminates the requirement for a sealed 
chamber. Such a system is therefore ideal for real time analysis using, 
for example imaging systems. However, as with most alternatives there 
is a down side, Ar will replace not only O2 but also C02, which will upset 
the bicarbonate buffer system.
1.5.2.2 Chemical ischaemia
The elimination of environmental O2 can be completely bypassed. 
Elements of ischaemic damage can be simulated effectively by using 
metabolic inhibitors in lieu of O2 deprivation. This is generally done at 
either the level of the mitochondrial respiratory chain or the glycolytic 
pathway. Salts of CN' have been used to inhibit the cytochrome aa3 
complex (Erkkila et al 2003) and Antimycin A has been used to inhibit 
electron flow between cytochrome b and c1 (Jeong et al 2003) thus 
causing a decline in ATP similar to that observed in the absence of O2 in 
vivo. Glycolysis can be blocked through the use of iodoacetate, an 
inhibitor of glyceraldehyde dehydrogenase (Uto et al 1995). A popular 
approach has been to use 2-deoxy glucose which is an inhibitor of 
glycogen phosphorylase when metabolised to 2-deoxy-glucose-6- 
phosphate (Dringen et al 1993).
The inhibition of respiratory chain elements results in a rapid decline in 
ATP similar to the falls recorded in vivo, however there is evidence that 
the cell may react in a fundamentally different manner to inhibitors of
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oxidative phosphorylation and so the method is not as physiologically 
relevant as O2 replacement (Shin et al 2003). Furthermore, the 
chemicals used tend to have complicating side effects, for example, 
iodoacetate inactivates thiol-containing enzymes. Also, it is slightly more 
difficult to remove the inhibition and make sure these agents have been 
eliminated if studying reperfusion injury.
1.5.2.3 Substrate deprivation
Anoxia can be combined with the deprivation of metabolic substrates to 
fully achieve ischaemia. This may involve the simple removal of glucose, 
pyruvate, and any other compounds capable of feeding into the glycolytic 
pathway and citric acid cycle, from the incubating media (Pauwels et al 
1985) or it may involve the removal of all trophic support, such as growth 
factor-containing serum, as well (Xu et al 2001, Goldberg et al 1993).
1.5.2.4 O2 detection
If a model of hypoxia is to be used based on the withdrawal of O2, it is 
important to be able to measure the levels of 0 2 within the system of 
study. There are a number of options available, some of which suit 
different experimental set-ups better than others. A common approach 
has been to determine O2 concentrations polarographically which gives 
online real-time measurements of O2 tensions. Some companies have 
produced miniature electrodes specifically for dipping into fluids (eg. MI- 
730 from Microelectrodes inc., Licox MCB from Harvard Apparatus), 
others have produced a more traditional arrangement where the solution 
of study is placed in the electrode chamber (eg. 782 Oxygen meter from 
Strathkelvin Instruments) which can be housed within an anaerobic 
incubator with little in the way of accompanying cables.
A complete departure from the use of O2 electrodes is the use of 
immunohistochemistry based on the binding of nitroimidazole compounds 
to hypoxic tissue and cells (Raleigh et al 2001, Raleigh et al 1999, Arteel 
et al 1998). Such compounds are reductively activated and bind to 
macromolecules at low 0 2 tensions. This chemistry was initially used to
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track hypoxia related radiation resistance within tumours, but Koch et al 
(2002) have developed methods for measuring hypoxia within both 
culture and intact tissue based on EF5 (a nitroimidazole) binding. 
Although extremely accurate, this method gives a snap shot rather than a 
continuous assessment of O2 concentrations.
It is desirable to precisely quantify the amount of O2 present in a given 
system, yet it is not always practical to do so on every experimental run. 
For this reason some groups turn to the use of chemical indicators that 
will produce a simple colour change upon the elimination of O2. This 
approach is common practice amongst microbiologists working with 
anaerobic bacteria. Popular examples would be the GasPak methylene 
blue system from Beckton Dickinson or the Oxoid resazurin based 
indicator.
1.5.3 Ischaemia in culture
1.5.3.1 Existing culture systems
Tissue culture models now provide a means to dramatically reduce the 
number of variables inherent in the study of neuroscience and crucially, 
allow for the delineation of cellular and molecular events. In essence, 
culture techniques allow the individual threads of biological processes to 
be teased apart, manipulated and reassembled into a coherent 
understanding of brain function.
Organotypic slice cultures are a popular tool with which to create a model 
of ischaemia in culture. They effectively offer themselves as the next step 
down from animal models of ischaemia in terms of complexity, as the 
cartography of the brain is largely retained without the involvement of 
factors such as blood pressure and body temperature (Strasser et al 
1995, Pringle et al 1997, Laake et al 1999). Particularly, hippocampal 
and neocortical slice cultures exhibit the phenomena of delayed death 
and regional vulnerability (Bernaudin et al 1998), important aspects of 
ischaemia research.
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Dissociated ceil cultures take pride of place in the study of ischaemia in 
terms of model simplicity. Glia and neurone rich cultures from the 
neocortex (Goldberg et al 1993), striatum (Xu et al 2001), hippocampus 
(Khaspekov et al 1998) and cerebellum (Scorziello et al 2001) have all 
been used extensively to model 02-glucose deprivation. These cultures 
can be highly pure for neurones (Dugan et al 1995, Meloni et al 2002) or 
astrocytes (Zhao et al 2000) or contain a mixture of neurones and glia 
(Goldberg et al 1993).
1.5.3.2 Advantages of dissociated ceil cultures
Ischaemia has profoundly differing effects on different brain cell types 
from different regions. For example, in response to a global ischemic 
insult, neurones of the CA1 hippocampal sub-field are most vulnerable to 
death (Cervos-Navarro et al 1991). There is a significant body of research 
into the effects of ischaemia on whole brain preparations and slice 
systems, particularly in identifying vulnerable and resistant cell 
populations (Lipton 1999). Their chief advantage is in the maintenance of 
the brain’s architecture and a close approximation of the global 
consequences of ischaemia. However, much along the lines of the 
Heisenberg uncertainty principle, maintaining the networks of the brain 
means that only a limited amount of knowledge can be gained from 
individual cell types with respect to molecular and biochemical processes. 
To gain such information it is therefore more logical to create ischaemia 
within a homogenous cell population.
An important advantage of dissociated cultures over in vivo models and 
sometimes slice systems is the ease with which the cellular environment 
can be manipulated. Body temperature, blood flow and the vasculature 
generally become very important parameters during in vivo ischaemia. 
For example, a change in temperature of just 2°C can have a dramatic 
effect on injury outcome (Dietrich et al 1990) and so must be tightly 
controlled. There is considerable literature on the contribution of vascular 
damage, blood brain barrier permeability and blood flow to ischaemic 
damage (Ayata et al 2002, Croll et al 2001), illustrating that there are an
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incredible amount of components to consider when analysing ischaemic 
injury. Furthermore, when considering the application of drugs, delivery 
across the blood brain barrier to the correct place and at the most 
effective concentration, can be a problem for in vivo models (Partridge
2002). By using cell cultures one can, not only control factors such as 
temperature more easily, but also the application of drugs is greatly 
simplified.
1.5.3.3 Relevance of dissociated cultures
There is a vast amount of literature showing that the regional and cellular 
vulnerabilities to ischaemia found within the intact brain also exist in 
dissociated cell cultures: Scorziello et al (2001) show differential 
vulnerability of cortical and cerebellar neurone cultures deprived of O2 
and glucose; Xu et al (2001) show hippocampal astrocytes to be more 
sensitive to 0 2 -glucose deprivation than cortical astrocytes; Meloni et al 
(2001) have succeeded in modelling delayed neuronal death in culture. 
This clearly illustrates that an important component of ischaemic damage 
is dependent upon the cell’s identity and thus justifies the elimination of 
the compounding factors mentioned above.
1.5.3.4 Building a more complex model
Pure astrocyte and neurone cultures can be viewed as building blocks 
from which more complicated models can be constructed. They can be 
used to determine the components of cell injury that are a property of the 
cell itself. Or, by adding any combination of metabolites, toxins or other 
signalling elements directly to the media it can be determined how much 
cell survival depends on extrinsic factors. This is popularly done for 
example when studying the effects of glutamate toxicity (Ahlemeyer et al 
2003, Sinor et al 2000). More importantly, monocultures can be built into 
a coculture structure, thus replicating the cellular conversations occurring 
in vivo. Often, it is necessary for a number of signalling elements to pass 
to and fro between cell types before the critical signal is received (Kelic et 
al 2001).
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1.5.3.5 Existing Coculture models
Some coculture models are based simply upon the idea of seeding one 
cell type on top of another (Drukarch et al 1998) or on creating a 
heterogenous mixture (Goldberg et al 1993) such that different cells are 
in physical contact but as a consequence, inseparable. As such these 
methods are ideal for imaging studies where cell types can be identified 
and assayed on an individual basis (Keelan et al 2001), but not for 
biochemical study. A popular approach to achieving separability of 
cultures is to grow one cell type on a porous membrane that can be 
suspended over another cultured in tissue culture plates (Stewart et al 
2000, Kelleher et al 1996). In this instance, the porous membrane lies 
between the cell populations and so acts as a barrier to the diffusion of 
some molecules. The distance between the cells is also stretched to an 
average of 2mm. One group in particular has defied the barrier and 
indeed distance elements by placing the cell supporting membrane 
directly onto the awaiting cells in the culture plate such that the cells are 
facing each other (Chen et al 2001).
Another approach is to grow one group of cells on coverslips, which are 
placed directly into the culture wells and on to the awaiting cells (Ohgoh 
et al 2000). This may however cause some stress to the underlying cells. 
Some groups have inverted the coverslips so that, again the cells are 
facing each other, and allowed them to rest on paraffin end feet, creating 
a space between the cells (Bartlett et al 1984, Lamigeon et al 2001). A 
huge advantage of coculture systems is in being able to treat one cell 
without the other and then allowing the cells to interact (Chen et al 2001, 
Tamatani et al 1998).
We must end this introduction by acknowledging the fact that culture 
systems such as those described, do allow a large amount of 
controllability, however what is gained in controllability is lost in 
reproducing the complexity of the whole system. Clearly, a balance must 
be reached according to the questions being asked by what one is 
studying.
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1.6 Objectives
The main objective of this thesis is to test the hypothesis that ‘astrocyte- 
derived factors are protective to neurones which have been exposed to an 
oxygen glucose deprivation/reoxygenation injury’. We have divided the thesis 
into two main sections each with its own objectives in order to test this 
hypothesis. The first section involves the establishment of a working model of 
Oxygen glucose deprivation/reoxygenation using cultured neurones and 
astrocytes. This section also includes the steps by which we arrived at a 
protocol for the reproduction of progressive neuronal death in the 
reoxygenation phase. The second section directly examines the role of 
astrocytes in eliciting neuroprotection during reoxygenation.
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Chapter 2 
Materials and Methods
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2.1 Materials
Earle’s balanced salt solution (EBSS), Hanks’ buffered salt solution 
(HBSS), antibiotic-antimycotic solution (10,000 units/ml penicillin, 
10mg/ml streptomycin, 25pg/ml amphotericin B), Dulbecco’s modified 
Eagle’s medium (DMEM; without glucose, sodium-pyruvate, sodium 
bicarbonate and phenol red), L-glutamine, bovine serum albumin (BSA), 
deoxyribonuclease type 1 (DNAse, EC 3.1.21.1; from bovine pancreas), 
trypsin (EC 3.4.21.4, from bovine pancreas), trypsin-EDTA (5g porcine 
trypsin and 2g EDTA/L), cytosine arabinofuranoside (AraC), 4- 
trifluoromethoxyphenylhydrazone (FCCP), trypan blue, poly-L-ornithine 
(P/O, molecular mass 30,000 -  70,000 g/mol), poly-D-lysine (P/L, 
molecular mass 300,000 g/mol), propidium iodide (PI), sodium 
bicarbonate solution (7.5%), oxygen trap model 1000, 
iodonitrotetrazolium chloride, hydrazine hydrate, perchloric acid, 13- 
nicotinamide adenine dinucleotide, glutathione (reduced and oxidised 
forms), monosodium glutamate, lactate standard (40mg/dl) and, sodium 
pyruvate, Botulinum Toxin (BoTox), 1-aminoindan-1,5-dicarboxylic acid 
(AIDA), MK801, DL-fhreo-(3-benzyloxyaspartate (TBOA), 2-Methyl-6- 
(phenylethynyl)-pyridine (MPEP) and Anaerobic indicator (Oxoid, 
Basingstoke, UK) were purchased from Sigma-Aldrich Chemical Co. 
(Poole, UK). Hoechst33342, tetramethyl rhodamine methyl ester 
(TMRM), rhodamine-123 and Fura-2 acetoxymethylester (AM) were 
purchased from Molecular Probes Europe BV (Leiden, the Netherlands). 
L-Lactate dehydrogenase, glutathione reductase, glutamate 
dehydrogenase, and diaphorase were purchased from Roche (Lewes, 
UK).
B-27 supplement (with and without anti-oxidants), Neurobasal medium 
(NB), minimum essential medium (MEM, L-valine based), goat serum, 
and foetal bovine serum (FBS) were purchased from Gibco BRL 
(Renfrewshire, UK). The 95%N2/5% C02 gas was purchased from BOC 
(Surrey, UK). Microscope coverglass was purchased from VWR (Poole, 
UK). Cell culture flasks, 6-well plates and single wells for astrocyte use
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were purchased from Nagle Nunc International (Naperville, IL, USA). Six- 
well plates and single wells for neurone use were purchased from Costar 
(Corning Costar, High Wycombe, UK). Beads were purchased from The 
Bead Shop (London, UK). Mouse anti beta III tubulin antibody and 
donkey anti mouse Fluorescein-isothiocyanate (FITC) conjugated 
antibody were purchased from Abeam (Cambridge, UK). Donkey serum, 
rabbit anti GFAP antibody and Cy5 conjugated goat anti rabbit antibody 
were purchased from Chemicon (Hampshire, UK). Mouse anti CD11b 
antibody was purchased from Serotec (Oxford, UK). Citifluor was 
purchased from Citifluor Ltd (London, UK). Silicone sealant (Unibond, 
Cheshire UK) was purchased from Robert Dyas. The 782 O2 meter 
(Strathkline instruments, Glasgow Scotland) was purchased from 
Strathkline instruments. Absolute digimatic, vernier callipers model no. 
CD-6”C (Mitutoyo, UK) was borrowed from th eengineerig dept, University 
College London.
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2.2 Tissue Culture
All animals were procured from colonies maintained at the Biological 
Services unit of University College London and used in accordance with 
Home Office guidelines.
All references to ‘cold’ temperature solutions correspond to solutions at 
4°C. All references to ‘warm’ temperature solutions correspond to 37°C.
2.2.1 Cortical astrocyte cultures from neonatal rat brain
2.2.1.1 Dissection
Neonatal Sprague Dawley rats were sacrificed at 0-48 hours of age by 
decapitation. Cerebella were carefully removed and discarded. 
Forebrains were placed in a dish containing Hank’s buffered salt solution 
(HBSS) on ice. Under the dissecting microscope, cerebral hemispheres 
were carefully teased apart and midbrain and hippocampi removed and 
discarded. Meninges were then removed and also discarded. Cortices 
were placed into a dish containing 10ml cold solution A (Earle’s 
balanced salt solution (EBSS) containing 20pg/ml DNAse and 3mg/ml 
BSA). Tissue was chopped until very fine using scissors and then 
triturated briefly with a 1ml Gilson pipette. The suspension was 
centrifuged at 500g for 5mins at 4°C.
The pellet was resuspended in 20ml of warm solution B (EBSS 
containing 3mg/ml BSA, 0.25mg/ml trypsin and 0.1 mg/ml DNAse). The 
cell suspension was incubated at 37°C for approximately 12mins to allow 
cell dissociation. The reaction was stopped by the addition of 1ml cold 
foetal bovine serum (FBS). The suspension was then centrifuged at 500g 
for 5mins at 4°C. The pellet was resuspended in 10ml solution A. The 
cell suspension was mixed 6 times with a 1ml Gilson pipette followed by a 
0.2ml Gilson pipette and allowed to settle for 3mins. Supernatant was 
removed and kept. This resuspension step was repeated and 
supernatants were pooled. The pooled suspension was centrifuged at 
500g for 5mins at 4°C.
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The supernatant was discarded and the pellet resuspended in culture 
medium (Minimum essential medium (MEM) supplemented with 10% 
FBS and 2mM L-glutamine). The suspension was filtered through a nylon 
mesh of 100pm pore size. The cortical suspensions were plated into a 
number of 80cm3 tissue culture flasks equivalent to the number of 
animals used. Flasks were then kept in an incubator at 37°C with 
humidity >90% in an atmosphere of 5%C02/95% air.
Medium was replaced with fresh culture medium after 24 hours and 
subsequently changed every 3 days. After 7 days or at such a time point 
that the cells reached confluency, oligodendrocytes and microglia were 
removed by shaking. The flasks were shaken on a Heidolph unimax 100 
shaker (Lab Plant, Huddersfield, England) housed in a standard 
incubator, for 16hrs at 200rpm. The media containing floating cells was 
removed and discarded and the flask contents were harvested (section
2.2.1.2) and reseeded to double the number of flasks originally obtained. 
The medium was subsequently replaced every 3 days.
2.2.1.2 Harvesting of astrocyte cultures
Medium was removed and the flasks rinsed with warm HBSS. 
Approximately 10mls of T/E solution (HBSS containing 5mg/ml porcine 
trypsin and 2mg/ml ethylene diamine tetraacetic acid (EDTA)) was added 
to each flask. The flasks were incubated at 37°C for 5mins. The 
trypsinisation reaction was then stopped with the addition of 1ml cold FBS 
to each flask. The cell suspensions were removed from each flask and 
pooled. Flasks were further rinsed with HBSS, which was also pooled 
with the cell suspensions. The resulting suspension was centrifuged at 
500g for 5mins at 4°C. The pellet was then re-suspended in 10mls of 
medium.
Astrocytes which had been seeded in 6-well plates were harvested upon 
completion of each experiment in a similar manner. Supernatant was 
removed and wells were washed with 1ml warm HBSS. The HBSS was
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then removed and 1ml of trypsin was added to each well. The reaction 
was stopped by the addition of 100pl cold FBS. The astrocytes were then 
removed with the aid of a cell scraper and the wells washed once again 
with HBSS. The resulting cell suspension was centrifuged at 500g for 
5mins at 4°C. The supernatant was removed and the pellet was 
resuspended in 300pl HBSS and placed in a 1.5ml eppendorf tube. This 
suspension was again centrifuged at 500g for 5mins at 4°C, the 
supernatant was discarded and the pellet was frozen and stored at -70°C.
2.2.1.3 Seeding of astrocytes for experimentation
After 14 days, cultures had reached confluence and were again 
harvested. The number of viable cells in the final 10ml suspension was 
counted based on trypan blue exclusion. For this, a 10pl aliquot of the 
harvested cell suspension was taken and mixed with 40pl trypan blue and 
30pl HBSS (giving a final trypan blue concentration of 0.2mM). The 
number of cells that excluded trypan blue were counted in a 10pl aliquot 
of this mixture placed on a haemocytometer using a phase contrast, 
inverted-microscope. The cell density was subsequently adjusted such 
that there were 106 cells/ml medium and 1ml of this suspension was 
added to each well of a 6-well plate (section 2.2.1.4). Wells were 
maintained for a further 24 hours to allow cells to settle.
For experiments involving imaging, cells were seeded onto coated glass 
coverslips (25mm, thickness 1) (section 2.2.1.4). For this 100|jl of the 
106cells/ml suspension was placed in the middle of the slip and incubated 
at 37°C in an atmosphere of 5% C02/95% air for 1 hour in order to allow 
cells to settle. This was followed by the addition of 2ml media (described 
above). Cells were used for experimentation 24 hours later.
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2.2.1.4 Coating of surfaces for astrocyte seeding.
Plastic 6-well plates were coated with poly-L-ornithine (P/O). 
Approximately 1 ml of a 0.01% P/O solution was placed into each well and 
allowed to incubate at 37°C for 1 hour. The solution was then removed 
and the well rinsed twice with sterile distilled H2O. Each plate was 
subsequently placed in front of a UV lamp for 20mins after which they 
were ready for use.
Glass coverslips were coated with poly-D-lysine (P/L). Coverslips were 
baked in an oven at 160°C for 2 hours and allowed to cool. 
Approximately 300pl of 0.01% P/L solution was added to the centre of 
each coverslip. They were then left at room temperature for 30mins after 
which time the P/L was removed and the coverslips washed twice with 
sterile distilled H20 . All coverslips were allowed to dry and were then 
placed in front of a UV lamp for 20mins.
2.2.1.5 Note on astrocyte care
We have found that astrocyte growth rate and health can be greatly 
improved by tapping the flasks sharply against the flow unit surface just 
prior to media change. This appears to aid in the clearance of dying cells 
and toxins.
2.2.2 Primary cortical neurone cultures from foetal rat brains
2.2.2.1 Dissection
Pregnant Sprague Dawley rats at 17 days of gestation were sacrificed by 
cervical dislocation. Foetuses were carefully extracted and placed in a 
Petri dish containing cold EBSS. Foetal heads were cut with scissors, so 
as to expose the brain, and the cerebellum was removed and discarded. 
Cortices were carefully removed and rolled gently on filter paper (which 
had been previously soaked with ethanol, allowed to dry, and exposed to 
UV light for 20mins) in order to remove meninges.
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The tissue was then placed in a Petri dish containing 10ml solution C 
(Neurobasal medium (NB) containing 3mg/ml BSA and 24pg/ml DNAse) 
and chopped until very fine with scissors. This suspension was then 
placed in a Falcon tube and allowed to settle for two minutes under the 
influence of gravity. The supernatant was removed and 10ml solution D 
(NB containing 3.25mg/ml BSA, 24pg/ml DNAse and 0.25mg/m! trypsin) 
was added. The cell suspension was incubated at 37°C for 15mins. The 
reaction was stopped by the addition of 1ml of cold FBS. The suspension 
was allowed to settle for 2 mins and the supernatant was removed. 12ml 
of solution C was added and the suspension was triturated gently 4 
times using a 1ml Gilson pipette followed by a 0.2ml Gilson pipette. The 
cell suspension was allowed to settle for 4 mins after which time the 
supernatant was removed and placed in another Falcon tube. This 
resuspension step was repeated and supernatants pooled.
The pooled suspension was centrifuged at 500g for 5mins at 4°C. The 
supernatant was discarded and the pellet resuspended in 3ml of NB 
supplemented with 2% B27 with antioxidants (B27+AO), 25pM glutamate 
and 2mM glutamine. The suspension was filtered through a nylon mesh 
of 100pm pore size. The number of viable cells was counted based on 
trypan blue exclusion (section 2.2.1.3) and the cell concentration adjusted 
to 1 million/ml with media. 100pl of cell suspension was added directly to 
the centre of treated coverslips (section 2.22.2) and incubated at 37°C in 
an atmosphere of 5%C02/95% air for 1 hour to allow cells to settle. After 
this time 2ml of supplemented NB was added carefully to each well. The 
cells were subsequently housed in an incubator at 37°C in an atmosphere 
of 5%C02/95% air at >90% humidity.
Cell medium was half changed on day 3 by replacement of 1ml of old 
medium with 1 ml of astrocyte conditioned NB (section 2.2.2.3) 
supplemented with 20pM cytosine arabinofuranoside (AraC) giving a final 
concentration of 10pM. AraC is added to prevent glial proliferation. 
Media was half changed again on day 7 with astrocyte conditioned NB. 
Neurones were used for experimentation on DIV10.
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2.2.2.2 Preparation of coverslips for neuronal cultures
Glass coverslips were soaked overnight in 20% nitric acid. They were 
removed, washed three times with fresh distilled deionised H2O and dried 
in acetone. They were then sterilised by baking in the oven for 2hours at 
160°C and allowed to cool.
Coverslips were placed in 6-well plates or Petri dishes and coated with 
300pl of 0.01% P/L for 1 hour at room temperature. The P/L was 
removed and the coverslips washed three times with sterile distilled H2O. 
Coverslips were allowed to dry and were then placed on front of a UV 
light for 20mins. 100pl NB containing 2% B27, 5% horse serum, 5% 
FBS, 2mM glutamine and 62.5pM glutamate was added to the centre of 
the coverslips and incubated at 37°C in an atmosphere of 5%C02/95% air 
for 3 hours. Cell suspensions were added directly to this solution.
2.2.2.3 Astrocyte conditioned neurobasal medium
NB containing 2% B27 (+AO) and 2mM glutamine, was placed on 
astrocyte cultures, aged between DIV13 and DIV15, for 24 hours. The 
media was then removed and centrifuged at 500g for 5mins at 4°C, to 
remove cell debris. Conditioned media was frozen at -80°C and stored 
for up to two weeks.
2.2.2.4 Harvesting of neurone cultures
Neurones were harvested such that the cells from three coverslips were 
combined in one pellet. Each coverslip was placed immediately in to 1ml 
of HBSS containing 5mg/ml porcine trypsin and 2mg/ml ethylene diamine 
tetraacetic acid (EDTA) (T/E). The plates were incubated at 37°C for 
5mins. The trypsinisation reaction was then stopped with the addition of 
100pl cold FBS to each well. A cell scraper was used to remove all 
remaining neurones. The wells were washed with 1ml HBSS, which was 
then added to the cell suspension. This was then centrifuged at 500g for 
5mins at 4°C. The supernatant was removed and the pellet was 
resuspended in 300pl HBSS and placed in a 1.5ml eppendorf tube. This
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suspension was again centrifuged at 500g for 5mins at 4°C, the 
supernatant was discarded and the pellet was frozen in liquid nitrogen 
and stored at -70°C.
2.2.3 Co-culture of Cortical neurones and astrocytes
Neurones grown on glass coverslips were used on DIV10 for co-culture. 
Astrocytes were seeded on modified 6-well plates (Costar) at DIV13. The 
6-well plates were altered as follows.
Four size 11 glass beads (cleaned and sterilised in the same manner as 
glass coverslips) were placed on the underside of each well of a 6-well 
plate to form a square of dimensions 10x1 Omm. Reproducibility was 
achieved through the use of a template, which was placed on the back of 
the 6-well plate. A soldering iron was then applied to the top of each 
bead causing the bead to heat and sink through the surface of the plastic 
well. The bead was allowed to sink through until its outer surface was on 
the same plane as the outer surface of the 6-well plate. The soldering iron 
was removed and forceps were quickly applied to hold the bead in place 
until the plastic hardened. The distance between the coverslip and the 
surface of the 6-well plate was measured using an ‘Absolute digimatic’ 
vernier callipers.
Astrocytes were seeded as described (Section 2.2.1.3) and allowed to 
rest for 24 hours. Co-culture was achieved by inverting the coverslips 
bearing the neurones and placing them on the beads.
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2.3 Immunocvtochemistrv
2.3.1 Antibodies used
I mmu nocytochemistry was performed on both astrocyte and neurone 
cultures in order to determine the cellular purity of each culture 
population. Antibodies against cellular markers specific for neurones, 
astrocytes and microglia were incubated with both cell types. The 
neurone specific marker is the beta III Tubulin subunit (Tub), the 
astrocyte marker is glial fibrillary acid protein (GFAP), both are 
cytoskeletal elements, and the microglial marker is the integrin CD11b.
Two different secondary antibody types were used in order to visualise 
primary antibody binding to the specific cellular markers. These were an 
anti-mouse Fluorescein-isothiocyanate (FITC)-conjugated antibody raised 
in goat and an anti-rabbit CY5-conjugated antibody raised in donkey. 
Both FITC and CY5 are fluorescent molecules, which absorb and emit 
light at different wavelengths and thus allow double staining of each 
culture to be carried out.
2.3.2 Application of antibodies
Cells on glass coverslips were rinsed with Tris buffered saline (TBS) and 
fixed by the addition of ice-cold methanol for 10 mins, on ice. Methanol 
was removed and the cells were rinsed twice for 5 mins with TBS and 
then treated with 4mM sodium deoxycholate for 10 mins. This step 
permeabilises the cells allowing access for antibodies.
Cells were then rinsed twice more for 5 mins in TBS containing 0.025% 
Triton X-100, to reduce surface tension and allow reagents to cover the 
entire cell preparation. The cells were blocked in 10% normal serum 
(from the animal in which the secondary antibody was raised) with 
1%BSA in TBS at room temperature for 2 hrs. The normal sera used 
were goat (for Tub and CD11b stains) and donkey (for GFAP stains). 
Blocking solution was removed and primary antibody applied at suitable 
concentrations overnight at 4°C. Astrocytes were incubated with rabbit
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anti-GFAP antibody (1:1000 with TBS/1 %BSA) and mouse anti-cd11b 
antibody (1:1000 in TBS/1%BSA). Neurones were incubated with rabbit 
anti-GFAP antibody (1:1000 in TBS/1 %BSA) and mouse anti-Tub 
antibody (1:500 in TBS/1 %BSA).
Cells were washed twice for 5 mins with TBS and then incubated with a 
solution containing FITC-conjugated secondary antibody (1:500) and a 
CY5-conjugated secondary antibody (1:500) for 1 hour at room 
temperature. The cells were again rinsed twice for 5 mins with TBS and 
then incubated with 0.01% 4,6-diamidino-2-phenylindole HCL (DAPI) for 
10mins followed by a final rinse with TBS. DAPI is a nuclear stain that 
allows all cells present to be visualised. The coverslips were then 
mounted on glass microscope slides as follows. 10pl of citifluor was 
placed in the middle of the slide and the coverslip placed carefully, cells 
facing down, onto it. Citifluor does not dry and so coverslips were held in 
place by dabbing small patches of nail varnish (60seconds, silver bullet, 
Rimmel London) along the edge.
Negative controls were carried out by the omission of primary antibody, 
secondary antibody or the omission of cultures. Single stains were also 
carried out in order to discount the possibility of the antibodies producing 
a signal by interfering with each other. Stains were visualised using 
confocal microscopy.
2.3.3 Imaging immunocytochemical stains
Immunocytochemical stains were visualised using confocal microscopy 
(section 2.6.2). The 364nm line of the argon UV laser was used to excite 
DAPI, the 488nm line of the argon laser was used to excite FITC and the 
633nm helium neon laser was used to excite Cy5. DAPI, FITC and Cy5 
emit blue, green and red light respectively which were collected on three 
separate channels using appropriate filters and mirrors.
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2.3.4 Quantifying immunocytochemical stain
A number of fields were chosen from each coverslip and imaged. The 
number of nuclei visible in each field was taken as the total number of 
cells present. Positively stained cells were counted as those whose 
nucleus had a surrounding stain. Purity was therefore expressed as the 
percentage of positively stained cells present with respect to the total 
number of nuclei.
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2.4 Oxyqen-qlucose deprivation/reoxvqenation
All experiments were carried out such that control and test cells were 
derived from the same culture. Control cells were handled in a manner 
as similar as possible to test cells, the only difference being the actual 
insult given.
2.4.1 O2 deprivation
To establish hypoxia, cells (astrocytes and/or neurones) were placed in 
an airtight glass desiccator with specially modified lid. This was then 
housed in an incubator at a temperature of 37°C. Humidity was 
maintained by the inclusion of H20  at the base of the desiccator. Air was 
removed by flushing the desiccator through with 5%C02/95%N2. This 
gas mixture was first of all passed through an 0 2 trap to remove trace 0 2 
from the stream.
The chamber was prepared before each experiment by flushing with gas 
for 15mins after which the cells were added and the chamber flushed 
again for approximately 60mins. Lack of 0 2 was indicated by a resazurin 
soaked pad, which turns from pink to white when low 0 2 concentration is 
reached. This change marked the start of the hypoxic time period.
The effectiveness of the resazurin pad was checked by measuring 0 2 
level in the chamber using a Clark-type oxygen electrode (Section 2.7). 
The electrode was placed within the chamber. The accompanying leads 
to the data storage unit were accommodated by cutting channels in the lid 
of the chamber and sealing the leads in with silicone sealant. 
Measurements were made whilst the chamber was gassed continuously, 
noting the length of time for 0 2 levels to reach their lowest. Temperature 
was monitored by placing a medical precision thermometer, 
(Ellab.Copenhagan Denmark) in the chamber at the same time. The 
leakiness of the chamber to 0 2 was determined by continuing the 
measurement of 0 2 after the cessation of gas flow.
77
Chapter 2
2.4.2 0 2 /glucose deprivation
2.4.2A Astrocyte Orfgiucose deprivation
To establish the 0 2 /glucose deprivation (OGD) injury, astrocytes were 
first rinsed with warm HBSS and then incubated in 1ml DMEM without 
glutamine, glucose, pyruvate or serum supplement. They were then 
placed in the above chamber to achieve hypoxic conditions. Control cells 
were rinsed with warm HBSS and 1ml of DMEM supplemented with 2mM 
glutamine, 5.5mM glucose, 1mM sodium pyruvate and 2% B27 (-AO) was 
added. Cells were incubated at 37°C in an atmosphere of 5%C02/95% 
air at >90% humidity for the duration of the OGD period.
2.4.2.2 Neurone 02/glucose deprivation
Neurones grown on coverslips were subjected to OGD by removal of the 
coverslip from the growth media and placing it directly into a well 
containing 2ml of DMEM without glutamine, glucose, pyruvate or serum 
supplement. This was then placed in the hypoxia chamber as described 
in section 2.4.1. Similarly, control coverslips were placed in wells 
containing 2ml of DMEM supplemented with 2mM glutamine, 5.5mM 
glucose, 1mM sodium pyruvate and 2% B27 (-AO), and incubated at 
37°C in an atmosphere of 5%C02/95% air at >90% humidity for the 
duration of the ischaemic period.
2.4.3 Reoxygenation
2.4.3.1 Astrocyte reoxygenation
Reoxygenation was achieved by replacing both test and control media 
with DMEM supplemented with 2mM glutamine, 5.5mM glucose, 1mM 
pyruvate and 2% B27 (-AO) following the OGD period. Cells were then 
housed in an incubator at 37°C in an atmosphere of 5%C02/95% air at 
>90% humidity.
2.4.3.2 Neurone reoxygenation
Reoxygenation was achieved by placing each coverslip (test and control) 
in a well containing 2ml of Neurobasal media supplemented with 2% B27 
(-AO) and 2mM glutamine. Both control and test neurones were then
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placed in an incubator at 37°C in an atmosphere of 5%C02/95% air at 
>90% humidity.
For some experiments neurones were reoxygenated in astrocyte 
conditioned media. This conditioned media was made using the method 
described in section 2.2.2.3 with the exception that B27 without anti­
oxidants was used.
2A.3.3 Co-culture reoxygenation
Some experiments involved insulting neurones, as described above, and 
allowing reperfusion to occur in the presence of astrocytes in co-culture 
conditions was as described in section 2.2.3. Reoxygenation was 
achieved by adding 2ml of NB (2% B27(-AO), 2mM glutamine) to each of 
the astrocyte wells 15mins prior to the addition of the neuronal coverslips. 
The coverslips were then inverted and placed carefully on the beads over 
the astrocytes.
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2.5. Cell survival
2.5.1 LDH assay
2.5.1.1 Principle
Lactate dehydrogenase (LDH, NAD+ oxidoreductase EC 1.1.1.27) 
catalyses the reversible oxidation of lactate to form pyruvate.
LDH
Lactate + NAD+ <--------> pyruvate + NADH + H+
This enzyme is predominantly cytosolic and its release from cells into the 
surrounding media was used as a measure of plasma membrane leakage 
and hence as a measure of cell death.
2.5.1.2 Protocol
The assay was carried out using astrocyte cultures from 6-well plates as 
follows. 50pl of supernatant was removed and snap-frozen in liquid N2. 
This represents the extra-cellular fraction. 10pl of 10% triton X-100 was 
added to each well to solubilise cell membranes and release LDH. The 
solubilised sample (total) was collected and also snap-frozen in liquid N2. 
Samples were later defrosted in a water bath at 37°C just prior to use.
The enzyme activity was measured using a Uvikon-XL spectrophotometer 
(BioTek Instruments Ltd). The decrease in absorbance at 340nm due to 
the oxidation of nicotinamide adenine dinucleotide (NADH) was 
monitored as a measure of the reduction of pyruvate to lactate by LDH. 
The assay was performed at a temperature of 30°C. The reaction 
mixture contained 100mM potassium phosphate buffer at pH 7.5, 
0.345mM sodium pyruvate and 8mM disodium NADH. The reaction was 
carried out in a 1 ml cuvette and initiated by the addition of 33jnl of sample. 
Absorbance changes were read against a blank cuvette containing all 
components of the reaction mixture without any sample. LDH activity in 
the extra-cellular fraction was expressed as a percentage of total LDH 
activity.
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2.5.1.2 Assay validation
The linear limits of the assay were ascertained by using pure lactate 
dehydrogenase (LDH) enzyme directly in the assay at various different 
concentrations. LDH was diluted to specific concentrations according to 
protein content, using NB medium. There was a linear increase in assay 
rate with LDH concentration from 0.005pg/ml to 5pg/ml. Between
0.005pg/ml and 0.1pg/ml R2=0.9992, between 0.1pg/ml and 5pg/ml R2=1 
(Fig2.1).
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Fig 2.1 LDH activity. The graph illustrates the rate of NADH oxidation by different 
concentrations of LDH, expressed as absorbance units/min. Linear trend lines have 
been fitted to the points obtained. A) illustrates LDH concentrations from 0.005pg/ml to 
O.lpg/ml, B) illustrates LDH concentrations from 0.1pg/ml to 5pg/ml.
2.5.2 Dye exclusion assay
Neuronal cell death was quantified by assessing the integrity of the 
plasma membrane, and the shape of the neuronal nucleus. This was 
accomplished through the use of vital dye uptake and a subsequent
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analysis of nuclear colour and shape in order to distinguish between 
apoptotic and necrotic cell death.
2.5.2.1 Dye application
Cells were loaded for 20mins with 10pM Propidium Iodide (PI) and 4.5pM 
Hoechst 33342 in HEPES buffered salt solution. Both PI and Hoechst 
are fluorescent molecules that target nuclear DNA. PI is cell impermeant 
and is thus excluded from cells with an intact plasma membrane. 
Hoechst is cell permeant and stains all nuclei present. Only dead cells 
will take up PI however, cell death by apoptosis does not always involve 
early disruption of membranes therefore the use of Hoechst allows 
apoptotic nuclei to be identified according to nuclear morphology only.
2.5.2.2 Dye visualisation
Nuclei were observed using fluorescence microscopy (section 2.6.3). 
Hoechst has an excitation peak at 360nm and an emission peak at 
460nm (blue colour) whereas PI has an excitation peak at 530nm and 
an emission peak at 615nm (red colour). Both dyes were visualised by 
eye following the passage of emitted light through a 390nm dichroic 
mirror and 420nm long pass filter.
2.5.2.3 Counting nuclei
Nuclei from 10 regions of interest (ROI) were counted according to shape 
and colour and assigned to one of five groups as shown below. These 
groups allow the nuclei to be counted as live, early apoptotic, late 
apoptotic or necrotic.
Group I (live)- Nuclei with blue fluorescence only, rounded appearance, 
and clear homogenous chromatin structures.
Group II (early apoptotic)- Blue nuclei, smaller than group I, some 
chromatin condensation and rounded shape maintained.
Group III (late apoptotic)- Small, homogenous bright blue nuclei, no 
clear chromatin structures, fragmented appearance.
Group IV (necrotic)- Red nuclei with appearance as in group I.
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Group V date apoptotic)- Red nuclei with appearance as in group III
Only nuclei that could be clearly fitted into these groups were considered.
Cell survival was quantified by expressing the number of nuclei in group I 
and group II as a percentage of the total number of nuclei present. Group 
II was considered as a live group as it was thought that these cells may 
be capable of being rescued. Necrotic nuclei were quantified by 
expressing the number of nuclei in group IV as a percentage of the total 
number in groups III, IV and V. Apoptotic nuclei were quantified by 
expressing the total number of nuclei in groups III and V as a percentage 
of the total number of nuclei in groups III, IV and V.
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2.6 Microscopy
2.6.1 Phase-contrast light microscopy
Cells were photographed using a digital camera (Nikon Coolpix950) 
mounted over a standard phase-contrast microscope (Nikon TMS) 
equipped with 20x and 10x air objective lenses. Digital images were 
stored and processed using Adobe Photoshop technology.
2.6.2 Confocal microscopy
Confocal microscopy was performed using a Zeiss 510 laser scanning 
confocal microscope equipped with x20 (air) and x40 and x63 (oil 
immersion), quartz objective lenses (NA 0.75, 1.3 and 1.4, respectively). 
A photomultiplier tube detected emitted light. Images were analysed 
using the Zeiss LSM image browser.
2.6.3 Fluorescence microscopy
Fluorescence microscopy for manual observation of fluorescence was 
performed using a Leitz Fluovert FU inverted fluorescence microscope 
(Leica, Wetzlar, Germany), equipped with a 40x objective lens.
2.6.4 Digital fluorescence microscopy 
2.6.4.11mage acquisition
Experiments were carried out using an inverted epifluorescence 
microscope (Nikon, Tokyo, Japan) equipped with a 20x fluorite objective. 
Excitation light was emitted from a xenon arc lamp and was passed 
through 10nm band pass filters centred at 340 and 380nm housed in a 
computer-controlled filter wheel (Cairn Research, Kent, UK). Emitted 
fluorescence was reflected through a 515nm long-pass filter to a frame 
transfer cooled CCD camera (Hamamatsu 4880). Data was collected at 
10 to 15sec intervals using the Acquisition Manager software package 
(Kinetic Imaging) and analysed using Lucida Analyse 6 (Kinetic imaging, 
Liverpool, UK).
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2.6.4.2 Measuring intracellular Ca2+ levels
Cells were loaded for 40mins at room temperature with 5pM Fura-2 AM 
and 0.005% pluronic (a mild detergent to aid access of the dye to the cell) 
in recording media: HEPES buffered salt solution composed of mM: 156 
NaCI, 3 KCI. 2 MgS04.7H20 , 1.25 KH2P 04, 10 glucose, 10 HEPES, 2 
CaCI2 adjusted to pH 7.35 with NaOH.
Fura-2 AM is a high affinity, intracellular calcium indicator that is 
ratiometric and UV light-excitable. Upon binding Ca2+, fura-2 exhibits an 
absorption shift from 340 to 380 nm. Emission is detected at 510nm. 
Ratioing the 340 and 380nm signal eliminates error produced by uneven 
dye loading, dye leakage and photobleaching. Fig 2.2 is an example of 
how the spectral characteristics of Fura-2 change with Ca2+ binding.
co
co
o
X
0
0o
c
0o
CO
o
LL
250 300 350 400 450 500 550 600 650
Wavelength (nm)
Fig 2.2 Fura-2/Ca2+ spectra. Fluorescence excitation (detected at 510 nm) and 
emission (excited at 340 nm) spectra of Ca2+-saturated (A) and Ca2+-free (B) fura-2 in 
pH 7.2 buffer. From molecular probes website
htto://www. probes, com/servlets/spectra ?fileid= 1200ca.
Cells were washed a number of times after loading to remove excess 
dye. The cellular Ca2+ response to glutamate was determined by
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exchanging the recording medium with medium containing IOOjjM 
glutamate.
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2.7 Oxygen Consumption
2.7.1 Electrode calibration
The 782 oxygen meter (Strathkelvin Instruments, Glasgow) was used to 
monitor O2 levels. Data was recorded using the on-board datalogging 
facility and analysed by uploading to the accompanying software package 
on PC. The meter was calibrated according to manufacturer’s
instructions. The zero O2 level was obtained by adding 50pl of a solution 
containing 2% sodium sulphite in sodium borate. Maximum O2 
concentration was registered by adding 50pl of respiration buffer (HBSS 
containing 2mM CaCh, 20mM HEPES). This solution had been fully 
oxygenated by vigorous shaking for 20mins and was estimated to contain 
O2 at a concentration of 200pM (calibration chart provided by Strathkline 
Instruments). Both solutions were warmed to 37°C and all
measurements were carried out within an incubator at this temperature 
also.
2.7.2 Measuring O2 during hypoxia
The hypoxia chamber was modified such that the O2 electrode could be 
sealed within it whilst remaining connected to the accompanying 
recording meter. This was done, by cutting a suitable area of glass from 
the lid, reshaping it with epoxy resin to the width of the attached wires 
and finally sealing the wires in with silicone sealant. O2 levels were then 
followed as air was evacuated from the chamber (section 2.4.1).
2.7.3 O2 measurements in an astrocyte suspension
Astrocytes were harvested and resuspended in respiration buffer (section 
2.7.1). They were counted and brought to a concentration of
100,000cells/ml buffer (section 2.2.1.3). 50pl of this suspension was
placed in the 0 2 meter chamber.
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2.8 Quantitation of Chemical Compounds
2.8.1 Protein
2.8.1.1 Principle
Protein content was determined using the Bio-Rad protein assay kit (Bio- 
Rad, Buckinghamshire, UK) and is derived from the method of Lowry et al 
(1951). The assay is based on the chemistry between tryptophan and the 
phenolic group of tyrosine residues within proteins, and alkaline copper 
tartrate solution and Folin-Ciocalteau reagent (consisting of sodium 
tungstate, molybdate and phosphate). The cuprous ion resulting from the 
protein-copper complex reduces the Folin reagent to produce a solution 
that has an absorbance maximum at 750nm. The absorbance is 
proportional to the protein content of the sample.
2.8.1.2 Protocol
The assay was carried out in triplicate. Standards of bovine serum 
albumin (BSA) in H2O were made in the range from 5-200pg protein.ml"1. 
10pl of sample were diluted in 200pl of H2O. 100pl of the alkaline copper 
tartrate solution and 800pl of the Folin reagent were added to each 
sample and standard. The reaction mixture was placed in the dark at 
room temperature for 20mins. Absorbance was then read at 750nm 
using a Uvikon 940 spectrophotometer (Kontron instruments Ltd. 
Watford, UK). Standard curves were linear within the range tested.
2.8.2 Sample deproteination
For some assays samples were deproteinated by acid extraction using 
perchloric acid (PCA). To every 1ml of sample, 250pl of PCA (24%) was 
added. The mixture was placed on ice over a magnetic stirrer and 
allowed to stir for 15mins. The resulting solution was then centrifuged at 
740g for 10mins at 4°C. The supernatant was removed and its volume 
recorded. The pH was then measured using a pH meter and brought to 
pH 5.5-6.0 with buffer solution (0.417M triethanolamine, 2M K2CO3 in 
H2O). The volume was again noted and the solution was centrifuged at
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120g for 10mins at 4°C. The supernatant was kept and the pellet 
discarded.
2.8.3 L-Glutamate
2.8.3.1 Principle
L-Glutamate concentration was determined by the method of Beutlar and 
Michal (1974) and is based on the use of glutamate dehydrogenase 
(GIDH, EC. 1.4.1.3), diaphorase (NADH:lipoamide oxidoreductase, EC.
1.6.4.3) and tetrazolium salts, with minor modifications. L-Glutamate 
reacts with nicotinamide adenine dinucleotide (NAD+) to produce 2- 
oxoglutarate, reduced nicotinamide adenine dinucleotide (NADH) and an 
ammonium ion (1). In the presence of diaphorase, the NADH produced 
reacts with iodonitrotetrazolium chloride (INT) to produce an orange 
formazan product (2 ), which can then be measured 
spectrophotometrically at 492nm. The reaction proceeds 
stoichiometrically and thus the concentration of glutamate is determined 
from the extinction coefficient of INT using the Beer-Lambert law.
1. L-glutamate + NAD* + H20  < GIDH > 2-oxoglutarate + NADH + NH4+
Diaphorase
2. NADH + INT + H+ ------------->  NAD+ + Formazan
2.8.3.2 Protocol
The assay was carried out using deproteinated sample (2.8.1). The 
assay was performed at a temperature of 25°C in a 1 ml cuvette. The 
reaction mixture contained final concentrations of: triethanolamine 
phosphate buffer (57mM TRA, 14mM potassium phosphate, pH 8 .6 ),
0.38mM NAD, 0.068mM INT, and 14.3U/ml diaphorase. Upon addition of 
143pl of sample to the reaction mixture, the cuvette was placed in a 
Uvikon 940 spectrophotometer (Kontron instruments Ltd. Watford, UK) 
and absorbance was continuously read at 492nm. After a flat baseline 
was reached (around 2 minutes), 14U/ml of GIDH was added to the 
mixture and absorbance read continuously for a further 30 minutes.
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Recording was stopped once a flat line had been reached and the 
maximum absorbance was noted. Absorbance changes were read 
against a blank cuvette containing all components of the reaction mixture 
with deproteinated sample medium instead of sample.
The extinction coefficient of the INT solution must be determined with 
every new solution. This is done by measuring the absorbance change in 
a standard glutamate solution made in H20  (136pM final concentration).
2.8.3.3 Assay validation
Three separate standard curves were constructed in the range 1-8pM, 
10-60pM and 70-136pM glutamate in NB. The assay was found to be 
linear in the range from 1pM to 60pM glutamate but this was lost in the 
final curve. Fig 2.3 is a combination of the standard curves using 1-60pM 
Glutamate, R2=0.9967. Samples found to exceed 60pM were diluted and 
re-assayed.
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Fig 2.3 Glutamate standard curve. The graph shows the absorbance values of 
glutamate standards made in deproteinated Neurobasal medium from 1-60pM. A linear 
trendline has been fitted to the data.
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2.8.4 L-Lactate
2.8.4.1 Principle
L-Lactate was measured according to the method of Gutman and 
Wahlfeld (1974) using lactate dehydrogenase (LDH, L-lactate:NAD 
oxidoreductase, EC.1.1.1.27) dnd nicotinamide adenine dinucleotide 
(NAD). LDH catalyses the reduction of NAD+ by lactate to produce 
reduced nicotinamide adenine dinucleotide (NADH) (1). NADH formation 
is measured spectrophotometrically at 340nm. The concentration of 
lactate is determined from the extinction coefficient of NADH using the 
Beer-Lambert law.
1. L-lactate + NAD+ < LDH> pyruvate + NADH + H+
2.8A.2 Protocol
The assay was carried out using deproteinated sample (2.8.1). The 
assay was performed at a temperature of 25°C in a 1ml cuvette. The 
reaction mixture contained final concentrations of: hydrazine/glycine 
buffer(0.43M gly, 0.34M hydrazine in H2 0 , pH 9.0) and 2.75mM NAD. 
Upon addition of 200pl of sample to the reaction mixture, the cuvette was 
placed in a Uvikon 940 spectrophotometer (Kontron instruments Ltd. 
Watford, UK) and absorbance was continuously read at 340nm. After a 
flat baseline was reached (around 2 minutes), 19U/ml of LDH was added 
to the mixture and absorbance read continuously for a further 30-60 
minutes. Recording was stopped once a flat line had been reached and 
the maximum absorbance was noted. Absorbance changes were read 
against a blank cuvette containing all components of the reaction mixture 
with deproteinated sample medium instead of sample.
2.8.4.3 Assay validation
A standard curve was constructed from a lactate standard solution, in the 
range 0-40pM in NB medium. The assay was found to be linear in this 
range, R2=0.9945 (Fig 2.4). Samples found to exceed 40pM were diluted 
and re-assayed.
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Fig 2.4 Lactate standard curve. The graph shows the absorbance values of lactate 
standards made in deproteinated Neurobasal medium from 1-60pM. A linear trendline 
has been fitted to the data.
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2.8.5 Nitrate and Nitrite
2.8.5.1 Principle
Nitrite (NO2') is measured according to the method of Green et al (1982), 
as a measure of nitric oxide (NO) formation. NO2' is one of two primary, 
stable and non-volatile breakdown products of NO. The other is NCV 
(Nitrate). The assay is done in 2 parts; the first part involves the 
conversion of all NO3' present to NO2' using nitrate reductase (NR, EC 
1.6.6.2), reaction 1 below. The second part involves the addition of Griess 
reagent for the detection of nitrite, reactions 2 and 3 below.
NR
1.
2.
N 03' -> N 02‘
SO2NH2
i
n o 2' + s o 2n h 2— <(q ) > - n h 2 — y i— >
n2+
Sulfanilamide
3.
S 0PNH2 N H / V NH2 n h / V NH2
NED
SO2NH2
Azo Product
The Griess reagent system relies on a chemical reaction which uses 
sulphanilamide and N-(1-Naphthyl)ethylenediamine dihydrochloride 
(NED) under acidic conditions, to convert NO2' into a deep purple azo 
compound. Photometric determination of the absorbance due to this azo 
compound accurately determines NO2" concentration. NADPH is 
essential for the nitrate reductase reaction however, it interferes with the
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chemistry of the Griess reagents and so excess NADPH must be 
removed. It is scavenged by the reaction between lactate 
dehydrogenase (LDH) and sodium pyruvate.
2.8.5.2 Protocol
Standards of sodium nitrite and sodium nitrate were made in neurobasal 
medium (NB) at concentrations of 5-50pM. A 50pl aliquot of each 
standard and sample was pipetted in triplicate on to a 96-well plate. To 
each well, 10pl of NR (O.lumits.ml'1, final concentration) and 10pl of 
NADPH (100pM, final concentration) were added. The plate was then 
incubated for 30mins at 37°C. Upon completion of the reaction, 10pl 
each of LDH (lOOU.ml'1, final concentration) and sodium pyruvate 
(100mM, final concentration) were added and the plate was incubated 
again for a further 15mins at 37°C.
Griess reagent was prepared by mixing equal volumes of NED (0.1% 
(w/v) in H2O) and sulphanilamide (1% in 5% (w/v) cone H3PO4). 100pl of 
Griess reagent was then added to each well and the plates were left in 
the dark at room temperature for 15mins. The absorbance of each well 
was read at 540nm in a spectrophotometric plate reader (SpectraMax 
Plus®, Molecular Devices, Wokingham UK) against blank wells without 
sample or standard. The nitrite standard curve was used to determine 
the nitrite concentration of each sample well. In theory both curves 
should be identical but in practice, small discrepancies are to be 
expected. An assay was accepted only if conversion of nitrate to nitrite 
was greater than 95%, as judged by a comparison between both nitrite 
and nitrate standard curves. Fig 2.5 shows that the standard curve was 
found to be linear in the range 0-50pM, R2> 0.98 for both lines. 
Comparison of slopes shows that >95% conversion is achieved.
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Fig 2.5 Griess assay standard curves. The graph shows the linear regression lines 
for the absorbance of both the nitrite standards (Blue line) and the reduced nitrate 
standards (Red line). The equations show that R2 values for both nitrite (Blue equation) 
and nitrate (Red equation) exceed 0.98. Mean ± SEM, n=3.
2.8.6 Glutathione (GSH)
GSH from test samples was isolated and quantified using a reverse- 
phase high performance liquid chromatography (HPLC) column and a 
coulometric electrochemical detector respectively. The method is derived 
from that of Riederer et al (1989).
2.8.6.1 HPLC System
The HPLC system consisted of the following. An autosampler (Model 
360, Kontron instruments, Watford, UK) was used to inject 20pl of sample 
on to a guard column (dimensions 3mm x 10mm) to protect the main 
column from possible contamination. Sample was then resolved by 
passing through an analytical column (dimensions 4.6mm x 250mm). 
Both columns were packed with 5pm octadecasilyl (Techsphere, HPLC 
technology, Macclesfield, UK). Column temperature was held at 30°C by 
a column block heater (Model 7970, Jones Chromatography, Mid. 
Glamorgan, UK). The mobile phase consisted of 15mM orthophosphoric
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acid (OPA) pH 2.5, which had been prepared in ultrapure H2O purified to 
an electrical resistence of 18MQ.cm'1(Purelab Maxima, Elga, Derbyshire, 
UK). Flow rate was maintained at 0.75ml/min by a pump (Jasco PU- 
1580, Great Dunmow, UK). Upon column separation, sample GSH was 
detected using a dual-electrode coulometric analytical cell made of 
porous graphite (Model 5010, ESA Analytical, Aylesbury, UK). A control 
module (Model 5100A, ESA Analytical, Aylesbury, UK) maintained the 
upstream electrode at a potential of +100mV to screen out molecules of 
lower oxidation potential than GSH whereas the downstream electrode 
was maintained at a potential of +520mV. The current at the downstream 
electrode is proportional to the amount of GSH present and was recorded 
by an integrator (Chromjet Ch-1, Thermo Separation Products, Florida, 
USA) at a chart speed of 0.25cm.min'1.
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Fig 2.5 HPLC setup. The black lines represent the flow of mobile phase (orthophosphoric acid) and sample as they travel through the HPLC 
and on to the electrochemical detector.
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2.8.6.2 Determination of Potential for GSH detection
GSH standards, at a concentration of 5pM (GSH in 15mM OPA, pH 2.6) 
were injected on to the HPLC system at various downstream electrode 
potentials in order to ascertain the optimal potential for the determination 
of GSH. The voltamogram generated is illustrated in Fig2.7 and
illustrates that a plateau was reached at around +530mV.
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Fig 2.7 GSH Voltamogram. 5|jM GSH standards were separated by HPLC and 
detected at various downstream electrode potentials. Upstream potential remained at 
+100mV, downstream potential was varied between +420mV and +570mV.
2.8.6.3 Sample and standard preparation
GSH standards were prepared in 15mM OPA (which had been prepared 
in ultrapure H20), at concentrations between 0.5 and 10pM. These were 
frozen at -70°C until used. Cell pellets suspended in HBSS were diluted 
further with HBSS if necessary. The cell suspension was then mixed 1:1 
(vol/vol) with 15mM OPA to extract GSH. The suspension was then 
centrifuged at 500g for 5mins at 4°C to precipitate out protein. The 
supernatant was removed and stored at -70°C. Cell culture medium was 
similarly treated. Medium was mixed 1:1 (vol/vol) with 15mM OPA and 
centrifuged at 500g for 5mins at 4°C. The supernatant was removed and 
stored at -70°C. All cell suspension samples were stable for at least one 
month when stored frozen. Medium samples were not stable beyond 2 
weeks.
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2.8.6.4 Sample handling
Acidified pellets, medium and standards were defrosted and 200pl was 
sealed in Chromacol autosampler vials. Such samples were rotated 
automatically using the cell changer of the autosampler and each was 
automatically injected every 15mins. Samples containing cell culture 
medium were placed on the autosampler and manually injected one at a 
time. Medium samples took 2hours to pass through the column due to 
late eluting peaks and so could not be allowed to remain in a queue for 
column injection. This is due to the fact that GSH degrades at room 
temperature in medium/OPA mix (Fig 2.8).
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Fig 2.8 GSH degradation at room temperature. A 5pM GSH standard was 
repeatedly injected on to the HPLC column using the automatic function of the 
autosampler unit. GSH concentration was reduced to 2pM after 20hours.
The current generated by each sample was converted to GSH 
concentration by comparing peak height with a standard GSH curve. Fig 
2.9 shows that electrochemical detection was linear from 0.5 to 10pM, 
R2=0.991. The retention time for GSH on the HPLC column was 6.6±0.1 
mins (mean±SD) (Fig 2.10). Previous to acid extraction, a sample of the 
cell suspension was removed for protein determination (section 2.8.1). 
GSH concentration was expressed as nmol/mg protein for cell 
suspensions and pM for medium samples.
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Fig 2.9 GSH Standard Curve. Glutathione standards at concentrations of 0.5, 1, 2, 5 
and 10fjM were injected on to the HPLC column. The points on the graph represent 
each sample, linear regression was performed using Microsoft excel.
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Fig 2.10 Chromatogram of Neurobasal sample. The figure is a representative 
chromatogram of neurobasal medium that had been removed from a layer of astrocytes.
2.9 S ta tis tics
Statistical analysis was carried out using Microsoft excel. Student’s t-test 
for paired samples was used, accepting p<0.05 as significant.
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Chapter 3 
‘Establishing a tissue culture 
environment for the study of oxygen 
glucose deprivation/reoxygenation 
related injury’
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3.1 Introduction
As detailed in chapter 1, a variety of models for the study of ischaemia 
exist. In order to answer questions of biological significance in the most 
accurate and informative manner, it is crucial to choose an appropriate 
model to the questions being asked. Because we are interested in 
tapping in to the complicated messaging systems that exist specifically 
between astrocytes and neurones we have chosen to take an approach 
that limits and controls most variables. We have therefore modelled 
ischaemia/reperfusion in dissociated cell cultures.
It has been necessary for us to produce a method both for the culture of 
primary cortical rat neurones and for the induction of hypoxia in these 
cells before studies on cell behaviour following oxygen glucose 
deprivation could be initiated. The following details our reasoning for this.
In the optimisation of the neuronal culture protocol we wished to meet 
three crucial criteria. Firstly, we wanted a culture of high purity in order to 
reduce noise in the gathering of biochemical data. That is to say, we did 
not want the response of one cell type to overwhelm the detection of a 
response from another cell type. Furthermore it has been documented 
on numerous occasions that the presence of contaminating cells affects 
the physiology and viability of neurones (Ahlemeyer et al 2002). We 
wanted to distil the insult given, to a response related entirely to the 
neurones themselves and not other cell types.
Secondly, we wanted to maintain a culture that would live until at least 
DIV10 in order that protein expression patterns within each cell would 
more closely parallel an in vivo insult. Chihab et al (1998) have shown 
how mature and immature neurones react differently to hypoxia. This is 
particularly important with respect to NMDA receptor sub-unit expression. 
A major focus of ischaemia research is excitotoxicity, which is mediated 
largely through NMDA receptor activation (Arundine et al 2003), yet the 
appropriate subunits are not expressed in culture until at least DIV7
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(Mizuta et al 1998). In a similar vein, it has been shown that synapse 
development begins and rapidly proceeds through the second week of 
culture (Lin et al 2002). Neurones rely heavily upon the supply of 
signalling/nutritive factors from other cell types and so it is difficult to grow 
long-lived and pure neurones in culture. It is common to achieve 
longevity by the use of a glial feeder layer (Rogers et al 1997) yet this 
reduces purity. Media supplementation with survival factors such as 
brain derived neurotrophic factor has been used (Negishi et al 2003). 
However, as shown by Dai et al (2003) the efficient survival of neurones 
is dependent upon a number of factors, identified and unknown, working 
in concert.
Thirdly, we wanted to establish growth of the culture on glass coverslips 
in order to carry out imaging studies of Ca2+ dynamics and 
immunocytochemistry to characterise the neurones and establish 
neuronal viability and identity.
The existing method for the growth of neuronal cultures within our 
laboratory led to a final product that had to be used on DIV6 , was around 
85% pure and could only be grown on plastic tissue culture plates. 
Clearly this did not meet our needs and so we had to seek an alternative 
approach.
We have arrived at the current culture method by focussing and 
improving on three crucial areas within the culture preparation namely, 1) 
the dissection and dissociation of cells from foetal brains, 2 ) the seeding 
of cells on suitable surfaces for culture, and finally 3) the use of 
appropriate feeding media. This method has evolved by piecing together 
information from a number of sources and observations.
With respect to the establishment of hypoxia, the introduction chapter 
details the complexities involved. We have chosen again to limit 
complicating factors by aiming to induce an ischaemic insult by the 
removal of metabolic support and not by the direct chemical inhibition of
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respiratory elements. We wanted to achieve OGD in a manner that would 
strike a balance between efficiency in terms of the speed of O2 removal, 
ease of use, reproducibility and cost effectiveness.
3.2 Aim
This chapter has two central aims. The first aim is to develop a pure 
cortical neuronal culture and the means with which to coculture neurones 
with pure cortical astrocytes. The second aim is to derive a method for 
the induction of hypoxia in cultured cells.
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3.3 Methods
3.3.1 Cell culture
Cultures of rat cortical neurones and astrocytes were used and prepared 
as described in section 2 .2 .
3.3.2 Cell death
Cell death was quantified in neurones using the method detailed in 
section 2.5.2 based on nuclear dye exclusion. Astrocytes cell death was 
quantified using the LDH release assay as described in section 2.5.1.
3.3.3 Hypoxia measurement
O2 concentration within the glass desiccating chamber was measured 
using the 782 oxygen meter (Strathkelvin Instruments, Glasgow) as 
described in section 2.7.
3.3.4 Immunocytochemistry
Immunocytochemistry was performed on neurone and astrocyte cultures 
using the method detailed in section 2.3.
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3.4 Evolution of methodology
3.4.1 Cortical neurone culture
We began with a method for the preparation of cortical neurone cultures 
from rat brain devised by Almeida et al (1998) and used routinely in our 
laboratory. Briefly, cells dissected from foetal rat brains were fed with 
FBS supplemented DMEM for 3 days followed by Horse serum 
supplemented DMEM for the rest of the culture life. However, as 
mentioned previously, this method is optimised for neuronal growth up to 
DIV6 for cells that were seeded on plastic dishes. The basic approach to 
the dissection was kept, most importantly the use of embryonic neurones 
as a starting point.
We also attempted to isolate cortical neurones from postnatal day 1 (P1) 
Sprague Dawley rats by this same method, but found them to be far more 
over run with glia (by phase contrast microscopy investigation). It should 
be mentioned that there are methods, which can be used to purify 
postnatal cultures such as immunopanning (Barres et al 1988). We 
chose to concentrate on the embryonic neurones rather than try different 
techniques ad infinitum with the P1 animals.
3.4.1.1 Trituration
We found that there was a considerable amount of debris within the 
culture wells and so we hypothesised that cytotoxic agents released 
during trituration were limiting cell growth. Our first step was therefore to 
try and limit tissue damage during the trituration process in an effort to 
reach a compromise between culture yield and viability. We have found 
that a maximum yield of healthy cells was achieved by using 4 strokes of 
the 1ml Gilson followed by 4 strokes of the 0.2ml Gilson on each repeat 
of the step. This limits the mechanical damage caused to the cells upon 
repeated pipetting.
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3.4.1.2 Seeding surface
The choice of seeding surface is vital for adhesion, growth and 
differentiation. The original method stipulated the use of plastic 6 -well 
plates however, we needed to seed on a surface that would allow us to 
image neurones using fluorescence microscopy, for reasons mentioned 
previously. However a) the plastic at the base of the 6 -well plates is quite 
thick and is therefore outside the working distance of the objective lenses 
used in our microscopes and b) the plates are composed of polystyrene, 
which is not conducive to fluorescence studies.
We came across Thermanox coverslips (Nunc, Rochester NY), which 
overcome these problems of imaging. They are made from a solvent 
resistant plastic material that allows for fluorescence studies and are 
more likely to encourage cell attachment due to the plastic composition. 
However we were unable to grow cells on their surface. At this point we 
speculate that other aspects that had yet to be sorted out in the protocol 
were probably responsible for this. We therefore, turned to the use of 
glass coverslips.
Glass cover slips were cleaned to remove oils and grit, and coated with 
poly-lysine (P/L). Basic amino-acid polymers, such as poly-ornithine (P/O) 
and P/L, apply a charge to the surface acting as an adhesive for cell 
surface proteins. This provides a means by which to anchor the cells and 
to aid in the extension of processes as the culture matures. This latter 
point is important to remember given the fact that the neurones have 
been sheared of axons and dendrites during tissue and cell dissociation 
and therefore must form processes afresh. We have tested a number of 
concentrations of P/O and P/L, in combination with various incubation 
conditions. We used concentrations ranging from 0.1 to 0.001%, for time 
periods ranging from 30mins to 24 hours whilst being incubated in a 
humidified atmosphere at 37°C or simply resting in a flow unit at room 
temperature. Higher concentrations and longer incubation periods 
resulted in no cell adhesion whereas the lower concentrations resulted in 
little cell adhesion by DIV2. We found that 0.01% P/L that has been very
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well mixed at room temperature gave the highest yield of healthy cells 
when allowed to sit on the coverslips for 30mins.
3.4.1.3 Feeding medium constituents
We have found that these neurones preferred a particular media 
preparation. We departed from the use of DMEM and turned instead to 
Neurobasal A medium (NB) throughout the preparation of this culture 
(Brewer et al 1995). According to the manufacturer’s guidelines, NB 
supplemented with 2mM glutamine and 2%B27 provides optimised 
conditions for long-term neuronal survival (Gibco, NB product sheet) and 
is sufficient to maintain cultures for up to four weeks in some instances.
In order to sustain cell growth beyond DIV2 the seeding surface was 
coated with modified NB (Section 22.2.2). We saw that a number of 
groups use this approach for preparing the seeding surface (Harms et al 
2000, Meloni et al 2002) and so we devised our own concoction based 
upon what we felt was most beneficial to the neurones. The mixture of 
equilibrated nutrients awaiting the cell suspension provides a rich 
environment in which the neurones can recover from the trauma of 
tissue/cell dissociation. Without this treatment, neurones on glass tended 
to form dense clumps connected by long phase bright processes. Fig 3.1 
is representative of the condition reached by neurone cultures when 
conditions were imperfect.
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Fig 3.1 Unhealthy neurones. Phase contrast image of cortical neurones in an 
unsuitable growth environment. Cell bodies associate to form large balls connected by 
threads of neuritic processes. 10X objective lens, scale bar represents 80pm.
Traditionally foetal bovine serum (FBS) and horse serum (HS) have been 
used in neuronal culture medium to promote growth and differentiation 
respectively. Animal sera contain a plethora of trophic/nutritive factors, 
however we found that the presence of sera in the staple media resulted 
in an increase in the number of glia. The small concentrations used in 
the coating media are clearly adequate to have a positive effect on 
neuronal survival and so we use them in the coating media only.
Glutamine is extremely important in providing carbon to the TCA cycle of 
cultured cells and is also an important supplier of organic nitrogen. B27 is 
a serum supplement containing a combination of amino acids, vitamins 
and anti-oxidants designed to function in conjunction with NB. Its 
advantage over animal sera lies in the fact that its components can be 
defined and controlled. NB does not contain the excitatory amino acids 
glutamate and aspartate partly in order to limit the instances of 
excitotoxicity during later culture life and also to limit the effects of excess
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glutamate on receptor desensitisation. However, glutamate is an 
important nutritive factor in aiding neurite outgrowth in early culture life. 
Although the B27 supplement has a certain amount of glutamate (25pM), 
it was necessary to add extra glutamate to the media to a final 
concentration of 50pM until DIV3. It may be the case in this instance that 
the cells have a heavier reliance on glutamine, which is catered for by the 
extra glutamate.
We have found through immunocytochemical analysis (Section2.3), that 
neurones at DIV10 contained a high proportion of astrocytes when fed 
only with the manufacturer’s formula (Table 3.3). We therefore included 
cytosine arabinofuranoside (AraC) in the feeding media, as per many 
other protocols (Almeida et al 1998) at DIV3 to a final concentration of 
1 OjllM. AraC is a nucleotide analogue that inhibits DNA replication in 
dividing cells. Because glia continue to proliferate but neurones do not, 
Ara-C selectively kills glia.
However, we observed a dramatic drop in viability by DIV7 (observed 
under phase contrast microscopy). Cells became detached from their 
surface and the remainders formed clumps (Fig3.1). We hypothesised 
that this was due to the lack of glial support and not directly due to the 
addition of Ara-C. We therefore overcame the problem by the use of 
astrocyte conditioned NB, from DIV3, under the premise that we could 
compensate for glial absence by providing essential glia derived 
trophic/protective factors directly. Cultures were fed with conditioned 
media on DIV3 and DIV7 and used for experimentation on DIV10. All 
feeds were carried out by half-changing the media, as the cells died 
within 24 hours of total media change. It appears that a total change may 
disturb trophic support. Table 3.1 summarises the entire feeding protocol 
according to essential modifications.
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DIVO - +
DIV3 + +
DIV7 + -
Table 3.1 Protocol for feeding of neuronal cell cultures. Medium used contained (+) 
or did not contain (-) elements in heading.
3.4.2 Coculture of astrocytes and neurones
A knock on effect of developing the current neurone preparation was that 
our choice for coculture technique became limited. Our lab routinely uses 
cell culture inserts. Basically neurones are grown on the bottom of a dish 
and astrocytes are suspended above them on a membrane that sits in a 
plastic holder. Neurones had to be grown on glass and so cell culture 
inserts could not be used efficiently. We found that, because the 
coverslips were significantly higher than the base of the culture dishes, 
the neurones were effectively suffocated. It became clear that the 
neurone containing coverslips would have to be inverted over the 
astrocyte cultures somehow.
We did not want to risk damage to the neurone layer by placing the 
coverslips directly on to the astrocytes. We decided that the space 
between the two cultures had to be at a minimum with as little impedance 
to diffusion of solutes as possible. Furthermore the space had to be 
highly reproducible from one preparation to the next. We first of all tried 
to dimple the seeding surface of the culture plates by applying a heated 
soldering iron. The idea was that heating the plastic would cause a 
raised doughnut shape upon which we could rest a coverslip. In our 
hands this did not work very well and the height was far from 
reproducible. The use of glass beads in the culture dish fills all our 
criteria nicely with the addition that they are inert and easily sterilised.
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We initially soldered three beads in to the seeding surface of the 6 -well 
plates on which we placed the coverslips. However, it was difficult to
create a reproducible height above the surface and leaks were quite
common. This was due to the fact that the walls of the wells made it
awkward to place and control the soldering iron. Furthermore, the
coverslips did not balance well on three points. We therefore turned to 
using four beads but melted them in to the outside bottom of the 6 -well 
plate instead. This gave us much better control over the height of the 
beads with the added benefit that the sterility of the system was 
maintained more carefully. We also created a template for the placement 
of the beads to ensure that each coverslip was in exactly the same 
position from well to well (Fig 3.2).
114
^ ^ e rs lip
~
Bead Neuronal surface
Bead
Fig 3.2 Co-culture system. A is an overhead view showing the position of the glass beads in a well of a 6-well plate. B is a side view showing 
the glass beads infused in the plastic well. The coverslip is resting on the raised surface with neurones facing the astrocytes lying on the bottom 
of the plate.
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3.4.3 Creating a hypoxic environment
The first step in creating a hypoxic environment for cell cultures was to 
find a way of housing the cells during the insult and almost as importantly, 
to find a suitable method to indicate low O2 levels. We initially used a 
Perspex box for the purpose of housing cells (Fig 3.3), which was sealed 
within a temperature-controlled incubator. We included a resazurin 
soaked pad as an indicator of hypoxia (section 2.4.1).
Fig 3.3 Perspex box. The box is housed within an incubator. The Box contains tubes 
for entry and exit of gas (left hand side of diagram), and a 6-well plate as a means with 
which to perceive the dimensions of the apparatus.
It quickly became apparent that the perspex was far too permeable to O2 
to efficiently induce hypoxia. We therefore turned to the use of a glass 
desiccating chamber using a modified lid (constructed by Radleys, Essex, 
UK) for inclusion of gas inlet/outlet ports (Fig 3.4), housed within an 
incubator.
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a/ / M m
V
Fig 3.4 Glass desiccator. The modified lid is seen at the top complete with tubing for 
passage of gases, the base in filled with H20  to achieve a humid atmosphere.
We achieved hypoxia by flushing the glass chamber with a mixture of 
9 5 %N2/5 %C0 2 , that had been passed through an 0 2 trap to remove trace 
0 2 from the stream. We also tested a number of chemical systems to 
limit the amount of gassing time necessary. These are summarised in 
Table 3.2. As none of these methods made a significant difference, they 
were not used for the final protocol.
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Glucose oxidase Oxidation of glucose 
eliminates 0 2, 
catalase used to 
eliminate H20 2 
byproduct.
0 2 not sufficiently low.
Na2C03/K2HP04 Ascorbate oxidises at 
alkali pH, using 0 2.
0 2 not sufficiently low.
Na2S204/K0H/Na2C03 Na2S20 4 is a reducing 0 2 removed but
agent at alkali pH. culture media very
Na2C 03 used to alkali.
prevent C 02
depletion.
Powdered Fe2+ Binds to 0 2. 0 2 not sufficiently low.
Table 3.2 Chemical scavenging mechanisms. Summary of the methods used in 
conjunction with the flushing of the chamber with gas.
3.4.4 Hypoxia in cultured cells
There were a number of extra factors to consider when making cell 
cultures hypoxic. First of all, the culture dishes tend to store a certain 
amount of 0 2 (Meloni et al 2001, Munns et al 2002). Also, the H20  at the 
base of the chamber was capable of releasing 0 2. To circumvent these 
potential sources of 0 2, we gassed the chamber, and where possible, the 
culture dishes before the experiment began. The culture media itself is 
another potential 0 2 source. Most groups tend to bubble the media with 
an anoxic gas mixture. However, we felt that this was an unnecessary 
step because in the length of time it took to prepare the cells for the 
chamber, the 0 2 would have rapidly returned.
3.4.5 Completing OGD/reoxygenation
With hypoxia established we completed the simulation of ischaemia by 
using Dulbecco’s modified Eagle’s medium (DMEM) deprived of essential
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energy substrates rather than a balanced salt solution suggested by the 
method of Goldberg (1993). The intention was to limit the number of 
variables being removed from the system. For astrocytes we simply 
washed the culture and exchanged the media however the neurone 
culture did not react well to this procedure. We therefore decided to 
quickly move the coverslips from one condition to the next.
We originally used complete DMEM for the reoxygenation media but 
again this resulted in high mortality in the control neurone culture, 
specifically 32±4.95% (mean±SEM) cell death after 24hours of 
reoxygenation (measured as described in section 2.5.2). We therefore 
used the NB/B27 combination but this time without the antioxidants so 
that there would be no masking of potential neurotoxic effects. The 
medium was also devoid of phenol red as it interferes with a number of 
biochemical assays used.
We have used relatively high glucose concentrations in the control and 
reperfusion media. Both contain 2.5mM, which is typical of 
concentrations required by neurones in primary culture. We opted for this 
concentration rather than a more physiologically accurate amount, as we 
did not want to add another stress variable to the equation. Because we 
used this concentration with neurone cultures, we matched it in astrocyte 
cultures.
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3.5 Model validation
3.5.1 A pure neurone culture?
The homogeneity of the cortical neurone cell culture was assessed by 
means of immunocytochemistry (Section 2.3) and gross morphology 
under phase contrast conditions (Section 2.6.1). Immunocytochemistry 
showed the cortical neurone cultures to be almost completely devoid of 
astrocytes and microglia by DIV10. Table 3.3 highlights this fact and 
shows how the alternative method of excluding Ara-C affects the purity of 
the neuronal culture.
NB on ly 12% none 85% 3%
NB + AraC 1% none 99% none
Table 3.3 Immunocytochemistry. Neuronal cultures were stained with antibodies as 
described in section (2.3). GFAP is the astrocyte marker, cd11b the microglial marker 
and Tub the neuronal marker. Orphan represents nuclei present that did not have a 
surrounding stain.
Confocal images show the specificity with which the anti-tub antibody 
stains neuronal processes and the intricate network of connections 
formed by these. Fig 3.5 shows the interconnecting neuronal processes.
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Fig 3.5 Immunocytochemical stain of DIV 10 cortical neurones. Image taken using 
confocal microscopy. Green colour represents the anti-tubulin stain and the blue colour 
represents DAPI stained nuclear DNA. 63x objective, scale bar represents 10pm.
Astrocytes, which have been detected on occasion in these cultures, 
appear quite spikey, resembling thick tree branches (Fig 3.6). This is in 
stark contrast to the more delicate neuritic processes and to the flat, 
rounded appearance of astrocytes in pure astrocyte cultures of the same 
age.
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Fig 3.6 Immunocytochemical stain of DIV10 cortical astrocytes in a neuronal 
culture. Image taken using confocal microscopy. Red colour represents the anti-GFAP 
stain and the blue colour represents DAPI stained nuclear DNA. 40x objective, scale bar 
represents 20pm.
Using phase contrast microscopy, neuronal soma can be seen to have a 
morphology that varies between pyramidal and slightly oblong, with a 
small dark nucleus at the centre. The culture was relatively dense and 
was marked by an intricate network of processes (Fig 3.7). There were 
no obvious glia present.
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Fig 3.7 Primary cortical neurones. Phase contrast image of neurones taken at DIV10. 
Neuronal soma can be clearly identified as almost spherical objects with extended 
neurites. The arrow is pointing to a typical neurone. 20X objective lens, scale bar 
represents 40pm.
3.5.2 Gross morphology of neurones through development
The morphology of the neurone culture was recorded as it developed 
from the original dissection to DIV10 (Fig 3.8). On DIV1, cells have 
successfully adhered to the growth surface and have begun to extend 
processes. By DIV3, just prior to AraC treatment, these processes have 
made contact with neighbouring cells to form the beginning of a network. 
At this point also, it is possible to see some astrocytes as cells that are 
flat, large and less phase dark than the neurones. As the culture 
advances to DIV10, the most notable feature is the increasing density of 
neurites, which is consistent with the timing of synapse formation (Lin et 
al 2002). The neuronal soma itself does not appear to get significantly 
bigger from DIV3, although there is some loss of phase dark character 
and a roundening of shape.
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Morphological Progression of Cortical Neurones
DIV 10
Fig 3.8 Morphology of cortical neurones in culture. Images taken at 1 hour, 1 day, 
4 days, 7 days and 10 days in vitro. 20X objective lens, scale bar represents 40pm.
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3.5.3 Health of neurone culture
The number of live cells in the culture as a whole was assessed at DIV7 
and DIV10 by analysis of nuclear morphology (section 2.5.2). It was 
found that the culture was 94.6±4.52% populated with live cells at DIV7 
(mean ± SEM, n=3) and 90.6±3.65% at DIV10 (mean ± SEM, n=6) at 
DIV10. The cultures were closely monitored for loss of adhesion and the 
appearance of cells in the culture medium, by phase contrast microscopy. 
By visual inspection, there was no significant cell loss between DIV4 
(following Ara-C treatment) and DIV10.
To confirm viability and identity of the cells we monitored intracellular 
Ca2+ dynamics in response to an application of 100pM glutamate (section 
2.6.2.1). Fig 3.9 is representative of a typical experiment and 
demonstrates how all cells monitored showed a rise in Ca2+ concentration 
following the application of glutamate. Cells exposed to vehicle (buffer 
solution only) did not show any response.
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Fig 3.9 Ca2+ dynamics in cortical neurones. Change in intracellular Ca2+ 
concentration in response to the application of 100pM glu. The lines represent the 
response from individual neurones within a single field of vision.
We finally wished to determine how amenable this neuronal prep was to 
experimentation. We moved a number of coverslips from one well
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containing NB to another. The culture contained 85% live cells 
immediately after moving and 82%, 24hours later.
3.5.4 Efficacy of bead system
The distance between each coverslip and the surface of the 6-well plate 
was measured using ‘Absolute digimatic’ vernier callipers and found to be 
0.55±0.009mm (mean ± SD, n=24). We compared the viability of 
neurones inverted over the beads, with neurones sitting right side up in 
the base of a 6-well plate. Cell death was measured as described in 
section2.5.2. Fig 3.10 shows that there is no statistically significant 
difference in the level of cell death between the two methods at each time 
point.
6 12 24
Time (hrs)
Fig 3.10 Bead system. Comparison between inverted and ‘right side up’ neurones. 
Neurones were assessed according to nuclear morphology at 6, 12 and 24 hours 
following placement of the coverslips either over beads ( | )  or in the bottom of a tissue 
culture plate ( ). Mean ± SEM, n=4.
We have also observed that the health of the neurone culture, as judged 
by phase contrast microscopy, is greater when in closer apposition to the 
astrocyte layer. This was observed by allowing 2 beads (of the 4) to be 
placed further back in to the plastic, thereby creating a graded decrease 
in distance between the 2 cell types.
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3.5.5 Confirming hypoxia
An 0 2 meter was used within the glass desiccator in order to measure the 
0 2 concentration (section 2.7). The 0 2 concentration of respiration buffer 
on its own was first measured and found to reach 1pM after 60mins of 
gassing (Fig 3.11). Over a period of 12 hours (after the end of the 
gassing period), the concentration of 0 2 did not rise significantly, 
indicating the system to be airtight. The colour change of the resazurin 
pad mirrored these results. As the 0 2 meter is far too large to place in the 
chamber for all experiments, the pad was used to confirm hypoxia on all 
subsequent occasions. The 0 2 concentration within a suspension of 
astrocytes in respiration buffer was then measured and found to reach 0 
pM by 60mins of gassing, reflecting 0 2 consumption by the cells. The 
suspension was at a concentration that would reflect that of cells present 
in an area of the culture wells equivalent to the area of the 0 2 electrode.
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Fig 3.11 0 2 depletion. Oxygen removal from glass desiccator. 0 2 concentration was 
measured using the 782 0 2 meter as 95%N2/5%C02 was flushed through the chamber.
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In order to confirm that suitably hypoxic conditions were being reached 
within the cell culture dishes, and that cells were in fact being made 
ischaemic and not just suffering from substrate deprivation, we deprived 
cortical astrocytes of essential metabolic substrates only. Astrocytes were 
deprived of glutamine, glucose and pyruvate as per an ischaemic insult 
but were incubated in 95% air. As can be seen in Fig 3.12 LDH release 
was extremely low even at 24 hours there was no statistically significant 
difference between control and test cells.
Control
Length of insult (hr)
Fig 3.12 Astrocytes subjected to glucose deprivation. The (pink line) represents 
astrocytes deprived of glutamine, glucose, pyruvate and serum supplement, the (light 
blue line) represents control cells. Data analysed using a paired t-test with p<0.05 
significance, n=4.
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3.5.6 Stability of temperature
Temperature was measured during gassing and throughout the 
ischaemic period. The temperature was found to drop from 37°C to 36°C 
over the 60mins of gassing but returned to 37°C within 10mins of the start 
of ischaemia.
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3.6 Discussion
3.6.1 Neurone culture
We have set out to build a culture that is highly homogenous for rat 
cortical neurones. The results show that this has indeed been achieved. 
We have observed that astrocytes in this culture exhibit a branching 
morphology, on the rare occasions that they have actually been detected. 
Ahlemeyer et al (2002 and 2003) suggest that this is due most likely to 
activation by the addition of AraC. However, Perez-Capote et al (2004) 
describe the same morphology in their mixed neurone-glia cultures, which 
have not been exposed to Ara-C. It is more likely therefore that the 
stellate morphology arises from either a) diffusible factors from neurones 
or b) physical contact between the two cell types.
Our viability studies showed that there was little cell death within the 
cultures when assessed at DIV10. The figure of 10% dead cells could be 
interpreted in a different manner because the counting method we use 
discounts floating material. It could be that 10% cells are dying each day 
from the time of plating in which case massive cell death has occurred by 
DIV 10. In dispute of this theory we have observed, by phase contrast 
inspection, that there is very little debris within the cell culture dishes as 
the growth in vitro continued from DIV 1. Indeed the clarity of the images 
in fig 3.8 is proof of this. It would appear therefore that the dead cells 
counted refer to an accumulation of dead cells from the time of plating to 
the time of counting at DIV10, and is minimal.
The cells that are alive at DIV 10 are also viable. We have shown this by 
looking at the response of the neurone cultures to an application of 
100pM glutamate. There was a clear and consistent rise in intracellular 
Ca2+ concentration amongst nearly all neurones present in the field of 
vision. Further to confirming the health of the neurone culture, the 
response to glutamate in most cells analysed, also confirms that the cells 
are in fact neurones as Ca2+ levels in astrocytes do not respond to 
glutamate.
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Perhaps the most intriguing part of the current method is in the use of 
astrocyte-conditioned media to promote the survival of neurones. 
However, this will be discussed in detail in chapter 5.
3.6.2 Co-culture
We have also produced a novel co-culture system, which we have shown 
to be effective in combining astrocytes and neurones. The method is 
highly reproducible, as judged by the error in measurements of bead 
height and is also a considerable improvement on the distance achieved 
by other methods (detailed in chapter 1).
The reproducibility of the distance is an important aspect of co-culture as 
we have seen that neuronal health is enhanced when neurones are 
closer to the astrocyte layer. Variability in height would inevitably lead to 
variability in results. The most logical reason for this observation would be 
a reduction in dilution of compounds being released by either cell type. 
This is always a problem with cell culture studies, when relating them to 
more physiological situations. The volume of medium above the cell 
cultures, vastly exceeds the volume of fluid normally bathing a cell, and 
thus dilutes anything being released.
We have not actively carried out a detailed analysis of the relationship 
between inter-culture distance and neurone viability. However, in theory, 
our co-culture system is perfectly set up to do this. The beads can be 
infused in the plastic to achieve much smaller or larger bumps but 
importantly this can be done in a reproducible manner.
3.6.3 Limits of neurone culture
It is not clear how closely this neurone preparation mimics the behaviour 
of cortical neurones of similar age in vivo. A crucial difference between 
this preparation and neurones growing in vivo is the absence of 
myelinating glia. It is unlikely that there are oligodendrocytes present and 
so the neurone axons most probably lack a myelin sheath, which will 
affect fast synaptic transmission. Neurones in culture have been shown
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to form synaptic connections but with highly inefficient results in terms of 
synaptic activity (Pfrieger et al 1997). Furthermore, it must be kept in 
mind that there is a significantly greater volume above the cultures than 
the equivalent compartment in vivo. As mentioned previously, this could 
have a diluting effect on signalling factors.
As with all monocultures, it is clear therefore that what we have 
developed is a tool that has to be used with careful consideration as to 
the nature of the specific questions being asked.
3.6.4 Hypoxia in culture
The results show quite clearly that O2 is being eliminated efficiently from 
the glass chamber with little adverse effect on temperature. Temperature 
change can effect ischaemic outcome (Adachi et al 1998) particularly 
when elements such as NMDA receptor activity is involved (Lipton 1999). 
We had to deduce O2 levels in the culture wells, as our detection system 
could not measure O2 in culture wells directly. Firstly, the cell suspension 
was deprived of 0 2 within the same time frame as respiration buffer only. 
Low levels were maintained over many hours. Because the O2 probe 
consisted of a relatively large box, with a lot of potential storage space for 
O2, we can assume that the length of time for O2 evacuation was actually 
over-estimated.
Secondly, astrocytes that had been deprived of glucose only, did not 
suffer significant cell death following a 24hour substrate free period. It 
has been shown that astrocytes, which have been deprived of substrate 
or O2 separately, take significantly longer to exhibit cell death than 
astrocytes given the combined insult (Pauwels et al 1985, Hertz et al 
1995). Our results agree with these observations and confirm that 
hypoxia had been induced.
3.6.5 Points to note
A possible problem with the current model is the length of time it takes to 
achieve hypoxia. In vivo, the interruption of blood supply causes a
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dramatic decline in O2 as trace amounts of the gas are quickly consumed 
by the mass of tissue surrounding the infarct area. However, this sharp 
decline is difficult to achieve in vitro. Because cytochrome oxidase has 
an apparent Km of 0.1 pM for 02, mitochondrial respiration can continue 
at very low levels of O2 (Clark et al 1976). Therefore, the cultured cells 
may receive a graded insult rather than an acute burst which may 
possibly allow time for adaptation.
The time taken to establish hypoxia can be reduced by using an 
anaerobic incubator with a glove box system (described in introduction), 
as this set up allows for media to be evacuated of O2 in a more efficient 
manner However these systems are expensive and as such were 
inaccessible for our uses. Furthermore, although the bulk O2 can be 
removed from the system quickly there would still be sufficient O2 in the 
vicinity of the cells, and particularly cytochrome oxidase, to support a 
graded reduction in respiration rather than a precipitous decline.
We could have used the approach of using metabolic inhibitors to more 
rapidly effect hypoxia but, in keeping with our main aim, we wanted to 
create a simple method. Inherent in this simplicity is the existence of as 
few variables as possible. As alluded to previously, chemical ischaemia 
is not very clear-cut in terms of the processes it effects within the cell and 
more importantly these chemicals may linger during reoxygenation.
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3.7 Conclusions
We have met the two central aims of this chapter and successfully 
created a culture system with which to carry out oxygen glucose 
deprivation. The neurone preparation is 1) relatively long lived, 2) pure 
and 3) robust. Likewise, the coculture system has no adverse effects on 
neuronal character that we could determine and allows for the efficient 
exchange of information between two different cell populations. Our 
method for the removal of O2 from cultured cells is simple and efficient. It 
is effective and reproducible, keeping complicating factors to a minimum.
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4.1 Introduction
Having established a culture system and the means with which to make it 
hypoxic, we now want to combine these techniques to do two things. 
First of all we want to produce a model of neuronal reperfusion injury in 
vitro. And secondly we want to characterise our model of O2 glucose 
deprivation with reference to existing models.
We hypothesise that the length of the OGD period determines the pattern 
of cell death in the reoxygenation period such that the 
progressive/delayed neuronal death seen in parts of the brain during 
reperfusion can be reproduced. Some groups have used 
pharmacological intervention to imitate aspects of ischaemic neuronal 
injury (Meloni et al 2001, Uto et al 1995, Gwag et al 1995). Although such 
models do succeed in producing features of in vivo cell death during 
reperfusion, we believe it is more prudent to keep the insult as pure as 
possible as complicating variables such as NMDA receptor blockade, a 
popular approach, may have effects beyond the scope of the true insult.
It is quite clear that the ischaemia/reperfusion insult involves the interplay 
of many different facets of cell signalling. It would therefore seem more 
logical to establish a model based on the insult-inducing parameters 
soley, rather than to establish a model based on a single pathway of the 
insult-inducing parameters. For this reason we will attempt to produce a 
steady increase in neuronal death, by varying the time of the insult only, 
without interfering directly with the cell’s signalling pathways. We have 
chosen to model a progressive neuronal loss as this mirrors focal 
penumbral damage and parts of global ischaemic damage (see chapter 1 
for description). By its nature, death after the ischaemic insult suggests a 
possibility for therapeutic intervention and so is worth exploring.
With respect to characterising our method of OGD, it is important to be 
able to compare and contrast results from one model to the next in order 
to make sense of data and ask the most appropriate questions. With this
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in mind, we will characterise this model using two related parameters. 
Firstly we will look at the temporal profile of cell death induction in both 
astrocytes and neurones individually. Secondly we will make a
comparison between the two cell types. Dissociated cell culture models 
highlight quite effectively the fact that astrocytes survive OGD of 
significantly greater lengths than neurones, although the time course for 
injury induction varies between one model and the next (discussed later) 
(Wang et al 2002, Goldberg et al 1993). It is therefore important for us to 
ask if such a difference exists in this model.
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4.2 Aim
The aims of this chapter are:
1) To create a model of reperfusion injury in cortical neurone cultures 
from foetal rat brain.
2) To ascertain the temporal parameters of cell death of both cortical 
astrocytes and neurons, in response to OGD.
4.3 Methods
4.3.1 Cell culture
Cultures of rat cortical neurones and astrocytes were used and prepared 
as described in section 2.2.
4.3.2 O2 glucose deprivation/reoxygenation
Neurones and astrocytes were subjected to OGD/reoxygenation as 
described in section 2.4.
4.3.3 Cell death
Cell death was quantified in neuronal cultures according to the method 
detailed in section 2.5.2. It was not necessary to immunolabel the cells 
being counted as previous immunocytochemistry showed the population 
to be devoid of other cell types. Astrocyte cell death was quantified using 
the LDH release assay as described in section 2.5.1.
4.3.4 Microscopy
The health of neurone and astrocyte cultures was monitored by visual 
inspection using phase contrast microscopy as detailed in section 2.6.1.
4.3.5 Immunocytochemistry
Immunocytochemistry was performed on neurone and astrocyte cultures 
using the method detailed in section 2.3.
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4.3 Results
4.3.1 Characterisation of neurone culture
See chapter 3.
4.3.2 Characterisation of astrocyte culture
4.3.2.1 Purity
The cortical astrocyte cultures were found to be completely devoid of 
neurones and microglia, as determined by immunocytochemistry. Almost 
all nuclei could be assigned to a surrounding GFAP stain, accounting for 
99% of nuclei present. A very strong positive stain was achieved through 
use of the anti-GFAP/Cy5 combination (Fig 4.1).
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Fig 4.1 Cortical astrocytes. Immunocytochemical stain of DIV14 cortical astrocytes. 
The confocal image is a z stack reconstruction, dark patches represent undulations 
beyond the limits of the plane acquired. Red colour represents the anti-GFAP stain and 
the blue colour represents DAPI stained nuclear DNA. 20x objective, scale bar 
represents 20pm
4.3.2.2 Morphology
The astrocyte monolayer has a flat cobblestone-like appearance under 
phase contrast conditions. The culture appears quite homogenous. The 
individual cell soma appear more phase bright than neurones with a 
nucleus that is difficult to discern from the cytosol (Fig 4.2).
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Fig 4.2 Cortical astrocytes. Phase contrast image of DIV14 cortical astrocytes. 10x 
objective, scale bar represents 40pm.
4.3.3 Effect of OGD/reoxygenation on neurone culture
4.3.3.1 Neuronal death increases with insult severity
Cortical neurones were subjected to OGD for 15, 30, 60 and 120mins and 
were then allowed to recover for up to 24hours. Cell death was quantified 
at defined time points during re-oxygenation by analysis of nuclear 
morphology (section 2.5.2). Fig 4.3 summarises the data obtained 
following 15, 60 and 120mins of OGD, showing the proportion of live cells 
in the whole cell population for each condition. The data for 30mins OGD 
are not shown, as we did not carry out enough experiments with which to 
judge statistical significance. To recapitulate, the total live cell count is 
the sum of the nuclei that fell in to the live and early apoptotic categories.
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Fig 4.3 OGD and re-oxygenation in cortical neurone cultures. Cortical neurones 
were subjected to an OGD insult of either 15mins (graph A), 60min (graph B) or 120mins 
(graph C) and allowed to recover for a 24 hour period. The graph shows the percentage 
of live cells present in the total cell population. The pink line represents neurones 
subjected to OGD, the blue line represents control neurones. Data, mean ± SEM, 
analysed using a t-test with p<0.05, (*) marks significant difference between control and 
OGD groups, n=4 for B and C, n=7 for A.
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An insult of 15mins OGD is less severe than an insult of 60 and 120mins 
OGD. There are two facets to the current data that illustrate this point 
quite clearly. These are the values obtained for live cell numbers at the 
start of the recovery period (ie end of the OGD period) and the rate of 
neuronal decline during the recovery period.
It can be seen when looking at TO, the time point at the end of the OGD 
period, that there is an immediate and considerable amount of cell death 
in OGD cultures of the 60 and 120mins conditions (Live cells, 42±2.8% 
60mins, 42±3.2% 120mins). However there are far more live cells in the 
15mins OGD culture (86±3.2%). The 15min TO was found to be 
significantly different to both the 60 and 120mins TO at p<0.005.
There was a significant difference in the number of live cells between 
control and OGD cultures at each time point following OGD of 60 or 
120mins (p<0.05). This contrasts with the data obtained following 15min 
OGD. Here, control and OGD values were almost identical at the onset of 
the recovery period (86±3.2% for OGD and 85±7.1% for control cultures) 
but significantly different there after (p<0.05).
Neuronal death proceeded throughout recovery but with a different rate 
profile between the 15, 60 and 120mins conditions. Fig 4.4 shows that 
the 60 and 120mins condition dropped to a plateau level of cell death 
within 6hours of the end of the OGD period. In contrast to this, the 
15mins condition declined at a steadier rate without reaching a plateau, 
but reaching the same final values as the 120 and 60mins conditions. 
The results are expressed as a fraction of the control values to account 
for cell death within the culture, not directly related to the OGD insult and 
to eliminate variability between separate cultures. It can be seen in both 
fig 4.3 and 4.4 that there is also a slight but still significant difference in 
the initial death rate between the 60 and 120 mins conditions. The 
120mins condition drops more quickly than the 60mins condition between 
0 and 6 hours of recovery. The number of live cells in the 15min
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condition was still significantly greater at 2hours of recovery than the 60 
and 120mins conditions at Ohours (p<0.05).
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Fig 4.4 Rate of cell death in cortical neurone cultures Cortical neurones were 
subjected to an OGD insult of 15mins (blue line), 60min (black line) or 120mins (pink 
line) and allowed to recover for a 24-hour period. The graph shows the level of live cells 
in the cultures subjected to OGD expressed as a percentage of the live cells in the 
control cultures. Data, mean ± SEM, n=4.
We also noted that cell death seemed more severe in areas of the 
coverslip in which there was a high density of cells. As much as possible, 
coverslip areas were counted in a random manner such that the overall 
counts reflect both sparse and densely populated areas.
4.3.3.2 Nuclear morphology
The nuclear stains showed that there was a marked difference in nuclear 
size between control and OGD neurones across the different insults. 
Essentially, nuclei that were counted as ‘live’ were smaller than their 
control counterparts, yet retained the homogenous light blue appearance. 
There also appeared to be more nuclei per field in the OGD cultures 
despite a similar plating density. (Fig 4.5). It was found that, although 
OGD nuclei could be counted in one group with respect to the 
appearance of the nuclear DNA, they were in fact hovering on the border
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with another group when compared with controls. Standardisation of 
group assignments therefore became difficult (see discussion).
4
i \
Fig 4.5 Neurones stained with fluorescent dyes targeting nuclear DNA. Blue colour 
corresponds to Hoechst, red colour corresponds to Propidium Iodide. Arrow 1 points to 
live healthy nucleus. Arrows 2 and 3 point to apoptotic nuclei. Arrow 4 points to necrotic 
nuclei.
4.3.3.3 Neuronal death is predominantly necrotic 
Dead and dying neuronal cells were identified as being necrotic or 
apoptotic (criteria detailed in section 2.5.2). Table 4.1 illustrates the 
spread of cell death type during the recovery phase following insults of 
15, 60 and 120mins duration. We have only shown data for necrosis 
here, as obviously, apoptosis constitutes the remaining fraction of cell 
death type. There is no significant difference between control and OGD 
groups with respect to cell death type. At each time point from each
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injury group (ie. 15, 60 or 120mins insult), the same proportion of 
necrosis (and therefore apoptosis) was observed in the control and test 
cells.
Necrotic cells, % o f total dead cells 
Time (hrs) 15mins 60mins 120mins
0 34±16.1 36±24.1 78±12.9 72±9.2 71±6.5 77±1.1
2 63±10.9 64±8.7 48±7.9 75±6.9 80±2.9 80±7.9
4 63±7.2 54±13.6 45±11.7 67±8.6 64±10.9 81±4.6
6 69±2.9 71±6.8 59±7.9 56±17.1 74±11.1 76±6.0
12 64±13.8 54±17 61±1.2 75±10.1 60.6±16.4 69±10.9
24 60±17.7 56±18.9 69±3.0 73±4.3 84±3.2 77±8.5
Table 4.1 Cell death type. This table shows the amount of necrotic death within the 
neurone cultures expressed as a percentage of the total amount of dead cells. Data, 
mean±SEM, n=4 or 5.
The table shows that necrosis was the dominant form of death type 
during recovery at most time points. However, there was less necrosis 
and more apoptosis observed at TO of the 15mins insult group.
4.3.3A Gross morphology
The gross morphology of the cortical neurones was also assessed by 
phase contrast microscopy (section 2.6.1). There was an obvious 
difference between control and OGD neurone cultures from the outset of 
re-oxygenation. The soma of OGD cells were more swollen than control 
and showed a more phase bright character (Fig 4.6). The figure clearly 
shows that the OGD culture has far fewer recognisable cells. There 
appeared also to be more remnants of broken cells such that the culture 
as a whole assumed quite a grainy appearance.
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Fig 4.6 Neurone death during reoxygenation. Phase contrast images of neurones 
following 20hrs of re-oxygenation after a 15min OGD period. The upper panel shows 
control neurones, the lower shows OGD neurones. 20x objective lens, scale bar 
represents 30pm.
Neurite breakdown was a salient feature of ischaemic cultures from 12 
hours of re-oxygenation (Fig 4.7). As reperfusion continued, control
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cultures assumed this morphology yet, in general, the cell bodies remain 
more phase dark and the cultures show less neurite breakdown.
Fig 4.7 Morphology of neurites following OGD. Phase contrast image of neurones at 
24hrs of re-oxygenation following a 15min OGD insult. Neurites are very grainy in 
appearance (arrow) and no longer appear to form connections with each other. 20x 
objective lens, scale bar represents 30pm.
4.3.4 Effect of OGD/reoxygenation on astrocyte culture
4.3.4.1 Astrocyte death increases with insult severity
Astrocytes were subjected to OGD for various lengths of time from Ohr to 
20hr and viability was assessed by means of the LDH release assay 
(section 2.5.1) Fig 4.8 shows that significant LDH release was observed 
immediately after 8hours of OGD.
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Fig 4.8 OGD in cortical astrocytes. LDH release following OGD of various lengths in 
cortical astrocytes, expressed as fraction of total. Blue line represents values from 
control cells, pink line represents values from cells subjected to OGD. Data, mean ± 
SEM, n=7, p<0.05 significance, marks significant points between control and OGD 
cells.
Astrocytes were also subjected to OGD of 30, 60 and 120mins and 
allowed to re-oxygenate for up to 24hrs. There was no significant cell 
death during re-oxygenation following insults of these lengths. Fig 4.9 
illustrates this point taking the case of a 60min OGD insult.
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Fig 4.9 60min OGD with reoxygenation in cortical astrocytes. LDH release during a 
24 hour recovery period following OGD of 60min duration in cortical astrocytes. Pink 
line represents control cells, blue line represents cells subjected to OGD. Data, mean ± 
SEM, n=5.
4.3.4.2 Morphology of astrocytes
Phase contrast microscopy of the astrocytes reflected the results of the 
LDH release assay in that no morphological changes were seen in the 
cultures until between 6 and 8hrs of OGD was achieved. At this point, 
single cells began to detach from the surface of the plate and the nucleus 
became more prominent, surrounded by a darkened cytoplasm. Fig 4.10 
illustrates this morphology
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Fig 4.10 Astrocyte morphology following OGD. Phase contrast image of cortical 
astrocytes taken after 8 hours of OGD. The arrow points to an astrocyte whose 
morphology has become altered. 20X objective lens, scale bar represents 40pm.
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4.4 Discussion
4.4.1 Choice of cell death assay
Cell death is a common endpoint for the determination of OGD induced 
damage giving information of both a qualitative and quantitative nature. In 
the latter case, quantifying dead cells is a clean method for statistical 
analysis. In the former, determining precisely which route a cell chooses 
to take towards its demise may provide an opportunity for therapeutic 
intervention. We were originally interested in looking at the type of 
neuronal death yet we only wanted to quantify astrocyte death as a 
means of establishing an injury end point.
For astrocyte cultures we chose to measure LDH release which has been 
shown to be an accurate indicator of culture viability (Koh et al 1987). 
This is generally not a viable option for neuronal cultures as they 
traditionally contain a small amount of glia and glia contain more LDH 
than neurones which could potentially mask neuronal results. Also the 
LDH assay cannot distinguish between apoptosis and necrosis. We 
therefore turned to a dye exclusion type assay (Juurlink et al 1993). Dye 
exclusion as we use it, was not an option for astrocytes, as they would 
have had to be grown on glass coverslips. We have found that, following 
relatively short periods of OGD, astrocytes lose adhesion to the glass 
surface and thus cannot be counted or observed in a similar manner to 
neurones. Loss of adhesion does not necessarily mean the cells are 
dead and so counts can be misleading.
Both assays rely on membrane integrity the compromise of which is an 
early indicator of cell death. The assessment of membrane integrity on 
its own is fairly non-specific in differentiating forms of cell death, 
particularly as the plasma membrane remains intact well into the 
apoptotic process (Smolewski et al 2002). For this reason, we 
incorporated an analysis of both nuclear and whole cell morphology by 
microscopy for neurone cultures.
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4.4.2 OGD and neurones
4.4.2.1 Cell death increases with insult severity
We have shown that there is significantly more cell death in neuronal 
cultures immediately at the end of a 60 or 120min OGD insult when 
compared with cultures at the end of a 15min insult. Furthermore, cell 
death reaches a maximum more rapidly during recovery following insults 
of a greater length.
It is not in the least bit surprising that depriving neurones of essential 
metabolic substrates for 120 and even 60mins is more damaging than 
15mins. It is well documented that the extent to which neurones die 
during re-oxygenation is dependent upon the length of the initial insult 
(Goldberg et al 1993, Wang et al 2002, Meloni et al 2001), which is also a 
corollary of our observations at the outset of recovery. It is however 
slightly surprising that there is no difference between the 60 and 120mins 
insults. Why should this happen?
In dealing with the OGD period itself, one could assume that there is a 
point of OGD duration at which maximum damage is done. We propose 
the idea that the insult may have a ‘maximum capacity’ with respect to 
insult severity. Because some injury takes time to develop and be 
observed, there would be a plateau point in cell death between the time 
when all immediate effects are seen and when late effects are beginning. 
Taking our data in to account, the beginning of this plateau is somewhere 
between 15 and 60mins and its end is somewhere after 120mins of OGD 
so that what we see at 15mins is the beginning of a steady decline. This 
could therefore account for the lack of distinction in initial death levels 
between the 60 and 120min periods.
Although there is no difference in the initial level of death between the 60 
and 120min insults, there is a clear difference in the rate at which death 
proceeds during the recovery phase. Both insults arrive at a similar level 
of death by 24hours of recovery and share an exponential decay profile 
with respect to time. However, the 60min insult takes longer to reach its
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maximum level of death. This does directly support and reflect the 
previously stated observations that OGD severity strongly influences the 
extent of cell death during recovery.
At first glance it would appear that the trend in our data with respect to 
insult severity and cell death marries well with the current literature 
however, there does seem to be some disparity in the length of time 
taken to induce cell death from modet to model using a system similar to 
our own. By this we mean systems, which use simple gas exchange to 
induce hypoxia without metabolic inhibitors or receptor antagonists. As is 
shown in the results section, we have seen an average of around 78% 
cell death within the culture by 24hours following an insult of only 15min. 
Goldberg et al (1993), register little cell death with insults of less than 
30mins. They report almost 90% cell death 24hrs after a 60min insult. 
These figures are supported by the results of Gwag et al’s control groups 
(1995). Strangely, the progressive cell death model of Meloni et al (2001) 
requires an insult of at least 4hours to produce levels of cell death that 
rise above controls. All cultures are of a similar age to ours. The Gwag 
and the Goldberg models use mouse cortex whereas the Meloni model 
uses rat, so species difference doesn’t appear to be a problem. So why 
does this difference in viability exist?
First of all, our system of evacuating O2 from the chamber whilst cells are 
present may actually result in the cell damage beginning before the 
60min gassing period has ended, thereby extending the period of 
ischaemia and underestimating the insult length (See section 3.6.4 and 
3.6.5 for discussion). With an extended OGD length in mind, our insult 
may possibly more closely approximate Goldberg’s or Gwag’s model. In 
these systems a matter of 15mins difference in the OGD period seems to 
have a significant impact on neuronal viability.
Another explanation, and perhaps the most likely, could be that our 
neuronal culture is more prone to injury due to its high purity. Both the 
Goldberg and Gwag models use neurone cultures, which are either a
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mixture of glia and neurones or neurones seeded on a glial monolayer 
whereas our culture consists of pure neurones. Astrocytes have a well- 
documented ability to aid neuronal survival and function (discussed in 
chapter 5). Astrocytes take significantly longer than neurones to die from 
OGD. At the short periods used to study neuronal survival the 
neuroprotective facilities of the astrocytes may be completely intact. 
Therefore, a neuronal culture rich in astrocytes could suffer less cell 
death. The Meloni model is quite pure yet shows an extraordinarily long 
amount of time to induce cell death despite the use of Ar instead of N2. 
Only by adding 2-deoxy-glucose do they come within the time period 
standard of Goldberg et al. It would seem that this group may not have 
achieved sufficiently low levels of O2, values were not quoted in their 
publications.
A third explanation could be down to the ability of plastic tissue culture 
vessels to store 0 2. Munns et al (2002) elegantly demonstrated a 
dramatic difference in neurone viability depending on whether they were 
made anoxic in a plastic or a glass culture vessel. Essentially, as 
mentioned in chapter 1, plastic acts as a sink for O2. Both the Gwag and 
Goldberg models used plastic vessels entirely, which would host a large 
concentration of O2 to supply the neurones once initial O2 evacuation had 
been completed. Our model consists of a glass coverslip resting on a 
plastic plate. We propose that the bulk of the plastic-stored O2 diffuses 
out into the glass chamber and through the outlet pipe but is prevented 
from being used by the neurones due to the barrier to the plastic provided 
by the glass coverslip. The Munns model achieves 92% cell death 
following 25min OGD in a glass dish (with an extra 15mins before anoxia 
is achieved making it 40mins in total), which most closely resembles our 
model.
4.4.2.2 Time of cell death measurement
A point, which has repeatedly surfaced, is that almost all the OGD studies 
we have come across involve insulting neurones for a defined period of 
time, then letting them recover for 24 to 48hrs before cell death is
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measured. Most groups cite the damage at 24hours as a measure of the 
OGD length and do not discuss the implications of re-oxygenation in the 
intervening period (reperfusion injury). Our approach has been to look at 
cell death in real time at points following the OGD insult up until 24hours. 
Clearly the former approach allows time for injury development, which 
may or may not be due exclusively to OGD length.
We have seen no distinction in cell death level between 60 and 120mins 
of injury yet the 15mins insult results in significantly more live cells at the 
end of OGD. By 24hours of recovery however, even the 15min insult has 
reached a level of death comparable to the longer OGD insults. 
Considering the recovery data alone, one would assume that the insults 
were identical when in fact the profile of death rate was quite different. 
The distinction between reperfusion injury and injury directly relating to an 
insult is therefore an important one. It is particularly important to 
understand this distinction in order to take advantage of a possible 
therapeutic window. We believe that the re-oxygenation period does 
contribute to cell injury and will continue to investigate the injury under 
this assumption.
4A.2.3 Cell morphology in the current model
We wanted to design the current system such that it parallels, as much as 
possible, cell death following a global ischaemic insult and penumbral 
damage following a focal insult. Essentially, little neuronal death is 
observed immediately following hypoxia yet death occurs progressively 
as reperfusion proceeds. We have ascertained that OGD of 15mins 
produces little cell death immediately but neurones show considerable 
decline throughout the re-oxygenation period.
Immediately following the 15min OGD period, insulted cells were found to 
be slightly more swollen than control cells yet membranes were still intact 
and impermeable to PI, likewise the neuritic network seemed 
undamaged. Although phase contrast images suggested continuing cell 
damage from the outset of re-oxygenation, cell death (by counting) did
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not reach significant levels until 6 hours of re-oxygenation, reflecting the 
time necessary for membrane lysis. Culture morphology mirrors previous 
observations (Goldberg et al 1993, Meloni et al 2001). The cellular 
appearance at this stage was due entirely to the OGD insult as 
reperfusion medium had not been introduced yet.
In our model, the early stages of re-oxygenation particularly showed that 
insulted cells tended to exhibit marked cytoplasmic swelling yet the nuclei 
either appeared normal or only slightly shrunken. Chromatin became 
less diffuse, within a normal nuclear shape, and then began to form 
irregular clumps, reminiscent of apoptotic nuclei. It was not clear if 
separate membrane bound chromatin bundles had formed as the method 
allows only nuclear DNA to be visualised and not the nuclear envelope 
itself. Many small spherical blobs of chromatin dominated in the late 
stages of reoxygenation. At this point the somata were quite phase bright 
and appeared ‘empty’. Only when taking in to consideration both 
apparent nuclear and somal shape could we see that we were witnessing 
a cell death close to what has been observed during in vivo ischaemia, 
and described as edematous cell change, a type of necrosis (Lipton 
1999). Cell swelling can be accounted for by a loss of ion homeostasis 
due to insufficient energy available for ion pumping at membranes. 
Enzymatic processes within the cell then digest its organelles giving the 
later appearance (Allen et al 1997).
We observed that ischaemic nuclei became considerably more shrunken 
than control nuclei. Most probably, due to a disturbance in ion balance 
between cytosol and nucleus. This caused a slight problem in 
determining a cut off point for cells that were early apoptotic or live so we 
erred on the side of labelling dubious cells as live. Nuclear shrinkage has 
been used in its own right as an early marker for cell death in 
hippocampal slices following OGD (Bonde et al 2002, Kasischke et al 
2001). We may therefore have underestimated the quantity of cells that 
were at an early apoptotic stage. In any event this raises an interesting 
point, what is the cut-off point for condemning a cell? It is not at all clear
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when the irreversible processes of cell death begin when just looking 
down a microscope.
Even if the ‘correct’ cut-off were assigned, another factor, which will blur 
the borders between cell groups, is the input of the individual doing the 
counting. It is one matter to fix on a cut-off criteria but it is quite another 
to rely on a person to rigidly stick to it on every experimental run, 
particularly if the cut-off criteria become difficult to spot. Demonstrating 
the acuity of 20:20 hindsight, It would perhaps be more useful to 
standardise nuclear counting by using a computer aided imaging system 
which could quantify staining intensity and nuclear size and shape more 
readily (Veltri et al 2000 for review).
Clearly, caution should be applied when using nuclear stains to determine 
death type. In this instance, siphoning nuclei into different counting 
groups based on appearance and colour could not effectively distinguish 
between apoptosis and necrosis. This could be due to the limited criteria 
chosen by us. However, it may also underline the fact that the traditional 
features of either necrosis or apoptosis can be found within the same 
population and furthermore negates the use of either term in defining, 
absolutely, a mode of death (as detailed in section 1.1.4).
4.4.3 Astrocyte survival
4.4.3.1 OGD and cell death
Changes in LDH release reached significant levels only after 8hrs of OGD 
in cortical astrocytes reaching a peak at 15hours of OGD. There was 
similarly, no visible injury until many hours of OGD had been imposed. In 
comparing these to previous observations, it is worth mentioning that we 
use the LDH release assay in a slightly different manner to many groups 
in this field. As mentioned above, we assessed LDH release, and thus 
astrocyte injury, immediately upon cessation of the insult, whereas almost 
all groups to which our insult compares, assessed LDH release 24 hours 
later. To re-iterate, our future work is concerned with the reperfusion 
phase following OGD and so it makes more sense for us to assess
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damage and its causes immediately following OGD without the added 
factors brought by re-oxygenation. In essence, we are purifying the 
insult.
A number of groups have observed that most of the LDH release occurs 
between 4 and 8 hours of OGD (Juurlink et al 1993, Zhao et al 2000, 
Goldberg et al 1993). In our hands, the bulk LDH was released between 
8 and 15hours of OGD. Not only is this later than previously observed 
but it also happened in a much slower manner. Furthermore, it appears 
that the total LDH released in our system was considerably lower than 
others. Juurlink et al (1993), show that 80% of total culture LDH is 
released by 9 hours whereas, even at 20hours we only see a 25% 
release (subtracting control values from OGD values). Other groups 
quote their figures as the percentage of total LDH released 24hours 
following the maximum OGD insult and not as a fraction of the total 
culture LDH. It is therefore difficult to directly compare our absolute 
figures.
We have established that O2 is indeed being adequately evacuated from 
the glass chamber. However, there may still be O2 remaining in the 
plastic culture dishes. This point was addressed in section 4.4.2.1 with 
respect to neuron cell death. As astrocytes do not have the experience of 
sitting on a glass coverslip to act as a barrier, they may well receive a 
supply of O2 that supports respiration for some time in to the OGD insult. 
This would explain the later and more gradual release of LDH that we 
observe. It does not however, account for the comparatively small 
amount released.
A major point of difference between our culture system and that of the 
groups mentioned, is that our experiments were carried out when the 
cultures were 14days old. This was simply because it was the established 
day for culture use within our laboratory. The other groups used cortical 
cultures, which were between 3 and 6 weeks old. Papadopoulos et al 
(1998) show a sharp rise in LDH release (and thus astrocyte death) from
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cultures aged between 15 and 22 days, following OGD of 8hours. 
Furthermore Rajapakse et al (2003) use cultures of 10-12 days old and 
show 60% viability following 12 hours of OGD. This more closely 
resembles our model. A number of hypotheses have been proposed as 
to why older cultures may be more susceptible to injury (Papadopoulus et 
al 1998, Pauwels et al 1998).
A far more simple explanation may be due to the assay itself. It may take 
a few hours for complete cell lysis to occur in response to an insult. This 
is the chief reason to allow a 24hour grace period before assessing 
damage. Again, for reasons stated in section 4.4.2.2, we did not want to 
do this. It is therefore more logical to accept our maximum release 
figures in a comparative rather than an absolute sense.
4.4.3.2 Recovery and cell death
We have assessed astrocyte cell death during a 24hour re-oxygenation 
period following OGD of up to 2hours. The results clearly show that there 
is no significant LDH release. Furthermore, there is no obvious 
morphological change. These observations are consistent with the 
current literature, when taking in to account that most groups measure 
acute death 24hours later (as mentioned above). Of course, lack of cell 
death does not necessarily mean that the astrocytes have not been 
affected by the OGD insult. As mentioned previously, astrocytes lose 
adhesion to glass coverslips long before cell death is registered on plastic 
dishes, showing that some physiological change is occurring in response 
to the insult. On a similar theme, Reichert et al (2001) demonstrate that 
astrocyte mitochondria become depolarized after relatively brief OGD 
without precipitating cell death.
4.4.4 Astrocytes are more robust than Neurones
Our results show that neurones are considerably more vulnerable to OGD 
than astrocytes in terms of duration necessary to cause significant cell 
death. Different aspects of the OGD insult have been studied to 
determine the underlying factors, which contribute to the observed
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differential vulnerability between astrocytes and neurons. An important 
difference lies in the greater metabolic capacity of the astrocytes. 
Astrocytes express a number of enzymes, which are not expressed in 
neurons such as glycogen phosphorylase, glutamine synthetase and 
pyruvate carboxylase to name but a few (Kirchhoff et al 2001). 
Furthermore they have a much larger glycolytic capacity to generate ATP 
readily from glycogen stores during ischaemia (Ransom et al 1997). 
Glycogen stores are also used by astrocytes to protect against oxidative 
damage rather than simply generate ATP: Almeida et al (2002) elegantly 
showed that astrocytes have an enhanced ability to regenerate GSH by 
shuttling glucose through the pentose phosphate pathway.
It is not surprising that there is a disparity between astrocyte and 
neuronal survival. To recapitulate, the brain appears to have evolved 
such that different cell types have become highly specialized for different 
functions, most obviously, neurones for fast synaptic signaling. In an 
energy conserving measure, astrocytes have been assigned the burden 
of providing neurones with metabolic support (Vega et al 2003, Pellerin 
and Magistretti 2003, Pellerin et al 1994). Indeed, this is not the extent of 
the astrocyte’s contribution to the maintenance of neuronal homeostasis, 
as has been described in detail in chapter 1.
Astrocytes may not die in the timely manner that neurones do, but there 
is a documented change in physiology following OGD that could lead to a 
reduction in neuronal support (Sugawara et al 2002, Reichert et al 2001). 
Clearly, when neurones are deprived of astrocyte support, under the 
extreme conditions of an ischaemic insult, they cannot cope. If neurones 
could be encouraged to adapt the features of astrocyte biology, that make 
them resistant to cell death, following an ischaemic episode, severe 
neuronal loss may be avoided. Similarly, astrocytes may be encouraged 
to boost their neuroprotective capacity. We will expand on this theme in 
the next chapter.
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4.5 Conclusion
In answer to the most fundamental part of our aim, we have succeeded in 
establishing a model of reperfusion injury. In keeping with trends in the 
current literature, we have shown that the extent, to which neurone 
cultures die during reoxygenation, is dependent upon the length of the 
initial insult. We have further shown that astrocytes survive OGD of 
considerably greater lengths than neurones. By illustrating these points 
we have validated our model as being fit for use in the study of OGD- 
reoxygenation, thereby meeting the aims of this chapter.
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The effect of astrocytes on neuronal 
survival following oxygen glucose 
deprivation ’
163
Chapter 5
5.1 Introduction
In chapter 4 we produced a model of neuronal injury in response to OGD- 
reoxygenation. This was done, not as an end in itself, but with the 
intention that the model could be used as a basis for the study of 
neuroprotection. In this chapter we will take a first step in this direction by 
looking at the effect astrocytes may have on neuronal survival.
The lives of neurones and astrocytes are intimately linked on many 
different levels in vivo and the role of astrocytes in sustaining neuronal 
function has already been described in chapter 1. There is much 
evidence to suggest that astrocytes are passively neuroprotective in vitro 
and much work has been done in characterising the basis of this 
neuroprotection. For example, Drukarch et al (1998) implicate astrocytes 
in extra-cellular ROS scavenging thus limiting oxidant attack on 
neurones. Dhandapani et al (2003) show that astrocyte derived growth 
factors prevent neuronal death due to serum deprivation. Wang et al 
(2001) show that astrocyte-released pyruvate attenuates cysteine-related 
neuronal death in culture. To reiterate, in each case the neuroprotection 
is a natural function of the astrocytes involved and is not a function of 
induction.
Because of the natural role of astrocytes in promoting neuronal survival a 
number of groups have targeted astrocytes in order to elicit a secondary 
effect of protecting neurones. For example, the stimulation of the 
pentose-phosphate pathway in astrocytes by the addition of fructose-1,6- 
bisphosphate has been shown to enhance neurone survival during 
hypoxia (Kelleher et al 1996); the transfection of astrocytes with the 
glutamic acid decarboxylase gene has been shown to increase their 
antioxidant capacity and ability to attenuate neuronal oxidative stress 
(Lamigeon et al 2001); and the overexpression of specific astrocyte 
genes is reportedly neuroprotective against OGD (Xu et al 1999).
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Clearly, evidence abounds as to the neuroprotective abilities of astrocytes 
under a range of different conditions. We will therefore assess the ability 
of cortical astrocytes to attenuate neuronal injury as a result of OGD- 
reoxygenation using cell death as a measurable endpoint of the injury.
5.2 Aim
The aim of this chapter is to test the hypothesis that astrocytes are 
capable of exerting a protective effect on neurones, which have been 
subjected to OGD.
5.3 Methods
5.3.1 Cell culture
Astrocyte cultures were prepared as described in section 2.2.1 and 
neurone cultures were prepared as described in section 2.2.2. Co-culture 
was carried out as described in section 2.2.3. Astrocyte conditioned 
medium (con med) was prepared as described in section 2.2.2.3. All 
experiments were carried out in 6-well plates.
5.3.2 0 2 glucose deprivation/reoxygenation
Neurones were subjected to OGD/reoxygenation as described in section 
2.4.2.
5.3.3 Cell death
Cell death was quantified in neuronal cultures according to the method 
detailed in section 2.5.2.
5.3.4 Griess assay
Nitrite was measured in the culture medium using the Griess assay as 
detailed in section 2.8.3
5.3.5 Microscopy
The health of neurone and astrocyte cultures was monitored by visual 
inspection using phase contrast microscopy as detailed in section 2.6.1.
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5.4 Results
5.4.1 Astrocytes attenuate neuronal death during reoxygenation.
We have subjected cortical neurone cultures to OGD for 15mins and 
allowed them to recover for up to 24hours in the presence or absence of 
astrocytes (Fig 5.1). The data for neurones recovering in the absence of 
astrocytes were first shown in chapter 4. There was no statistically 
significant difference in the number of live cells between the control 
cultures from each group at all time points. However there was a 
significant difference between OGD-exposed cultures and their respective 
sister control cultures at 6, 12 and 24hours of recovery (marked as “**’ on 
the graph). There were significantly more live cells at 6 and 24hrs of 
recovery in the OGD-exposed culture recovered in the presence of 
astrocytes (57.2±2.5% for 6hrs and 47.5±5.1% for 24hrs) than in the 
OGD-exposed culture recovered in neurobasal (NB) medium only 
(52.3±2.63 for 6hrs and 27.2±4.38% for 24hrs).
100 - ♦  Cast
OGDast
OGD
w
a>o
<D
>
-I
25 300 5 10 15 20
Time after OGD (hrs)
Fig 5.1 Recovery of cortical neurones in the presence of astrocytes. The graph 
shows the number of live cells present in neuronal cultures during recovery from 15mins 
OGD in the presence and absence of astrocytes. The lines (C) and (OGD) represent 
control and OGD-exposed neurones respectively, recovering in NB medium only. The 
lines (Cast) and (OGDast) represent control and OGD-exposed neurones respectively, 
recovering in NB medium in the presence of astrocytes. Data, mean ± SEM, n=7, 
marks points of significant difference, “**’ marks significant difference between sister 
cultures p<0.05.
166
Chapter 5
5.4.2 Astrocyte-conditioned medium can reduce neuronal death to 
the same extent as the presence of astrocytes.
In order to determine whether or not astrocyte presence was a crucial 
factor, neurones subjected to OGD for 15mins were allowed to recover in 
the presence of astrocyte-conditioned medium (con med) for up to 24 
hours (Fig 5.2). Again, the data for neurones recovering in the absence 
of astrocytes were first shown in chapter 4. There were significantly more 
live cells in the control cultures than in the OGD-exposed cultures when 
recovered in the presence of con med and when recovered in NB 
medium only, at 6,12 and 24hours of recovery (marked as '**’ on the 
graph). Taking only the OGD-exposed cultures into consideration, there 
were significantly more live cells in cultures recovered in con med than in 
cultures recovered in NB medium only at 12hrs (51.7±2.24% and 
37.2±3.5% respectively) and 24hrs (41.9±4.67 and 27.2±4.38% 
respectively) of recovery.
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Fig 5.2 Recovery of cortical neurones in the presence of astrocyte-conditioned 
medium. The graph shows the number of live cells present in neuronal cultures during 
recovery from 15mins OGD in the presence and absence of astrocyte-conditioned 
medium. The lines (C) and (OGD) represent control and OGD-exposed neurones 
respectively, recovering in NB medium only. The lines (CCon) and (OGDCon) represent 
control and OGD-exposed neurones respectively, recovering in conditioned medium. 
Data, mean ± SEM, n=7, marks points of significant difference, '**’ marks significant 
difference between sister cultures p<0.05.
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Fig 5.3 summarises the data obtained for OGD-exposed neurones only. 
Here we can see that exposure to con med actually resulted in less cell 
death at 12hrs than exposure to astrocytes. There is no statistically 
significant difference between conditioned medium-exposed and 
astrocyte-exposed cultures at either 6 or 24hrs of recovery.
70 
60 -I 
50 -I
8 40
30
20
10
0
■  OGD
■  OGDast 
□  OGDCon
12
Time after OGD (hrs)
24
Fig 5.3 Recovery of OGD-exposed cortical neurone cultures. Cortical neurones 
were subjected to OGD for 15mins. The number of live cells was counted at intervals up 
to 24hrs of recovery. Neurones were allowed to recover in the presence of NB medium 
only (OGD), astrocytes (OGDast) or astrocyte-conditioned medium (OGDcon). Data, 
mean ± SEM, n=7, marks points of statistically significant difference, p<0.05.
5.4.3 Astrocytes are not activated by the presence of injured 
neurones
We wanted to determine if astrocytes were being activated during the 
course of the experiments. A hallmark of the activation of astrocytes is 
the induction of the inducible nitric oxide synthase enzyme (iNOS). This 
leads to an elevation of NO. We have measured the concentration of the 
NO breakdown product nitrite, in the co-culture medium and in astrocyte 
medium alone as an index of NO production. As detailed in the methods 
section we have assayed for the presence of nitrite following the
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conversion of nitrate to nitrite. We will therefore refer to the total nitrite 
detected as NOx. Fig 5.4 clearly shows that the OGD-exposed neurones 
do not precipitate an increase in the level of NOx, when compared with 
controls at any time point. Furthermore, there is a low basal level of NOx 
produced by astrocytes which rises to a concentration of ~10pM by 24hrs 
and is unaffected by the presence of neurones.
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Time after OGD (hrs)
Fig 5.4 Nitrite production following OGD. Nitrite concentration in culture medium of 
astrocytes co-cultured with neurones and in culture medium of astrocytes only was 
determined. Neurones were exposed to OGD for 15mins and allowed to recover for up 
to 24hrs. The first two rectangles represent control neurones (CAst) and OGD-exposed 
(OGDAst) recovering in the presence of astrocytes. The third rectangle represents 
astrocytes incubated in NB medium only for 24hrs. Data, mean ± SEM, n=3.
Morphological investigation confirmed that the astrocyte cultures were 
healthy at all time points measured, assuming the flat cobblestone 
appearance described in chapter 4. Astrocytes that did not conform to 
this morphology at the outset of experimentation were discarded.
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5.5 Discussion
We have allowed neurones, which have been insulted for 15mins, to 
undergo reoxygenation in the presence of cortical astrocytes and 
astrocyte-conditioned medium (con med). The results show that both 
these conditions are neuroprotective and suggest that protection is at 
least partly due to constitutive release of diffusible factors.
Let us consider the hypothesis that astrocytes constitutively release 
neuroprotective factors. There was significantly less death at T6 in the 
presence of astrocytes, but not at T12 when compared to neurones on 
their own. However, in the presence of con-med, there was no 
significance at T6 but there was at T12. At first glance it would appear 
difficult to reconcile these observations apart from considering the data to 
be an experimental fluke! The very fact that any neuroprotection at all 
was seen with con-med, is proof of constitutive release. The con-med 
was allowed to sit on the astrocytes for 24hours and so in theory it has a 
greater capacity to protect neurones immediately at the start of 
reoxygenation than the presence of astrocytes who are just beginning to 
pump out the neuroprotective factors. At T12 there is greatest survival in 
the con-med exposed neurones, which does reflect more neuroprotective 
activity in the earlier part of reoxygenation. In fact this was almost on a 
par with the control values for the neurones reoxygenating on their own. 
So why is there less death in the cultures reoxygenated with astrocytes at 
T6? Flukes aside the real issue may be that the neuroprotection we are 
seeing is arrived at by completely different mechanisms.
The use of conditioned medium removes the element of conversation yet 
it allows for the signalling components to be distilled and either identified 
or at least categorised. Many different groups have examined the effects 
of conditioned medium on neuronal survival with positive and negative 
results; Microglia conditioned medium induces apoptosis in hippocampal 
cultures in some circumstances (Flavin et al 1997): Astrocyte conditioned 
medium promotes cortical neurite outgrowth (Le et al 2002): Activated-
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astrocyte conditioned medium increases hippocampal neuronal 
susceptibility to glutamate (Ahlemeyer et al 2003). Not forgetting of 
course the use of glia conditioned medium in the maintenance of primary 
neuronal cultures (Dugan et al 1997).
A new dimension is opened up when astrocytes are present. Yes, they 
may still be releasing the same factors that are present in the conditioned 
medium but they may also be directly asked by the neurones to release a 
host of other factors. More crucially, the astrocytes may be removing a 
neurotoxin from the environment rather than specifically releasing a 
neuroprotectant. We will explore the nature of the neuroprotection in the 
next chapter.
A particular point to note about the current work is that we are not 
subjecting the astrocytes to any insult (intentionally at least!). To our 
knowledge no group has reoxygenated OGD-exposed neurones in the 
presence of un-insulted astrocytes. Curiously, the incubation of insulted 
astrocytes with non-insulted neurones has been examined (Tamatini et al 
1998). It is more usually the case that glial influence is monitored in the 
context of a mixed glia-neurone culture (Goldberg et al 1993), coculture 
(Kelleher et al 1996) or slice preparation (Schurr et al 1997) such that 
both cell types are present during the relatively short neuronal insult. 
Why do we mention this? We believe that it is worth considering the role 
of unchallenged astrocytes in the study of neurone-astrocyte 
communication and further, neuroprotection.
It is well accepted that glia are considerably more resistant than neurones 
however even short insults have been shown to cause some 
physiological change. For example, Reichert et al (2001) evidence 
mitochondrial depolarisation during OGD, which has no effect on ultimate 
astrocyte survival. Such a change in astrocyte homeostasis may 
however effect communication with neurones. Indeed Lian et al (2004) 
have shown that, in vivo, a drop in astrocyte ATP levels increases 
neurone susceptibility to injury. The change in communication is not
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always negative, Ruscher et al (2002) elegantly demonstrated in vitro, 
using conditioned medium, that a brief OGD insult to astrocytes 
enhanced their neuroprotective abilities. A similar conclusion can be 
drawn in vivo from the work of Kitagawa et al (1990) on ischaemic 
tolerance. What we don’t know however, is how perfectly healthy 
astrocytes react to and communicate with injured neurones.
The study of how OGD-exposed neurones and uninsulted astrocytes 
interact is of particular relevance in preventing the spread of infarction 
following a focal ischaemic insult. If we are to assume that cells of the 
peri-infarct area are ‘normal’ it is more accurate to study their responses 
to injured neurones when they themselves are in a ‘normal’ physiological 
state. This could then lead to the development of therapeutic strategies 
by which the natural neuronal survival-promoting pathways of astrocytes 
could be bolstered immediately following the ischaemic episode 
effectively establishing a shield against further infarction.
5.6 Conclusion
We have determined that astrocytes are capable of attenuating neuronal 
death following OGD in this model. We have further taken steps to 
characterise this neuroprotection and have shown that astrocyte- 
conditioned medium also significantly reduces neuronal death.
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Chapter 6 
‘The elements of astrocyte-neurone 
communication’
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6.1 Introduction
In chapter 5 we asked the question are astrocytes capable of 
rescuing neurones from OGD-reoxygenation induced cell death? We 
found that indeed they are. The next obvious question is how is this 
possible? We intend to follow three different yet related lines of 
investigation; 1) astrocytes are removing a neurotoxin from the 
environment; 2) astrocytes are providing metabolic support; 3) 
astrocytes are working in an antioxidant capacity. It is our intention 
to identify the existence of elements, which may support one or all of 
these hypotheses in the context of the current model so that we may 
arrive at a mechanism of neuronal injury.
Glutamate stands as the best candidate for a possible neurotoxin in 
this model. The function and consequences of glutamate as an 
excitotoxin have been elaborated upon section 1.2. In brief, 
excessive glutamate release causes over activation of NMDA 
receptors and a cascade of intracellular signalling that derails 
physiological cell function. Glutamate release has been documented 
as a result of ischaemia/reperfusion both in vivo (Erecinska et al 
1984, Molchanova et al 2004,Taguchi et al 1996, Yang et al 2001, 
Mori et al 2004) and in vitro (Hauptman et al 1984, Goldberg et al 
1990, Marcoli et al 2004). Elevated glutamate levels have been 
directly linked with ischaemic cell death (Arundine et al 2004) and 
inhibitors of glutamate receptors have been shown to attenuate 
damage following ischaemia (McIntosh et al 1989, Pohorecki et al 
1990, Pellegrini-Giampietro et al 1999, Meli et al 2002).
The provision of metabolic support by astrocytes most probably 
comes mainly in the form of lactate. Lactate was shown to be a 
metabolic fuel for neurones some time ago (Mcllwain 1953) and 
there is a significant amount of evidence suggesting its use as the 
preferential neuronal fuel under a variety of conditions in vitro (See 
Pellerin et al 2004 for list). It has long had a negative association with
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brain ischaemia due to circumstantial evidence of its concomitant 
increase with falling pH and further the relationship between high 
preischaemic glucose values and subsequent acidosis (Siesjo et al 
1996). However lactate has been shown to have beneficial effects in 
vitro.
Schurr et al (1997c) show that lactate and not glucose aids neuronal 
recovery following hypoxia in hippocampal slices; Cater et al (2001) 
show that lactate is protective during glucose deprivation and 
glucose-metabolism inhibition in hippocampal slice cultures; Cater et 
al (2003) elaborate on their previous work to show that lactate is 
more beneficial than glucose during reoxygenation following hypoxia 
in the hippocampal slice system. Cronberg et al (2004) take the 
matter a step further and show that high glucose can actually 
exacerbate injury but lactate does not.
When we introduce neuroprotection by astrocytes in to the equation 
we revisit the ‘lactate shuttle’ hypothesis (Fig 1.4). In a nutshell, this 
suggests that neurones release glutamate which stimulates the 
upregulation of glycolysis in astrocytes which then release lactate for 
neurones to use as metabolic fuel under conditions of increased 
energy demand (Magistretti et al 1999, Pellerin et al 2004). In part 
agreement of this Schurr et al (1997a,b,c) have shown in 
hippocampal slices that not only can lactate be used to enhance 
posthypoxic neuronal recovery but that glia are its main source. 
Piecing all these facts together, a case emerges for the investigation 
of lactate in our model system.
Finally, glutathione (GSH) represents the putative antioxidant 
support. In section 1.4.4 we have already detailed how astrocytes 
can both support neuronal GSH levels and how they actually are 
neuroprotective in a GSH dependent manner. Artificially increasing 
glutathione levels has also been shown to be neuroprotective
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following ischaemia (Anderson et al 2004 a and b). We intend to 
look at the role of GSH both inside and outside the cell.
6.2 Aims
The aim of this chapter is to test three hypotheses for the protection 
of neurones by astrocytes:
1. Astrocytes remove a toxin from the neuronal environment
2. Astrocytes provide metabolic support
3. Astrocytes provide antioxidant support
6.3 Methods
6.3.1 Cell culture
Astrocyte cultures were prepared as described in section 2.2.1 and 
neurone cultures were prepared as described in section 2.2.2. Co- 
culture was carried out as described in section 2.2.3. Astrocyte 
conditioned medium was prepared as described in section 2.2.2.3. 
All experiments were carried out in 6-well plates.
All astrocytes were seeded at a concentration of 1x106 cells per well. 
Neurones were seeded at an estimated concentration of 100,000 
cells per coverslip.
6.3.2 O2 glucose deprivation/reoxygenation
Neurones were subjected to O2 glucose deprivation 
(OGD)/reoxygenation as described in 2.4.2.
6.3.3 Glutamate, lactate and GSH 
6.3.3.7 Sample handling
Three coverslips of neurones were used for each of the control and 
OGD conditions at each time point. Three wells of astrocytes were 
therefore used for each of the control and OGD conditions during co- 
culture experiments. The medium (2ml per coverslip) above each 
coverslip was pooled, giving 6ml per condition. Medium form
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astrocytes alone was prepared as follows. Astrocytes were 
incubated in neurobasal medium (NB) for 24 hours at 37°C in an 
atmosphere of 5% C02/95%air. Each well contained 2ml of NB. 
Samples of conditioned medium alone were similarly prepared. 2ml 
of conditioned NB was placed in each well and allowed to incubate at 
37°C in an atmosphere of 5%C02/95%.
For some experiments, medium was spiked with GSH. Medium was 
filtered through a 20pm filter after spiking to remove any micro 
organisms that may have affected the growth of the cell cultures.
1ml of medium was kept for lactate and glutamate determination. 
This was deproteinated according to the protocol in section 2.8.2. A 
further 1ml was deproteinised by mixing with 1ml of the mobile phase 
orthophosphoric acid (OPA) and centrifuged at 500g for 5min at 4°C. 
Supernatant was kept for GSH determination.
Cell suspensions were prepared from astrocytes as detailed in 
section 2.2.1.3. Pellets were prepared from neurones by a slight 
modification of this protocol. Each coverslip was directly transferred 
to 1 ml of warm trypsin solution that had been placed in a 6-well plate. 
For neurones a single cell suspension was made from all three 
coverslips used in a condition. Likewise if more than one well was 
used for an astrocyte condition, a pooled suspension was made. 
Cells were pelleted from all suspensions by centrifugation at 500g for 
5min at 4°C and subsequently frozen.
6.3.3.2 Protocol
Glutamate was measured spectrophotometrically as described in 
section 2.8.2. All samples that had been incubated in neurobasal 
(NB) medium were measured against a blank containing the assay 
mixture and 143pl of deproteinated NB medium. Similarly, samples 
that had been incubated in Dulbecco’s modified Eagle’s medium
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(DMEM) were measured against a blank containing the assay 
mixture and 143|jI of deproteinated DMEM.
Lactate was measured spectrophotometrically as described in 
section 2.8.3. All samples that had been incubated in neurobasal 
medium (NB) were measured against a blank containing the assay 
mixture and 200pl of deproteinated NB. Similarly, samples that had 
been incubated in Dulbecco’s modified Eagle’s medium (DMEM) 
were measured against a blank containing the assay mixture and 
200pl of deproteinated DMEM.
GSH was measured by HPLC as described in section 2.8.4
6.4 Results
6.4.1 Glutamate
Glutamate concentration is expressed relative to volume only. We 
could not accurately determine the amount of protein in the NB 
medium due to interference with the assay. Neither could we 
express glutamate against protein in the cell pellets as it became 
difficult to compare results using co-culture experiments. We did 
however seed exactly the same number of cells per well and 
coverslip, and have determined cell loss to be minimal before time of 
experimentation. Therefore, it is acceptable to express glutamate as 
concentration in the medium. Concentration is expressed as total 
glutamate minus glutamate in the NB medium only.
6.4.1.1 Glutamate levels in neurone medium increase during 
recovery
We wanted to ascertain the level of glutamate in the medium of 
neurones subjected to 15mins OGD and recovery in order to 
determine if there is a correlation between OGD and glutamate 
concentration.
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Neurones were subjected to OGD of 15mins and allowed to recover 
for 24hours in NB medium only. Glutamate that was measured 
immediately at the end of the OGD period (0 hours) represents 
glutamate accumulated during the 15min insult. Glutamate was also 
measured at 6, 12 and 24 hours of recovery. Fig 6.1 shows that 
there is significantly more glutamate in the culture medium of OGD 
exposed neurones at each time point during recovery when 
compared with control cultures (p<0.05). Furthermore glutamate in 
the OGD exposed culture medium rose from 16.8±3.0pM at 6hours 
to 26.7±0.8pM at 24hours, a statistically significant increase (mean ± 
SEM, n=4, p<0.05). All OGD cultures contain significantly more 
glutamate at 6, 12 and 24hours than at Ohrs. Exactly the same 
pattern is seen in the control cultures. Control glutamate levels 
remained similar between 6, 12 and 24 hours.
0 6 12 24
Time after OGD (hrs)
Fig 6.1 Glutamate Concentration following 15mins OGD. The graph shows 
glutamate concentration in the culture medium of cortical neurones following 
15mins OGD minus glu in NB medium only. The Ohrs timepoint represents 
glutamate concentration in DMEM immediately at the end of the OGD period. The 
other time points correspond to glutamate concentration in NB medium up to 24 
hours after the OGD insult. The cream rectangle represents control cultures and 
the brown rectangle represents the OGD-subjected cultures. Data, mean ± SEM, 
n=4. represent points of statistical significance, p<0.05.
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6.4.1.2 Glutamate concentration is lowered in the presence of 
astrocytes.
Neurones were subjected to OGD for 15mins and allowed to recover 
in the presence of astrocytes in order to investigate the possibility 
that co-culture with astrocytes could reduce extracellular glutamate 
concentration. Glutamate concentration was measured at 6, 12 and 
24 hours of recovery and was also measured in NB medium of 
astrocytes alone. Fig 6.2 shows that there was a significant 
decrease in glutamate concentration in medium of co-cultured OGD- 
subjected neurones at all time points measured when compared with 
OGD-subjected neurones recovering in NB medium only (p<0.05). 
There was significantly more glutamate in the medium of control 
neurones recovered in NB medium only, than there was in the 
medium of control neurones recovered in co-culture, at 6 and 24 
hours only (p<0.05).
There was no significant difference between control and OGD 
glutamate levels when neurones were recovered in co-culture at any 
time point nor was there a significant increase in glutamate with time. 
Fig 6.2 also shows that there was a significant increase in the 
glutamate concentration of medium incubated with astrocytes only 
from 6 to 24 hours. There was no significant difference in glutamate 
levels between the medium of astrocytes without neurones and the 
medium of either control or OGD-subjected neurones at any time 
point measured.
Data for neurones recovering in NB medium only was presented first 
in fig 6.1 and so statistical significance within this data is not shown 
again in fig 6.2.
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Fig 6.2 Glutamate in co-culture medium. Neurones were subjected to OGD of 
15min and allowed to recover in the presence of astrocytes. The graph illustrates 
OGD-subjected neurones recovering in co-culture with astrocyte (OGDAst) and in 
NB medium alone (OGD). Control neuronal cultures were also incubated in co­
culture (CAst) and in NB medium alone (C). Glutamate was measured in NB 
medium of astrocytes alone (Astro). Data ± SEM, n=4 for neurone and co-culture 
data, n=3 for astrocytes alone, marks significant difference, p<0.05.
We have determined the level of glutamate in the medium of 
neurones recovering in conditioned medium (con med) to ascertain 
whether or not glutamate decline is a function of astrocyte presence. 
Fig 6.3 shows that there is a significant decrease in the level of 
glutamate in medium from OGD-subjected neurones recovering in 
con med when compared with OGD-subjected neurones recovering 
in NB medium only, at all time points measured. There was a 
significant difference in the control culture values at 24 hours only. 
There was no difference between control and OGD cultures 
recovering in con med at each time point. Again, the data for the 
neurones recovering in NB medium only has been presented in fig
6.1 and so statistical significance is omitted within these values for fig
6 . 3 .
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Fig 6.3 Glutamate in con med incubated with neurones. Neurones were 
subjected to OGD of 15min and allowed to recover in con med. The graph 
illustrates OGD-subjected neurones recovering in con med (OGDCon) and in NB 
medium only (OGD). Control cultures were also recovered in con med (CCon) and 
in NB medium only (C). Data ± SEM, n=4, marks significant difference, p<0.05.
Fig 6.3 also shows that there was a basal level of glutamate present 
in con med that did not change significantly over time. There was no 
significant difference in glutamate concentration between con med 
without neurones and con med incubated with control and OGD- 
subjected neurones, at 6 and 12 hours of recovery. At 24 hours of 
recovery, there was significantly more glutamate in the OGD- 
subjected con med than in the con med incubated without neurones 
(p<0.05).
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Table 6.1 summarises the combined data for all neuronal conditions 
and timepoints. This table shows all points of significant difference 
between OGD-subjected neurones at each time point and their sister 
control cultures.
6 7.39±0.63* 3.20±1.69 5.51+1.69 16.813.0* 7.2712.90 3.71+0.60
12 10.73±2.55* 5.21±1.54 4.80+1.19 21.6512.59* 4.9311.04 4.2310.76
24 10.84±0.85* 5.2211.45 3.5710.98* 26.68i0.81* 4.13+2.06 8.75+1.40*
Table 6.1 Glutamate Concentration in neurone medium following OGD. The
figure shows glutamate concentration in the medium of cortical neurones subjected 
to 15mins OGD and allowed to recover for 24hours. Control and OGD-subjected 
neurones were recovered on their own (Solo), in the presence of astrocytes (Astro) 
or in con med (Con). Data, meaniSEM, n=4, marks significant difference 
between C and OGD within a single condition p<0.05.
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6.4.2 Lactate
Lactate concentration is expressed relative to volume only. We could 
not accurately determine the amount of protein in the NB medium 
due to interference with the assay. Neither could we express lactate 
against protein in the cell pellets as it became difficult to compare 
results using co-culture experiments. We did however seed exactly 
the same number of cells per well and coverslip, and have 
determined cell loss to be minimal before time of experimentation. 
Therefore, it is acceptable to express lactate as concentration in the 
medium. Concentration is expressed as total lactate minus lactate in 
the NB medium only.
6.4.2.1 Lactate concentration increases over time in astrocyte 
medium
Lactate concentration was measured in the medium of neurones 
subjected to OGD for 15mins and allowed to recover in NB medium 
alone, in astrocyte co-culture or in conditioned medium (con med). 
Lactate was also measured in NB medium incubated with astrocytes 
alone for a 24hour period and in con-med incubated alone for 
24hours.
Fig 6.4 shows that lactate concentration increased in a linear manner 
over time in medium of astrocytes alone, from 1.67±0.13pM at 
6hours to 5.62±0.25pM at 24hours (MeaniSEM, n=4). The linear 
accumulation was also evident in the presence of neurones. There 
was no significant difference between OGD-subjected and control co­
cultures at 6 and 12 hours of recovery. There was also no significant 
difference between either control or OGD-subjected co-cultures and 
astrocytes cultured alone at 6 and 12 hours of recovery. However, 
there was significantly less lactate in the medium of OGD-subjected 
neurones than either control neurones or astrocytes alone at 24 
hours.
184
Chapter 6
Astro
—■ — CAst 
 OGDAst
T T
0 5 10 15 20 25 30
Time after OGD (hrs)
Fig 6.4 Lactate in co-culture medium. Neurones were subjected to 15mins OGD 
and allowed to recover in NB medium co-cultured with astrocytes. The graph 
shows lactate detected in culture medium of astrocytes in NB medium alone 
(Astro), control (CAst) and OGD-subjected co-cultures (OGDAst) at 6, 12 and 24 
hours of recovery. Data ± SEM, n=4, marks significant difference, p<0.05.
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6.4.2.2 Lactate is stable in astrocyte-conditioned medium
Fig 6.5 shows that the concentration of lactate in con-med did not 
change significantly over time from a value of 5.60±0.30|jM at 6hours 
(Mean ± SEM, n=3). There is no significant difference between this 
value and that measured in astrocyte medium alone at 24hours. 
There was also no significant difference in medium lactate 
concentration between control and OGD-subjected neurones at any 
time point. Furthermore, there was similarly no difference between 
either control or OGD-subjected neurones and con med alone 
(p<0.05).
■  Con
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Fig 6.5 Lactate in conditioned medium. Neurones were subjected to 15mins 
OGD and allowed to recover in astrocyte-conditioned NB medium. The graph 
shows lactate detected in culture medium of con med alone (Con), control (CCon) 
and OGD-subjected cultures (OGDCon) in con med at 6, 12 and 24 hours of 
recovery. Data ± SEM, n=4, marks significant difference, p<0.05.
Table 6.2 summarises the data obtained from the measurement of 
lactate and includes lactate measured in the medium of control and 
OGD-subjected neurones recovering in NB medium only. There was 
no significant difference between control and OGD cultures at any 
time point. There was significantly less lactate in the cultures of 
neurones in NB medium only than there was in cultures of neurones
7i
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in con med or in co-culture with astrocytes, at all time points 
(p<0.05).
6 0.05±0.02 1.1610.23* 5.4610.35** 0.0310.00 1.4710.09* 5.5610.69**
12 0.05±0.02 2.35±0.09* 4.8310.53** 0.0510.01 2.7910.10* 5.74+0.17**
24 0.11±0.04 4.8010.08* 5.4610.38** 0.0510.01 4.5410.06* 5.1911.57**
Table 6.2 Lactate Concentration in neurone medium following OGD. The
figure shows [lactate] in the medium of cortical neurones subjected to 15mins OGD 
and allowed to recover for 24hours. There was 5.56±0.69mM lactate in 
conditioned medium at Ohrs. Control and OGD-subjected neurones were 
recovered in NB medium alone (Solo), in the presence of astrocytes (Astro) or in 
con med (Con). Data, meaniSEM, n=4, '*’ marks significant difference between 
Solo and Astro groups, ***’ marks significant difference between Solo and Con 
groups, p<0.05.
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6.4.3 GSH
6.4.3.1 GSH in astrocyte medium
We first of all wanted to establish if astrocytes are capable of 
constitutively releasing GSH in to NB medium. Astrocytes were 
incubated in NB medium for 6, 12 and 24 hours as described in 
section 6.2.3.1. NB medium alone was also incubated for the same 
period of time. GSH was measured in the supernatant as detailed in 
section 6.2.3. Fig 6.6 shows that GSH concentration increased in the 
astrocyte medium to a value of 6.25±0.91pM (mean ± SEM, n=4) by 
24hrs. There was a basal level of GSH in NB medium that did not 
change significantly with time and which was significantly less than 
the level observed in astrocyte medium at all time points.
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Fig 6.6 GSH in astrocyte medium. GSH in NB medium alone (NB) and NB 
medium in the presence of astrocytes (Astro) was measured at 6, 12 and 24 hours. 
The Ohrs point repeats the value for GSH concentration observed in NB at 6 hours. 
Data ± SEM, n=4 for Astro, n=3 for NB, marks significant difference, p<0.05.
The first point is the GSH observed in NB medium, before being 
incubated and with no astrocytes present and so represents the GSH 
level from which both sets of data in the graph would start. The 
figure shows that there is a significant increase in GSH between 0 
and 6 hours but this lost between 6 and 12 hours. The increase 
between 12 and 24 hours is significant again.
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We next wanted to determine the level of GSH in astrocyte- 
conditioned medium (con med) as a means with which to test the 
stability of astrocyte-released GSH. To reiterate, con med is NB 
medium that has been incubated with astrocytes for 24 hours. Con 
med was incubated on its own for a further 24hours and GSH was 
measured at 6, 12 and 24 hours as detailed in section 6.2.3. Fig 6.7 
compares the data obtained for con med to the data obtained for NB 
medium on its own that we have already seen in fig 6.6. This figure 
shows that GSH concentration was significantly greater in 
conditioned medium than in NB medium at all time points and further 
that GSH levels in con med did not change over the 24hour period, 
from the initial value of 7.57± 1.32pM (Mean ± SEM, n=4).
12 i
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Fig 6.7 GSH concentration in conditioned medium. GSH in NB medium on its 
own (NB) and in con med (Con) was measured at 6, 12 and 24 hours. Data ± 
SEM, n=4 for Con, n=3 for NB, “*’ marks significant difference, p<0.05.
Because of findings in our lab that GSH stability depends on the 
medium, and that astrocytes release a form of superoxide dismutase 
(SOD), we wanted to determine if GSH preservation in our conditions 
was a function of NB medium or if it was a function of astrocyte 
release. This was done by spiking the NB medium with 10pM GSH
■  Con
■  NB
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and allowing it to incubate for 24 hours. This value was chosen, as it 
was slightly higher than the maximum values observed by us in the 
medium and would therefore stand out clearly if it were preserved. 
The GSH level was determined at 6, 12 and 24 hours. Fig 6.8 shows 
that there was no significant difference between spiked and unspiked 
samples at all time points measured. Therefore, NB medium is not 
capable of preserving GSH on its own.
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Fig 6.8 GSH-spiked NB medium. NB medium was spiked with GSH to a 
concentration of 10pM and was allowed to incubate for up to 24 hours. GSH level 
was determined at 6, 12 and 24 hours. Graph shows spiked (NB+GSH) and 
unspiked NB medium (NB). Data ± SEM, n=3, p<0.05.
We finally wished to determine if either con med or NB medium in the 
presence of astrocytes, were capable of preserving exogenously 
applied GSH. NB medium was spiked with 10pM GSH and allowed 
to incubate with astrocytes for up to 24 hours. Likewise, con med 
was spiked with 10pM GSH and allowed to incubate on its own for up 
to 24 hours. Fig 6.9 compares the GSH levels in spiked samples at 
6, 12 and 24 hours with unspiked samples. All data from unspiked 
samples were seen previously in either fig 6.6 or 6.7. There was no 
significant difference between spiked and unspiked samples of the 
same condition at any time point (p<0.05). The figure also shows
"  D NB
■  NB+GSH
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that by 24hours [GSH] in NB incubated with astrocytes reaches a 
similar level to con med (6.25±0.91 and 8.18±1.33|jM respectively, 
mean ± SEM, p<0.05). This confirms that exogenously applied GSH 
is not preserved and furthermore reiterates the point that astrocyte- 
derived GSH is preserved in con med.
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Fig 6.9 Astrocyte-mediated stability of GSH. Con med and astrocyte-exposed 
NB medium were spiked with GSH to a concentration of 10pM and were allowed to 
incubate for up to 24 hours. GSH level was determined at 6, 12 and 24 hours. 
Con med was spiked (Con+GSH) or unspiked (Con). NB medium in the presence 
of astrocytes was spiked (Astro+GSH) or unspiked (Astro). Data ± SEM, n=4, 
p<0.05.
S.4.3.2 GSH in recovery medium of OGD-subjected neurones
Having established that astrocytes release GSH in this system and 
furthermore that this GSH is preserved in con med, we now wish to 
investigate the possible role of released GSH in neuroprotection. We 
have subjected cortical neurone cultures to 0 2 glucose deprivation 
(OGD) for 15mins and allowed them to recover for up to 24hours in 
NB medium, in con med or in NB medium whilst in co-culture with 
astrocytes.
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First of all we want to determine if there is a correlation between 
GSH concentration in the extracellular environment and exposure to 
OGD. GSH concentration in the culture medium was measured at 6, 
12 and 24hours of recovery. Fig 6.10A shows that there is no 
significant difference between control and OGD levels at any time 
point measured. We have also used this figure to compare GSH 
levels in neuronal medium to the levels of GSH in NB on its own (first 
presented in fig 6.6). There is significantly greater GSH in the 
neuronal medium from both control and OGD groups at 6 hours of 
recovery.
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Fig 6.10 Extracellular GSH concentration following OGD. Cortical neurones 
were subjected to an OGD of 15mins and allowed to recover for 24hrs in NB 
medium only (A), in con med (B) or in astrocyte coculture (C). Control cultures are 
marked as (C) and OGD subjected cultures are marked as (OGD) in each panel. 
A) includes GSH in NB medium without neurones, B) includes GSH in con med 
without neurones C) includes GSH in NB medium of astrocytes without neurones. 
Data ± SEM, n=4, **’ marks significant difference, p<0.05.
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At 12 hours there is significantly more GSH in the control group only 
and at 24hours there is significantly more GSH in the OGD group 
only.
Fig 6.1 OB illustrates the data obtained when neurones were 
recovered in con med. It also includes GSH levels measured in con 
med without neurones, which was first presented in fig 6.7. It can be 
seen that there was no statistically significant difference in GSH 
levels between control and OGD groups at any time point. 
Furthermore there was no difference between con-med only and 
neuronal medium, from either control or OGD groups, at any time 
point.
Fig 6.10C illustrates the data obtained when neurones were 
recovered in co-culture with astrocytes. It also includes GSH levels 
measured in NB medium incubated with astrocytes only, which was 
first presented in fig 6.7. We have measured the GSH concentration 
in the medium at 6, 12 and 24 hours and compared them with the 
GSH levels found for astrocytes incubated on their own. OGD- 
exposed medium contained significantly more GSH at 6hours of 
recovery than either the control culture medium or the medium from 
astrocytes on their own. There was no statistically significant 
difference between any other groups at either 12 or 24 hours.
6.4.3.3 Intraneuronal GSH
The concentration of intraneuronal GSH was measured following 
recovery in the presence of astrocytes in order to determine if 
astrocytes influenced GSH level in neuronal cells that had been 
subjected to OGD-reoxygenation. Fig 6.11 shows the intraneuronal 
GSH concentration of neurones subjected to OGD and allowed to 
recover in NB medium only or in NB medium co-cultured with 
astrocytes, measured at 6, 12 and 24 hours of recovery. GSH 
concentration was also measured immediately at the end of the OGD 
period for control and OGD-subjected cultures. Therefore the Ohours
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GSH level of both the astrocyte and con med lines start in exactly the 
same place for control and OGD groups respectively.
There is significantly less GSH in neurones subjected to OGD than in 
control neurones, marked by ***’ on the graph, at 0 hours (12.47±1.43 
and 7.02±0.63 nmol/mg respectively, mean ± SEM, n=4). There was 
no significant difference between control and OGD groups of each 
condition (ie with and without astrocytes) at each time point. There 
was however significantly less GSH in OGD-subjected neurones 
recovering in NB medium only, than in OGD-subjected neurones 
recovering in the presence of astrocytes at 6, 12 and 24 hours of 
recovery. There was also significantly more GSH in control neurones 
recovering with astrocytes than without astrocytes at 24hours of 
recovery only.
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Fig 6.11 Intracellular neuronal GSH . Neurones were subjected to 15mins OGD 
and allowed to recover in the presence or absence of astrocytes. Neuronal GSH 
was measured and expressed as nmolGSH/mg protein. OGD-subjected neurones 
were recovered with astrocytes (OGDAst) or without astrocytes (OGD); control 
neurones were also recovered with astrocytes (CAst) or without astrocytes (C). 
Data ± SEM, n=4, marks significance between conditions, “ *’ marks significance 
within conditions, p<0.05.
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GSH levels dropped considerably and significantly over time in all 
conditions measured from the outset of the recovery period to 
24hours of recovery. There was a trend to an increase in GSH in all 
groups between 6 and 12hours of recovery however, this rise was 
only significant in OGD cultures recovering in NB only.
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6.4.3.4 Intracellular astrocyte GSH levels
The intracellular GSH level of astrocytes incubating on their own in 
NB medium and incubating in the presence of OGD-exposed and 
control neurones was determined in order to see if the presence of 
injured neurones influences astrocyte GSH turnover. Fig 6.12 shows 
that there is no significant difference in GSH levels of astrocytes 
incubated with control and OGD exposed neurones at 6 and 24hours 
of recovery but there is at 12hours of recovery. There is also a 
significant drop in GSH level of astrocytes incubated with neurones 
(C and OGD) at 24hours of recovery (Not indicated as significant on 
figure due to clutter). The GSH level of astrocytes incubating on 
their own did not change significantly over time from a level of 
34.5±0.9nmol/mg (mean ± SEM, n=4) at 6hours. This was 
significantly greater than the level in astrocytes incubated with 
neurones at 6 and 24 hours. The difference at 12hours was not 
statistically significant.
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Fig 6.12 Intracellular astrocyte GSH. Neurones were subjected to 15mins OGD 
and allowed to recover in the presence of astrocytes. Intracellular GSH of 
astrocytes co-cultured with control neurones (CAst) and OGD neurones (OGDAst) 
was measured at 6, 12 and 24hours of recovery. The intracellular GSH level of 
astrocytes incubating on their own for 24hours in NB medium was also determined 
(Astro). Data±SEM, n=4, marks significant difference, p<0.05.
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6.5 Discussion
In meeting the aims of this chapter we have begun to investigate the 
neuroprotective properties of astrocytes within the confines of the current 
model by looking at the behaviour of three separate molecules. Each is 
representative of one of the three lines of investigation stated in the 
opening paragraph of this chapter; glutamate, the neurotoxin to be 
removed; lactate, the metabolic substrate; glutathione, the protective 
antioxidant. To be absolutely clear, the aim of this chapter is not to 
conclusively determine if the use of these molecules can elicit 
neuroprotection per se but rather to determine if they elicit 
neuroprotection in our model. We want to know if the presence of 
astrocytes makes them available to, or in the case of glutamate, removes 
them from, neurones in this model specifically.
6.5.1 Removing a neurotoxin?
We have detailed quite clearly in chapter one, how glutamate acts as a 
neurotoxin. The sequence of events in ischaemia has so far been 
established to follow this order. Energy deprivation causes a drop in 
ATP, which stops the plasma membrane K+/Na+ pump from working. The 
increase in extracellular K+ causes the cells to depolarise, and the Na+ 
gradient is diminished. There is then no driving force for released 
glutamate to be pumped back in to the cell. The extracellular glutamate 
concentration increases and glutamate activates NMDA receptors 
(primed by the depolarisation), which causes further depolarisation and 
release of intracellular glutamate.
The accepted theory on glutamate release is that reversal of glutamate 
transporters, predominantly present on glia, cause the increase in 
extracellular glutamate (Rossi et al 2000, Phillis et al 2000). This 
increase is responsible for excitotoxic neuronal death during the 
ischaemic insult (Choi et al 1990). Glutamate release during reperfusion 
is less well characterised but it has been documented following brain 
ischaemia in vivo (Taguchi et al 1996, Yang et al 2001, Mori et al 2004).
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In agreement with these observations, we have shown that there is an 
increase in the concentration of glutamate with time in the NB medium of 
neurones recovering from OGD of 15mins compared to the concentration 
in NB medium of their sister control cultures. It can be assumed therefore 
that the increase in glutamate reflects a release event from the neurones 
themselves, as there are no other cell types present. All glutamate 
detected was released during the recovery period only as medium was 
changed immediately at the end of the 15min injury time.
It is fair to say that we were initially surprised to find that there was no 
difference in extracellular glutamate concentration between control and 
OGD-subjected cultures immediately following 15mins of OGD. But on 
reflection, it is probably too short a period for a significant difference to be 
observed in a system such as ours. Goldberg et al (1990) report that 
OGD of less than 30mins had no impact on extracellular glutamate 
concentration in cortical cultures. Marcoli et al (2004) show in their 
human cortical slice model that significant glutamate efflux occurs at 
18mins of OGD, returning to normal quickly upon reperfusion. Toner et al
(2001) show that glutamate efflux during OGD is significant only after 
15mins in their corticostriatal slice model.
An important point to note is that we culture our cells in a very large 
volume (2ml), which may dilute and hence make it difficult to measure the 
glutamate accumulated. It also means that glutamate could be lost to the 
bulk medium rather than staying at the level of the cell so there would be 
less glutamate in the immediate vicinity of the cell than there would be in 
vivo. Furthermore our measurements and indeed those of the groups 
mentioned, only give an average concentration in the whole solution, 
however it may be possible that glutamate at the level of the cell surface 
is in fact far more concentrated, and a gradient exists that slopes away 
from the cell. Jabaudon et al (2000) show that glutamate concentration 
does actually rise in their hippocampal slice model (chemical ischaemia) 
from around 650nM to 1pM in the vicinity of the crucial NMDA receptors, 
within 10mins.
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As we have shown, glutamate levels do rise significantly in the medium of 
OGD-subjected neurones throughout the recovery period and in chapter 
one we have discussed at length the abilities of glutamate to cause 
neurodegeneration in its capacity as an excitotoxin. Could the increase 
during recovery possibly perpetuate neuronal death or more specifically, 
is glutamate acting as a neurotoxin in our model?
It is common practice to model neuronal injury by an excitotoxic 
mechanism, through the addition of high concentrations of glutamate. 
The concentrations, which are normally used to induce cell death, are 
between 100 and 500pM (Machetti et al 2004, Nagy et al 2004, Sinor et 
al 2000). The figures we have reported for glutamate are underestimating 
the actual concentration that the cells are exposed to by 25pM, as there 
is 25pM glutamate in the B27 serum supplement. The way in which we 
have carried out the glutamate assay is responsible for this because we 
measure samples against their respective media and hence subtract the 
amount of glutamate added to the medium by the manufacturers. The 
maximum concentration of 25pM that we have observed at 24hours is far 
less than that necessary to induce significant death (at the level we 
observe at least) but so too is 50pM. Neither is there sufficient glutamate 
released during the OGD insult itself or at 6 or 12hours. However, as 
mentioned previously, the concentration of glutamate at the cell surface 
may be a lot higher. Also, the OGD insult itself may sensitise the 
neurones to much lower concentrations of glutamate. For the moment 
we can only link glutamate with cell death in a circumstantial manner, in a 
sense we are assuming its guilt before proving its innocence!
This brings us on to the principal aim of this section, to find out if the 
neuroprotection we observed is elicited by the removal of glutamate, a 
proven neurotoxin at least in other systems. We have shown that 
coculture with astrocytes significantly reduces the amount of glutamate in 
the recovery medium of not only OGD-subjected neurones but their sister 
controls as well. In fact, there is no difference between OGD-subjected 
and control cultures in the presence of astrocytes at any time point.
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There does appear to be a basal amount of glutamate release from 
astrocytes alone, however we did not factor this in to the co-culture data 
as we could not be certain that this release would stay the same in the 
presence of neurones. Directly comparing the data between co-culture 
and astrocytes alone, it would seem that glutamate from the astrocytes 
could account for some of that measured and so there may be even less 
attributable to the neurones.
At first glance it is tempting to suggest that astrocytes are mopping up the 
accumulated glutamate through a transporter activity, essentially 
removing the neurotoxin. Astrocyte cultures have been shown to express 
functional glutamate transporters on numerous occasions so this option is 
at least possible (Hansson 1985, Waniewski et al 1986, Gegelashvili et al 
1996, Perego et al 2000). However the presence of conditioned medium 
also reduces the amount of glutamate detected so removal seems less 
likely (we are not ruling this option out completely and will discuss it 
further in chapter 7). What is most striking about the data is that for the 
first 12 hours of recovery, there is no difference between the glutamate 
level in con med alone and in either the OGD-subjected or the control 
neuronal cultures recovering in con med. The glutamate levels of the 
OGD-subjected con med cultures become significantly greater than 
control values only at 24 hours of recovery, which is most likely a 
reflection of cell death. Therefore, we must conclude that nearly all the 
glutamate present has come from astrocytes. Have the astrocytes 
merely prevented neuronal glutamate accumulation in the first place?
It is interesting to note that there is always significantly more cell death in 
the OGD-subjected cultures than in the sister control cultures of every 
condition at all time points (see chapter 5). But this is not the case with 
glutamate accumulation as more often than not control and OGD values 
are the same when neurones are recovered in con med or co-culture. 
Shouldn’t more neuronal death in OGD-subjected cultures equate to 
more glutamate release, particularly as our method of cell death detection 
is largely based on membrane rupture as a marker of cell death? Perhaps
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it should in which case the following chain of logic emerges. Because the 
control cultures from each of the three conditions have the same amount 
of cell death it would appear that the glutamate detected in the cultures 
recovered in NB medium alone was released in a controlled manner and 
not released due to membrane lysis. So, because the neurone 
membranes of the cultures recovered in con med and co-culture are of a 
similar permeability to those recovered in NB medium alone it would 
appear that glutamate transport has stopped. Furthermore it has stopped 
due to the influence of astrocyte-derived factors.
The function of astrocyte-derived elements therefore may be to prevent 
the glutamate accumulation, not directly remove it. It would appear that 
in the absence of these elements early events in recovery cause the 
spiralling release of more glutamate, resulting in the death we observe for 
neurones recovering in NB alone.
So in answer to our question, yes, astrocytes remove a neurotoxin, but by 
preventing its accumulation in the first place. Precisely how glutamate 
accumulates and therefore where the astrocytes fit in, is a matter that we 
have begun to look in to. It is unclear if the rise in glutamate is the direct 
result of increased vesicular release or membrane lysis or if it is the result 
of transporter reversal or malfunction. Similarly, we have begun to 
address the role of glutamate in eliciting cell death in the absence of 
soluble astrocyte derived factors. These are issues we will address in the 
final chapter. For now, we will look further in to the putative 
neuroprotective factors.
6.5.2 Metabolic support
Our results suggest that lactate is produced by astrocytes at a steady rate 
and is stable for at least 24 hours as part of conditioned medium. So, 
there is an abundant supply of lactate ready for neuronal use. However, 
neither our control nor OGD-subjected neurones appear to use this 
lactate during the recovery period. This is most clearly illustrated by the 
fact that the lactate concentration in con med incubated with neurones
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does not differ from con med incubated alone over the entire 24 hour 
period. Clearly, usage by neurones would result in a reduction in lactate 
in con med as there are no astrocytes present to replace it. More 
pertinent to our aims is the fact that the OGD insult has placed no extra 
demands on lactate usage by neurones at least as far as we can tell from 
the unwavering con med lactate concentration.
For much of the recovery period in co-culture there are exactly the same 
trends in lactate concentration as there are for con med i.e. the 
concentrations at each time point are similar. Neurones are releasing a 
small amount of lactate but not enough to significantly alter the data when 
added on to the lactate values for co-culture. It is interesting however 
that at 24 hours of recovery there is less lactate in the medium of OGD- 
subjected neurones recovering in co-culture than there is in either its 
sister control or in the medium of astrocytes alone. This does suggest 
the possibility of neuronal lactate uptake and poses an intriguing 
question. Will the neurones only use lactate if it comes directly from 
astrocytes?
If they do, a number of scenarios are possible to resolve our co-culture 
data. First, neurones could have used lactate when it was most needed 
at the start of the recovery period but astrocytes have since continued to 
pump it out so that levels are even later on. Essentially by 6 hours the 
system has become balanced again. The reduction in OGD culture 
lactate at 24 hours may reflect a second period of intense use. Second, 
the astrocytes may actually be pumping out lactate more quickly when in 
co-culture with neurones, the neurones may be taking it up and using it 
leaving the concentration in the medium appearing the same as astrocyte 
medium alone. Waltz et al (1990) suggest that astrocytes do not 
accumulate lactate under increased production, they actually release it. 
This option certainly fits in with the evidence of a neuronal stimulation of 
astrocyte glucose uptake and glycolysis (Magistretti et al 1999).
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This discussion raises an issue we have hinted at in chapter 5 and which 
we will continue discussing in chapter 7. The co-culture of astrocytes and 
neurones allows for a two-way communication and therefore for neurones 
to stimulate astrocytes so that the mechanism of neuroprotection may 
actually be different between con med and co-culture.
Returning to the issue of preferential lactate use for just a moment, there 
is one small argument to follow through. There is a considerable amount 
of glucose in the recovery medium (as part of the NB medium formula) in 
the presence and absence of astrocytes, which would immediately 
prompt one to suggest that they do in fact have an abundant source of 
metabolic fuel so why use or need lactate? It has been shown that in the 
presence of glucose and lactate, cultured neurones appear to use lactate 
more (Tabernero et al 1996, Bouzier-Sore et al 2003). A possible 
consequence of the presence of lactate during recovery is that neurones 
could use their glucose through, for example, the pentose-phosphate 
pathway for the synthesis of NADPH. The consequence of this will be 
discussed later. For now, we have succeeded only in showing that 
lactate is available to be used but the question of whether it is used as a 
metabolic fuel remains open.
6.5.3 Antioxidant support
6.5.3.1 Preservation of released GSH
Our first step in elucidating a possible role of astrocyte-derived GSH in 
neuroprotection was to characterise any GSH release in this system with 
respect to quantity and stability. We have shown that our rat astrocyte 
cultures are indeed capable of releasing GSH in this system, which is in 
agreement with the published literature (Yudkoff et al 1990, Sagara et al 
1996, Dringen et al 1997, Stewart et al 2002, Hirrlinger et al 2002). Such 
release has been shown to be carrier mediated and is suggested to occur 
via the multidrug resistance protein 1 (Sagara et al 1996, Hirrlinger et al 
2002). It should be noted that it was not our intention to study GSH 
release per se, and so we did not use the ‘GSH-preservation friendly’ 
minimal medium preferred by Dringen et al (1997). We wanted to see if
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GSH could be released into, and be preserved by, NB medium, the 
medium used for all neuronal re-oxygenation experiments, as this more 
accurately reflects what would be available to neurones.
We have noted a rise in extracellular GSH concentration in the medium of 
astrocytes cultured alone to a level of 6.25±0.91pM by 24 hours. There 
was a very small amount of GSH detected in NB medium that remained 
constant over time. We can assume therefore that all GSH observed in 
the extracellular medium of astrocytes comes directly from the astrocytes 
themselves.
Our observations suggest that the rate of GSH accumulation is not 
constant over the entire 24hour period as there was no significant rise 
over the 6 hours period between 6 and 12 hours of incubation, the levels 
remaining at a plateau of around 1.2pM (median value). This suggests 
the possibility of a biphasic increase in GSH concentration. Although two 
distinct periods of increase are evidenced by our data, there is not 
sufficient data before 6 hours to establish where the first increase stops 
or whether the increases are linear or not. So how does our system of 
GSH release compare with others?
There is some discrepancy in the literature as to the rate and level of 
GSH release from astrocyte cultures. Yudkoff et al (1990) recorded a 
linear increase to a plateau value of around 3pM after 1 hour of 
incubation. Like Yudkoff et al, Sagara et al (1996) report a linear 
accumulation of GSH within the first hour of incubation to 1.9pM, however 
they do not report any later values and the existence of a plateau is not 
implied. Similarly, Stone et al (1999) also report a linear increase in GSH 
over an 8-hour period but to a level of 1,13pM. However this group later 
reports a linear increase to a maximum of 2.6pM at 4hours (Stewart et al 
2002). Dringen et al (1997) also report GSH increase to be entirely linear 
and in later work show an accumulation profile similar to ours over 24 
hours in co-culture medium (Dringen et al 1999). It would appear that the 
medium chosen might be behind this discrepancy. Yudkoff et al (1990)
206
Chapter 6
use a complicated mixture, Ham’s F-12 medium, composed of amino- 
acids, metal based salts and a host of potential GSH scavenging 
molecules
(http://www.cambrex.com/Content/Documents/Bioscience/Hams.pdf for 
formulation). In contrast Sagara et al use a simple phosphate buffer 
whilst the Stone, Stewart and Dringen systems use a simplified minimal 
medium, which is essentially a balanced salt solution with glucose added.
We have looked at GSH release on a much longer timescale than the 
works mentioned (with the exception of Dringen et al 1999) and have no 
data within the first 6 hours to compare directly. However, other elements 
remain the same and so comparison of release data is justified in trying to 
understand our system. It is important to realise however that GSH 
accumulation, such as we have documented, is not the same as GSH 
release. Our results show clearly that the accumulation of GSH is not 
entirely linear but that does not mean that release isn’t. There may well 
be factors in the medium that oxidise, scavenge or breakdown released 
GSH. In fact we have shown that exogenously applied GSH is lost from 
NB medium by 6 hours of incubation which proves the existence of 
medium-related GSH removal. With respect to medium complexity, our 
system would therefore appear to closely resemble that of Yudkoff et al. 
We report a value of around 1.2pM by the time of the plateau which is 
approximately half that observed by Yudkoff. This difference could be 
accounted for by the greater density of astrocytes (2x106 cells) in the 
Yudkoff preparation, as it is double the density we use.
But what about the increase in GSH after 12 hours? The most obvious 
explanation for this would be that there isn’t actually a plateau in GSH 
accumulation, there is just a very very slow increase up to 12 hours. By 
constantly pumping out GSH, and indeed other elements, the astrocytes 
are managing to overcome whatever factor it is that may be removing 
GSH in the period up to 6 and 12 hours. It is likely then that the more 
GSH is released at this point, the further the redox balance is swung in 
favour of an antioxidant environment and so there may actually be an
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exponential accumulation of GSH. The inclusion of extra data points 
would test this idea and would allow for a rate to be calculated, however it 
is not entirely relevant to the main questions being asked by this chapter.
We did however attempt to measure total GSH in the medium (GSSG 
plus GSH) by converting GSSG to GSH by the method of Anderson et al 
(1985) in an effort to tackle the question of GSH disappearance. 
However we could not get the assay to work with NB medium, which is 
probably further proof of its GSH scavenging abilities! Hirrlinger et al
(2002) and Stone et al (1999) both show that only GSH is released from 
astrocytes, not GSSG. This point is particularly relevant to neuronal 
survival because it means there may be more GSH immediately available 
to neurones than we can see.
Of particular relevance at this juncture is the fact that only GSH that is 
released by astrocytes is preserved, at least partly, in NB medium. We 
have shown that astrocyte-conditioned medium retains its GSH 
concentration when incubating alone for 24 hours. More importantly, we 
have further shown that exogenous GSH is lost from the system by 6 
hours of incubation, not only from NB medium but also from con med and 
from NB medium incubating with astrocytes.
Stewart et al (2002) have shown that astrocytes release a factor, which 
they identify as superoxide dismutase, concomitant with GSH release that 
slows down its oxidation. Such a process may be happening here. The 
released factor may only be able to cope with the protection of just the 
amount of GSH released by the astrocyte. Any excess GSH is not 
protected and immediately lost. Stewart et al do show some protection of 
exogenous GSH. The oxidation of the applied GSH was merely slowed 
in con med compared to native medium so that over a 5 hour period there 
was a significant drop in GSH. Extracting this data and comparing it to 
ours, the results observed by us at 6hours of incubation are quite 
comparable to the results obtained by the Stewart model at 5hours. 
Nevertheless, we were surprised to see how well GSH was preserved in
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con med over the 24 hour incubation (following the 24 hour conditioning 
period) and can only conclude that all potential GSH sinks had been 
completely overwhelmed over the course of the 24 hour conditioning 
period.
We have shown that the intracellular GSH concentration of astrocytes in 
this system is around 35nmol.mg protein-1. This level does not change 
appreciably over the 24hour incubation period when extracellular GSH is 
increasing in NB medium. Our astrocytes are incubating in ‘normal’ 
medium, replete with sufficient GSH precursors to replace lost GSH over 
the 24 hour period so the result is not surprising. Sagara et al (1996) 
report a higher initial level of intra-astrocyte GSH but also show no 
reduction in level over the course of their 1-hour release experiment.
Juurlink et al (1996) claim that there is no GSH release from astrocytes 
under normal conditions and in fact state that any release in their system 
is due to cell death and subsequent membrane rupture. This is unlikely in 
our system as a) morphological analysis shows the astrocytes to be 
healthy b) there is no significant membrane rupture (deduced from results 
in chapter 4) and c) release of GSH does not result in intracellular 
decline.
6.5.3.2 GSH loss may perpetuate neurone death
We have measured GSH in the recovery medium of control and OGD 
subjected neurones and compared this with the basal levels found in NB 
medium. We did find a greater amount in the neuronal medium of both 
control and OGD-subjected cultures particularly at 6 hours of recovery 
and so must conclude that neurones are also releasing some GSH. 
Hirrlinger et al (2002) detected GSH release from their neuronal cultures 
but conclude that it was due to glial contamination and damage to 
neuronal membranes. Although we do not have a significant glial 
presence in our neuronal cultures (see chapter 3), we have shown that 
there is damage to both control and OGD-subjected cultures (see chapter 
3). Compounding this is the fact that we did not see the steady rise in
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extracellular GSH evident in astrocyte cultures and a significant 
difference from NB medium alone was not consistent over time. The 
evidence so far suggests therefore that release is passive and due to 
slight membrane rupture. The most important part of these data however 
is that there was no difference in release between control and OGD- 
exposed cells, despite significantly more death occurring in the OGD 
cultures. This is reflected also in the values obtained for intracellular 
GSH.
There was significantly more intracellular GSH in control neurones than 
there was in OGD-subjected neurones immediately following the15mins 
OGD period. However both conditions resulted in severe GSH loss as 
the reoxygenation period continued, so much so that there was no 
difference in GSH level between the two conditions throughout recovery, 
again, despite greater cell death in the OGD cultures. Looking at the 0- 
hours time point only, we have shown in chapter 4 that there is no 
significant difference in cell death between control and test cultures. As 
our cell death method is based mostly on membrane permeability, the 
reduction in GSH is unlikely to be due to leakage as a result of membrane 
rupture. It is more probable that OGD-subjected cells have used their 
endogenous GSH in an intracellular defensive effort.
Looking at the recovery period, it is curious that control cultures exhibit far 
less cell death yet they have an equivalent amount of GSH. How do we 
reconcile these data? It is possible that there is a significant amount of 
release of both GSH and intracellular protein from OGD-subjected 
cultures so that they would appear to have the same specific 
concentration as the control cultures. We have shown that OGD- 
subjected neurones have a more permeable membrane than control 
neurones so this is quite a plausible explanation (see chapter 4, cell 
death data). This should however result in GSH accumulation in the 
medium, which we don’t see. We have already shown in section 6.5.3.1 
that NB medium rapidly degrades GSH so it is possible that any GSH 
released by neurones, due to cell death or otherwise, cannot be
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registered by us. Again, we did try to determine if GSH was being 
oxidised but interference with the assay prevented this.
Stewart et al (2002) report that neurones release GSH and a GSH 
protective element, in the same manner as astrocytes, which makes it 
unlikely that released GSH was significantly degraded. Instead we favour 
the possibility that the intracellular demand on neuronal GSH in our 
system attenuates any release. Retained GSH is oxidised by the cell 
itself, as concluded previously.
We do see cell death in the control cultures and we have shown that they 
have a certain amount of membrane leakiness. The very fact that cell 
death is seen in the controls at all is a sign that just placing the neurones 
in the Dulbecco’s modified eagle’s medium (DMEM) for 15mins is 
stressful (see chapter 3) and so the controls are also open to ‘reperfusion 
injury’. The origin of this stress may actually be GSH related. DMEM 
does not contain cysteine, which is necessary for GSH synthesis and this 
may affect cell physiology. This is in fact the principal reason why all 
experiments are carried out with careful consideration of control 
conditions to match all aspects of the injury except metabolic substrate 
withdrawal.
The higher GSH level in the controls at TO could explain why they suffer 
less cell death during recovery with an equivalent amount of GSH. 
Although they lose GSH during the recovery period they may have had it 
when they most needed it, at the start of recovery. Without intending to 
labour the point, the higher level of GSH in the controls at the start of 
reoxygenation, would appear to make them better able to cope with the 
stress. This leads us directly on to a possibility first suggested by the 
glutamate data.
Is the fight against cell death fought entirely at the start of the 
reoxygenation period? The evidence suggests it is. We have 
hypothesised that glutamate release, as a consequence of stress in early
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recovery, begets further glutamate release and cell death. Astrocyte- 
derived factors attenuate early stress and stop the cycle before it 
continues. At this point we can only assume that our cultures are losing 
their intracellular GSH as a result of fighting oxidative stress immediately 
after OGD so can we fit astrocytes in to this picture?
6.5.3.3 Astrocytes to the rescue
We have shown in chapters 4 and 5 that neurone cultures subjected to 
15mins OGD die in a steady progressive manner over a 24-hour 
reoxygenation period. However the presence of astrocytes and 
astrocyte-conditioned medium significantly reduce the amount of death 
observed. We have proven that GSH is released from astrocytes and is 
preserved well in the form of conditioned medium. So the crucial question 
is could GSH release by astrocytes play a role in this neuroprotection?
Based on observations in the literature we wanted to test two hypotheses 
with respect to a link between astrocyte-released GSH and 
neuroprotection in our system of OGD-reoxygenation. First, it is used to 
scavenge extracellular radicals and thus reduce attack on neurones. 
Second it is used as a substrate for increasing neuronal GSH.
There was no difference in GSH concentration in the medium of control 
and OGD-subjected neurones recovering in con med. Furthermore, at no 
time point was there a significant reduction in GSH when compared with 
con med alone. Initially, much the same picture is seen when neurones 
are co-cultured with astrocytes. There is no difference between either the 
GSH levels in co-cultured control or OGD-subjected populations and the 
levels in astrocytes incubating alone in NB medium for most of the 
recovery period. However, at 6 hours of recovery there is more GSH in 
the OGD-subjected culture medium than either of the other two cultures.
We will start with the first hypothesis. All things being equal, one would 
expect there to be more GSH in the medium of control and OGD co­
cultures than in the astrocyte cultures alone if passive neuronal release,
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shown earlier in section 6.5.5 is factored in (indeed, the same is also true 
of con med). This is possibly what has happened in the OGD cultures at 
6 hours. GSH concentration is 1.829±0.16pM, which is roughly equivalent 
to the addition of 1.04±0.08pM in the astrocyte medium, and 
0.98±0.05pM in the OGD-subjected cultures recovering in NB medium 
only. So why is this the only point of significant difference?
We have accepted in section 6.5.5 that, to a certain extent, both control 
and OGD-subjected cultures are stressed. Astrocyte-derived factors may 
therefore be used to the same extent in both sister cultures during the 
recovery period explaining why GSH values are the same at each time 
point. We will continue with this in mind for the time being. It may very 
well be that ‘extra’ GSH has actually been used to rid the medium of 
radical species but as it has been used, we can’t detect it. Again, this 
would explain why there is no difference between control and OGD 
values and astrocyte cultures. However, if radical scavenging were 
occurring, one would expect there to be less GSH in the con med over 
time. Indeed, as we know OGD-subjected neurones are more stressed 
than controls (as judged by cell death, chapter 5) even in co-culture and 
in con med, we would expect them to have even less GSH in their con 
med than controls. This is in fact the same argument we made with 
lactate. Our first hypothesis therefore seems unlikely to be true unless of 
course, as we have mentioned in the discussion on lactate, the online 
release of GSH from astrocytes themselves changes the way the system 
behaves. And our second?
The presence of astrocytes significantly increased neurone GSH levels in 
both control and OGD-subjected cells when compared with their 
counterparts recovering in NB medium only. This agrees with previous 
studies showing that co-culture with astrocytes results in increased 
neuronal GSH (Yudkoff et al 1990, Sagara et al 1993, Dringen et al 1999, 
Wang et al 2000). We should make the point here again that the 
increased GSH is not due to retention by the neurones as a consequence 
of reduced cell death and membrane permeability as we have already
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shown that there is no difference in cell death particularly between control 
neurones recovering in NB medium only and control neurones recovering 
in either con med or co-culture (see chapter 5). The neurones appear to 
have actually synthesised GSH. Is the astrocyte-released GSH itself 
causing the increase in GSH or is there another factor involved?
Neuronal usage of astrocyte-derived GSH requires that it be broken down 
extracellularly before acting as a precursor for neuronal GSH synthesis. 
Dringen et al (1999) show that breakdown is mediated by the astrocyte 
ectoenzyme y-glutamyl-transpeptidase, which cleaves GSH to produce 
Cys-Gly, which is then taken up and used by the neurones. Wang et al 
(2000) show that the astrocyte-derived GSH is actually used to reduce 
cystine to cysteine, which the neurones then use for GSH synthesis. 
Previously, because we did not see a reduction in GSH in con med of 
neurones compared with con med alone, we had weakened the 
hypothesis that GSH acts as an extracellular scavenger. The same 
argument also applies to the breakdown of GSH for the provision of 
neuronal precursors. On the other side of the coin, Iwata-lchikawaw et al
(1999) elegantly show that neurones incubated in glial conditioned 
medium upregulate the transcription of y-glutamylcysteine synthase (the 
rate limiting enzyme in GSH synthesis) when confronted with an oxidative 
insult. The only problem with this option is the length of time it would take 
for a transcription event to translate to increased GSH within the cell. 
We are assuming in this model that the neuroprotective factor(s) must 
exert its effects at the very beginning of recovery which may not give 
enough time for a growth/survival factor to elicit its effects.
One of the key points that has emerged in this chapter is whether the 
presence of injured neurones stimulates astrocytes in to action. It would 
seem that neuronal injury has no effect on the GSH response but the very 
presence of neurones, injured or otherwise, does. We have shown that 
the intra-astrocyte GSH level does actually change when neurones are 
present. At both 6 and 24 hours of recovery, there is significantly less 
GSH in astrocytes co-cultured with neurones than there is in astrocytes
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incubating in NB medium alone. There is in fact a massive drop in GSH 
level between the 12 and 24-hour period. What’s going on?
One possibility is that astrocytes are becoming stressed in the presence 
of the neurones and so are using up their own GSH in defence. 
However, we showed in chapter 5 that they exhibit no sign of injury that 
we could detect. Another option is that the astrocytes are releasing their 
GSH more quickly than it can be synthesised particularly at 24 hours. 
Our data shows that there is no extra accumulation but this may be due 
to significant scavenging activities or indeed extra GSH breakdown. 
Alternatively, the presence of neurones has caused a reduction in GSH 
synthesis itself. This is a matter we will explore in chapter 7.
6.5.4 Bringing it all together
Putting all our data together the following scenario seems most likely. 
The OGD insult somehow causes a reduction in intraneuronal GSH. The 
introduction of O2 at the start of recovery further stresses the neurone 
whose GSH is already too low to cope. This results in an accumulation of 
glutamate and the excitotoxic release of further glutamate and cell death. 
Astrocyte-derived factors stimulate an increase in neuronal GSH, which 
attenuates significant oxidative stress at the beginning of recovery and 
the subsequent mass release of glutamate and cell death.
We are suggesting that cell death during recovery is directly related to an 
inability to replace GSH during the OGD event. During the 15mins 
incubation the neurones do not have access to cysteine as DMEM 
contains cystine not cysteine. OGD-subjected cultures therefore cannot 
synthesise GSH they are using as a direct result of the insult, nor can 
they recycle GSH due to lack of glucose derived NADPH, which reduces 
the GSH available and accelerates its loss. No such burden is placed on 
the control cells, the stress they are exposed to is clearly much milder as 
they at least have energy substrates.
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We can fit lactate in to this story by recalling that, using lactate as a fuel 
rather than glucose, allows glucose to be used for other pathways. In this 
instance, perhaps glucose can be used to generate NADPH via the 
pentose phosphate pathway, which is then used to regenerate GSH. 
This is certainly faster than the protein synthesis mentioned previously. 
Delgado-Esteban et al (2000) have actually shown that neurones are 
capable of attenuating glutamate-induced injury by using exogenously 
applied glucose for the regeneration of GSH. Of course lactate only has 
a place here if astrocytes are present themselves. We will continue this 
story in the next chapter.
6.6 Conclusions
We have tested the three hypotheses stated in the aim of this chapter 
and have arrived at a possible mechanism for neuronal death following 
0 2 /glucose deprivation. Our data has opened up avenues of thinking, 
which was the main intention, rather than present any conclusive data. 
Furthermore we have hinted at the fact that a) other factors of 
neuroprotection are involved and b) the mechanism of neuroprotection 
may differ between conditioned medium and astrocyte co-culture.
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Chapter 7 
‘Where do we go from here?’
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7.1 Summary
Chapters 3 and 4 were entirely focussed on creating a working model of 
ischaemia/reperfusion injury. In chapter 3 we set out to build a robust 
model of ischaemia in a tissue culture environment. This chapter 
produced a method for the culture of almost pure cortical neurones, a 
novel approach to co-culturing these neurones with cortical astrocytes 
and finally a simple method for the simulation of ischaemia. In chapter 4 
we built on this foundation to arrive at a protocol for the induction of 
‘reperfusion’ injury in cortical neurones. Essentially, we set out to create 
a model that would result in neuronal death during the recovery phase 
that had a relatively linear rate profile.
Having finally arrived at our model in chapter 4, we set out to apply it by 
testing the hypothesis in chapter 5, that astrocytes can attenuate 
neuronal death. As expected, astrocytes proved to be neuroprotective, 
as did astrocyte-conditioned medium. This begged the question as to 
how this was possible and so in chapter 6 we proposed a number of likely 
mechanisms based on our observations.
In this chapter we will detail possible avenues of future research directly 
related to the work in chapter 6. This includes points of notice that 
surfaced repeatedly in chapter 6 and preliminary data on the role of 
glutamate in our model system.
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7.2 Points to consider
7.2.1 Co-culture V conditioned medium
In chapter 6 we tended to use the data gained from the conditioned 
medium experiments to prove or disprove astrocyte involvement directly. 
However as alluded to previously, the mechanisms of neuroprotection 
afforded by con med and astrocyte co-culture may be quite different. 
This is probable because of the ability of neurones to directly influence 
astrocyte physiology. Although we could not prove it conclusively, 
neurones do stimulate astrocyte activity. This is of particular relevance to 
the clearance of glutamate.
The astrocyte glutamate transporters GLAST and GLT-1 are credited 
most heavily with maintaining extracellular glutamate levels within 
physiological norms. Both glutamate directly and neurone-derived factors 
have been shown to alter astrocyte transporter expression (Gegelashvili 
et al 1996 and 1997). In fact Swanson et al (1997) demonstrated that 
astrocytes in co-culture with neurones express both GLAST and GLT-1 
whereas astrocytes in mono-culture express GLAST only. Further to this 
Perego et al (2000) showed that the neuronal soluble factors responsible 
were released by neurones in an activity dependent manner. Clearly, 
glutamate (and other factors) released from neurones can directly modify 
astrocytes to alter the neuronal environment. This is not a possibility in 
conditioned medium. The consequences of not having astrocytes present 
may be more exaggerated than they first seem.
Consider that neurones release factors to astrocytes, which release 
factors to neurones, which then release further factors to astrocytes. For 
example, we have just mentioned how astrocyte glutamate transport 
depends on neuronal activity. The opposite is also true, astrocytes effect 
neuronal glutamate transporter expression (Canolle et al 2004). It is not 
difficult to picture a scenario whereby the signals are volleyed back and 
forth, each time the cells are adjusting to the message until an acceptable 
level of activity is reached for both cell types to function happily.
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We have given a number of reasons in chapter 6 as to why we may not 
have seen a difference between OGD-subjected and control neurones 
with respect to lactate and GSH in the presence of astrocytes. These are 
quite valid if conditioned medium and astrocytes do ultimately differ in 
their mechanisms of neuroprotection.
7.2.2 Future direction
We have made the point on a number of occasions in chapter 6 that the 
events leading to neuronal death are likely to occur in the early part of 
reperfusion. We have also said that as a consequence, at least in co­
culture, the levels of lactate and GSH may be quite different to controls in 
the OGD-exposed cultures at this point. The most obvious way to 
determine the accuracy of this assumption would therefore be to focus on 
time-points before the 6-hour recovery point and specifically within the 
first hour. This may also as a consequence differentiate between 
conditioned medium and co-culture.
It would be of great interest to determine exactly what mechanism is 
behind this early dysfunction. We have postulated that oxidative stress is 
a likely perpetrator of early damage. So, obviously we need to determine 
if the cultures are indeed exposed to an oxidative stress. This would in 
part clarify the matter of glutamate accumulation and glutamate-related 
cell death. It would also place the proposal of GSH as a neuroprotectant 
in a more reasonable context.
We have questioned the ability of neurones to use the lactate available to 
them and have suggested that the actual presence of astrocytes may be 
a determinant. There is no doubt that neurones can and do use lactate in 
other culture systems and so we should consider why we do not see this 
in ours. It is possible that lactate usage (and indeed GSH usage for that 
matter) occurs within a concentration band that is hidden by the error in 
our experimental design. A more sensitive method of neurone 
metabolism, such as carbon labelling, should therefore be considered. 
Furthermore, we have also made the point that neurones may demand
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lactate and GSH from astrocytes, encouraging a systems upregulation 
similar to glutamate transport. This could be tested simply by placing 
neurone conditioned medium ie medium that has been sitting on OGD- 
exposed neurones for at least one hour, on astrocytes and then 
measuring the release of molecules such as lactate and GSH.
The work in chapter 6 has generated a lot of ifs and maybes, most of 
which we have not been able to follow up. We suggest that the most 
immediate question to be answered is that of the function of 
glutamate/glutamate toxicity in this instance. To this end, the following 
section builds a case in support of this proposition.
7.3 Suggestion for glutamate experiments
In chapter 6 we suggested that glutamate accumulation during 
reoxygenation following O2 glucose deprivation (OGD) of 15mins was 
responsible for neuronal death during the recovery period. In this section 
we will outline work being carried out whereby this hypothesis can be 
tested. Quite apart from the obvious pattern in our data of accumulating 
glutamate with increasing cell death, we speculate that glutamate is 
perpetuating death as a result of its track record as a potent neurotoxin.
The neurotoxic actions of glutamate are mediated through over activation 
of cell surface receptors (described in chapter 1) and so these have 
become targets for the prevention of neuronal death. The NMDA 
receptor has been well documented as contributing to neuronal damage 
following ischaemia largely due to the neuroprotection afforded by its 
competitive antagonist MK801 both in vivo (Gerriets et al 2003, Gorgulu 
et al 2000, Li et al 1999) and in vitro (Finley et al 2004, Velly et al 2003, 
Gerlach et al 2002). More recently, the metabotropic glutamate receptors 
have gained attention in the precipitation of neurodegeneration 
particularly the group I member mGluRI (Bruno et al 2001). The mGlul 
subtype has been shown to be involved in post ischaemic neuronal death 
both in vivo and in vitro (Meli et al 2002) as judged by the neuroprotection
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afforded by inhibitor, 1-aminoindan-1,5-dicarboxylic acid (AIDA). 2- 
Methyl-6-(phenylethynyl)-pyridine (MPEP) an inhibitor of the other group 
1 member, mGluR5, has been attributed with neuroprotective activities 
but this is thought to be a consequence of cross reaction with NMDA 
receptors at high concentrations (Pellegrini-Giampietro 2003).
We have also hypothesised in chapter 6 that an early event of 
reoxygenation is the release of glutamate. We further speculated that the 
early release was carrier mediated, leading to later release as a result of 
combined membrane rupture and a carrier mediated event. There are a 
few different ways of looking at the observed glutamate accumulation; 
transporter malfunction leads to decreased uptake or reversal of 
transporter leads to increased release; release may also be vesicular. 
Although a rise in extracellular glutamate has been recorded during 
reperfusion (Erecinska et al 1984, Molchanova et al 2004,Taguchi et al 
1996, Yang et al 2001, Mori et al 2004) there is sparse evidence to 
explain it. During the actual ischaemic event a sequential occurrence of 
different mechanisms has been observed. Asai et al (2000) present 
evidence that an early increase in extracellular glutamate is due to 
vesicular release, whilst a late phase is due to reversal of the Na+ 
dependent transporter. Jabaudon et al (2000) show that uptake inhibition 
is also an early event and add to an already convincing body of data that 
later accumulation is due to transporter reversal.
We have suggested that an oxidative stress at the beginning of 
reperfusion is responsible for dysregulation of glutamate homeostasis. 
This is supported by Tretter et al (2002) who provide evidence that the 
Na+ loading observed during ischaemia followed by the oxidative stress at 
the start of reperfusion determines the extent of glutamate release during 
reperfusion. This would suggest a role for the dysregulation of Na+ 
glutamate transporters. Glutamate transporters have been shown to be 
vulnerable to oxidative stress and therefore allow an extracellular 
accumulation of glutamate (Trotti et al 1998).
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It would be our intention therefore to explore the possibilities of vesicular 
release using botulinum toxin (an inhibitor of exocytosis) and transporter 
involvement using DL-ffrreo-p-benzyloxyaspartate (TBOA), which inhibits 
all classes of glutamate transporters mentioned in section 1.2.2. We 
would also try to correlate the prevention of glutamate accumulation with 
an attenuation of cell death. This directly tests our hypothesis that early 
glutamate release stimulates further release and cell death. Finally as a 
further test of this hypothesis, we would attempt to inhibit glutamate 
receptor mediated damage through the inhibition of the NMDA receptor 
and the mGluRI receptor.
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7.4 Conclusion
The current thesis has largely been designed to establish a reproducible 
model of ischaemia within a tissue culture environment such that 
astrocyte-neuronal cross talk could be explored. We have successfully 
met this aim and have laid the foundations for an investigation into the 
specific elements important to astrocyte-communication following an 
ischaemic insult.
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